The table below lists the options of the executed module.
Option | Value |
---|---|
analyze.sites | yes |
differential.report.sites | yes |
region.types | promoters |
differential.permutations | 0 |
differential.comparison.columns | Age Group |
differential.comparison.columns.all.pairwise | default |
columns.pairing | default |
differential.site.test.method | limma |
differential.variability | yes |
differential.variability.method | diffVar |
covariate.adjustment.columns | Genome-wide methylation, Gender |
differential.adjustment.sva | yes |
differential.adjustment.celltype | yes |
differential.enrichment.go | yes |
differential.enrichment.lola | no |
differential.enrichment.lola.dbs | ${LOLACore} |
Differential methylation analysis was conducted on site and region level according to the sample groups specified in the analysis.
The following comparisons were made:
The table below summarizes information on the comparisons.
comparison | adjustment | covariateTable | |
1 | young vs. senior (based on Age Group) | Genome-wide methylation,Gender,ct_1,ct_2,ct_3,ct_4,ct_5,ct_6 | csv |
In the following anlyses, p-values on the site level were computed using the limma
method. I.e. hierarchical linear models from the limma package were employed and fitted using an empirical Bayes approach on derived M-values.
Differential methylation on the site level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each site: a) the difference in mean methylation levels of the two groups being compared, b) the quotient in mean methylation and c) a statistical test (limma or t-test depending on the settings) assessing whether the methylation values in the two groups originate from distinct distributions. Additionally each site was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) rank among the three ranks. The smaller the combined rank for a site, the more evidence for differential methylation it exhibits. This section includes scatterplots of the site group means as well as volcano plots of each pairwise comparison colored according to the combined ranks or p-values of a given site.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated sites:
Rank Cutoff | |
young vs. senior (based on Age Group) | 59023 |
comparison | |
differential methylation measure |
Scatterplot for differential methylation (sites). If the selected criterion is not rankGradient
:
The transparency corresponds to point density. If the number of points exceeds 2e+06 then the number of points for density estimation is reduced to that number by random sampling.The1% of the points in the sparsest populated plot regions are drawn explicitly (up to a maximum of 10000 points).Additionally, the colored points represent differentially methylated sites (according to the selected criterion).
If the selected criterion is rankGradient
: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
comparison | |
difference metric | |
significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the site level for the individual comparisons are provided in this section. Below, a brief explanation of the different columns can be found:
The tables for the individual comparisons can be found here:
Differentially variable sites were computed with diffVar
. For more information about the method, have a look at the missMethyl Bioconductor package.[1] This section contains plots and tables describing the results of this test and further analyses of the sites that were selected as differentially variable. Please note that missing methylation values have been imputed with knn.
The following rank cutoffs have been automatically selected for the analysis of differentially variable sites:
Rank Cutoff | |
young vs. senior (based on Age Group) | 22582 |
comparison | |
differential variability measure |
Scatterplot for differential variable sites. The transparency corresponds to point density. If the number of points exceeds 2e+06 then the number of points for density estimation is reduced to that number by random sampling. The1% of the points in the sparsest populated plot regions are drawn explicitly (up to a maximum of 10000 points). Additionally, the colored points represent differentially variable sites (according to the selected criterion).
Differential methylation on the region level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each region: the mean difference in means across all sites in a region of the two groups being compared and the mean of quotients in mean methylation as well as a combined p-value calculated from all site p-values in the region [2]. Additionally each region was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) value among the three ranks. The smaller the combined rank for a region, the more evidence for differential methylation it exhibits. Regions were defined based on the region types specified in the analysis. This section includes scatterplots of the region group means as well as volcano plots of each pairwise comparison colored according to the combined rank of a given region.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated regions:
promoters | |
young vs. senior (based on Age Group) | 996 |
comparison | |
regions | |
differential methylation measure |
Scatterplot for differential methylation (regions). If the selected criterion is not rankGradient
:
The transparency corresponds to point density. The 1% of the points in the sparsest populated plot regions are drawn explicitly.
Additionally, the colored points represent differentially methylated regions (according to the selected criterion).
If the selected criterion is rankGradient
: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
comparison | |
regions | |
difference metric | |
significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the region level for the individual comparisons are provided in this section.
The tables for the individual comparisons can be found here:
promoters | |
young vs. senior (based on Age Group) | csv |
Differential variability on the region level was computed similar to differential methylation, but the mean of variances, the log-ratio of the quotient of variances as well as the p-values from the differentiality test were employed. Ranking was performed in line with the ranking of differential methylation.
The following rank cutoffs have been automatically selected for the analysis of differentially variable regions:
promoters | |
young vs. senior (based on Age Group) | 2340 |
comparison | |
regions | |
differential variability measure |
Scatterplot for differential variable regions. The transparency corresponds to point density. The 1% of the points in the sparsest populated plot regions are drawn explicitly. Additionally, the colored points represent differentially methylated regions (according to the selected criterion).
comparison | |
regions | |
difference metric | |
significance metric |
Volcano plot for differential variability quantified by various metrics. Color scale according to combined ranking.
comparison | |
regions | |
rankCutoff |
Scatterplot comparing differentially methylated (DMRs) and variable regions (DVRs), as well as regions that are both differentially methylated and variable. The dotted lines corrspond to the respective rank cutoffs used to call a region differentially methylated/variable.
GO Enrichment Analysis was conducted. The wordclouds and tables below contains significant GO terms as determined by a hypergeometric test.
comparison | |
Hypermethylation/hypomethylation | |
ontology | |
regions | |
differential methylation measure |
Wordclouds for GO enrichment terms.
comparison | |
Hypermethylation/hypomethylation | |
ontology | |
regions | |
differential methylation measure |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0021520 | 0 | 81.7418 | 0.0501 | 3 | 13 | spinal cord motor neuron cell fate specification |
GO:0060913 | 0 | 535.5357 | 0.0116 | 2 | 3 | cardiac cell fate determination |
GO:0001708 | 3e-04 | 14.5419 | 0.3082 | 4 | 80 | cell fate specification |
GO:0021953 | 3e-04 | 9.1522 | 0.6087 | 5 | 158 | central nervous system neuron differentiation |
GO:0021517 | 6e-04 | 20.9189 | 0.1618 | 3 | 42 | ventral spinal cord development |
GO:0021903 | 6e-04 | 66.9107 | 0.0385 | 2 | 10 | rostrocaudal neural tube patterning |
GO:0007389 | 8e-04 | 5.1676 | 1.5219 | 7 | 395 | pattern specification process |
GO:0048699 | 9e-04 | 3.1439 | 4.9123 | 13 | 1275 | generation of neurons |
GO:0021515 | 9e-04 | 17.3489 | 0.1926 | 3 | 50 | cell differentiation in spinal cord |
GO:0010454 | 9e-04 | 53.5214 | 0.0462 | 2 | 12 | negative regulation of cell fate commitment |
GO:0048935 | 9e-04 | 53.5214 | 0.0462 | 2 | 12 | peripheral nervous system neuron development |
GO:0007411 | 0.0013 | 6.8067 | 0.8091 | 5 | 210 | axon guidance |
GO:0060850 | 0.0017 | 38.2194 | 0.0616 | 2 | 16 | regulation of transcription involved in cell fate commitment |
GO:0014031 | 0.0017 | 13.8092 | 0.2389 | 3 | 62 | mesenchymal cell development |
GO:0048864 | 0.0017 | 13.8092 | 0.2389 | 3 | 62 | stem cell development |
GO:0014033 | 0.002 | 13.1384 | 0.2504 | 3 | 65 | neural crest cell differentiation |
GO:0007130 | 0.0021 | 33.4375 | 0.0694 | 2 | 18 | synaptonemal complex assembly |
GO:0048663 | 0.0023 | 12.5295 | 0.262 | 3 | 68 | neuron fate commitment |
GO:0007420 | 0.0023 | 3.8059 | 2.3618 | 8 | 613 | brain development |
GO:0051961 | 0.0025 | 5.7759 | 0.9478 | 5 | 246 | negative regulation of nervous system development |
GO:0003151 | 0.0027 | 11.8 | 0.2774 | 3 | 72 | outflow tract morphogenesis |
GO:0008344 | 0.0029 | 11.4661 | 0.2851 | 3 | 74 | adult locomotory behavior |
GO:0007141 | 0.0029 | 28.1523 | 0.0809 | 2 | 21 | male meiosis I |
GO:0035640 | 0.0032 | 26.7429 | 0.0848 | 2 | 22 | exploration behavior |
GO:0010721 | 0.0034 | 5.3891 | 1.0133 | 5 | 263 | negative regulation of cell development |
GO:0060914 | 0.0035 | 25.4677 | 0.0886 | 2 | 23 | heart formation |
GO:0048562 | 0.0038 | 5.2442 | 1.0403 | 5 | 270 | embryonic organ morphogenesis |
GO:0003142 | 0.0039 | Inf | 0.0039 | 1 | 1 | cardiogenic plate morphogenesis |
GO:0021568 | 0.0039 | Inf | 0.0039 | 1 | 1 | rhombomere 2 development |
GO:0042404 | 0.0039 | Inf | 0.0039 | 1 | 1 | thyroid hormone catabolic process |
GO:0060807 | 0.0039 | Inf | 0.0039 | 1 | 1 | regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification |
GO:0071329 | 0.0039 | Inf | 0.0039 | 1 | 1 | cellular response to sucrose stimulus |
GO:1904425 | 0.0039 | Inf | 0.0039 | 1 | 1 | negative regulation of GTP binding |
GO:1904530 | 0.0039 | Inf | 0.0039 | 1 | 1 | negative regulation of actin filament binding |
GO:1904708 | 0.0039 | Inf | 0.0039 | 1 | 1 | regulation of granulosa cell apoptotic process |
GO:0021884 | 0.0041 | 23.25 | 0.0963 | 2 | 25 | forebrain neuron development |
GO:0035295 | 0.0043 | 3.761 | 2.0612 | 7 | 535 | tube development |
GO:0009653 | 0.0043 | 2.4027 | 8.0507 | 16 | 2193 | anatomical structure morphogenesis |
GO:0000902 | 0.0045 | 3.1388 | 3.2286 | 9 | 838 | cell morphogenesis |
GO:0009954 | 0.0055 | 19.8003 | 0.1117 | 2 | 29 | proximal/distal pattern formation |
GO:0030154 | 0.0056 | 2.1383 | 13.1048 | 22 | 3575 | cell differentiation |
GO:0007399 | 0.0066 | 2.4851 | 6.1741 | 13 | 1755 | nervous system development |
GO:1900026 | 0.0067 | 17.8167 | 0.1233 | 2 | 32 | positive regulation of substrate adhesion-dependent cell spreading |
GO:0014003 | 0.0076 | 16.7009 | 0.131 | 2 | 34 | oligodendrocyte development |
GO:0001828 | 0.0077 | 263.0702 | 0.0077 | 1 | 2 | inner cell mass cellular morphogenesis |
GO:0007493 | 0.0077 | 263.0702 | 0.0077 | 1 | 2 | endodermal cell fate determination |
GO:0008050 | 0.0077 | 263.0702 | 0.0077 | 1 | 2 | female courtship behavior |
GO:0035332 | 0.0077 | 263.0702 | 0.0077 | 1 | 2 | positive regulation of hippo signaling |
GO:0051729 | 0.0077 | 263.0702 | 0.0077 | 1 | 2 | germline cell cycle switching, mitotic to meiotic cell cycle |
GO:0060184 | 0.0077 | 263.0702 | 0.0077 | 1 | 2 | cell cycle switching |
GO:0061010 | 0.0077 | 263.0702 | 0.0077 | 1 | 2 | gall bladder development |
GO:0061386 | 0.0077 | 263.0702 | 0.0077 | 1 | 2 | closure of optic fissure |
GO:0071657 | 0.0077 | 263.0702 | 0.0077 | 1 | 2 | positive regulation of granulocyte colony-stimulating factor production |
GO:0072272 | 0.0077 | 263.0702 | 0.0077 | 1 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
GO:1903899 | 0.0077 | 263.0702 | 0.0077 | 1 | 2 | positive regulation of PERK-mediated unfolded protein response |
GO:1904616 | 0.0077 | 263.0702 | 0.0077 | 1 | 2 | regulation of actin binding |
GO:2000043 | 0.0077 | 263.0702 | 0.0077 | 1 | 2 | regulation of cardiac cell fate specification |
GO:2001111 | 0.0077 | 263.0702 | 0.0077 | 1 | 2 | positive regulation of lens epithelial cell proliferation |
GO:0001755 | 0.008 | 16.1937 | 0.1348 | 2 | 35 | neural crest cell migration |
GO:0031103 | 0.008 | 16.1937 | 0.1348 | 2 | 35 | axon regeneration |
GO:0014014 | 0.0094 | 14.8413 | 0.1464 | 2 | 38 | negative regulation of gliogenesis |
GO:0048483 | 0.0094 | 14.8413 | 0.1464 | 2 | 38 | autonomic nervous system development |
GO:0048667 | 0.0098 | 3.5661 | 1.8339 | 6 | 476 | cell morphogenesis involved in neuron differentiation |
GO:0021510 | 0.0099 | 14.4238 | 0.1503 | 2 | 41 | spinal cord development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002275 | 0 | 3.8654 | 6.7033 | 23 | 476 | myeloid cell activation involved in immune response |
GO:0002263 | 0 | 3.4747 | 8.4496 | 26 | 600 | cell activation involved in immune response |
GO:0043312 | 0 | 3.8897 | 6.0415 | 21 | 429 | neutrophil degranulation |
GO:0042119 | 0 | 3.794 | 6.1823 | 21 | 439 | neutrophil activation |
GO:0045321 | 0 | 3.2887 | 8.1869 | 24 | 605 | leukocyte activation |
GO:0002444 | 0 | 3.5281 | 6.6153 | 21 | 474 | myeloid leukocyte mediated immunity |
GO:0002544 | 0 | 26.1748 | 0.2093 | 4 | 15 | chronic inflammatory response |
GO:0045055 | 0 | 2.7636 | 9.1396 | 23 | 649 | regulated exocytosis |
GO:0016192 | 1e-04 | 2.0505 | 23.0674 | 42 | 1638 | vesicle-mediated transport |
GO:0032094 | 1e-04 | 11.9259 | 0.4929 | 5 | 35 | response to food |
GO:0045730 | 3e-04 | 15.003 | 0.3239 | 4 | 23 | respiratory burst |
GO:0009991 | 3e-04 | 2.9398 | 5.8725 | 16 | 417 | response to extracellular stimulus |
GO:0006968 | 3e-04 | 9.4101 | 0.6056 | 5 | 43 | cellular defense response |
GO:0070098 | 5e-04 | 6.5207 | 1.0139 | 6 | 72 | chemokine-mediated signaling pathway |
GO:1903039 | 6e-04 | 3.7575 | 2.8588 | 10 | 203 | positive regulation of leukocyte cell-cell adhesion |
GO:0019730 | 8e-04 | 5.9749 | 1.0984 | 6 | 78 | antimicrobial humoral response |
GO:0007186 | 9e-04 | 2.0193 | 15.6176 | 29 | 1109 | G-protein coupled receptor signaling pathway |
GO:0048870 | 0.001 | 2.4407 | 7.9436 | 18 | 593 | cell motility |
GO:0050911 | 0.0011 | 3.0537 | 4.1966 | 12 | 298 | detection of chemical stimulus involved in sensory perception of smell |
GO:0033013 | 0.0011 | 7.0053 | 0.7886 | 5 | 56 | tetrapyrrole metabolic process |
GO:0055114 | 0.0013 | 2.1093 | 12.266 | 24 | 871 | oxidation-reduction process |
GO:0050896 | 0.0013 | 1.7205 | 44.8271 | 62 | 3716 | response to stimulus |
GO:0045785 | 0.0016 | 2.7614 | 5.0134 | 13 | 356 | positive regulation of cell adhesion |
GO:0031295 | 0.0017 | 6.3777 | 0.859 | 5 | 61 | T cell costimulation |
GO:0042113 | 0.0017 | 3.5319 | 2.7179 | 9 | 193 | B cell activation |
GO:0045087 | 0.0017 | 2.1724 | 10.3648 | 21 | 736 | innate immune response |
GO:0034097 | 0.0017 | 2.0552 | 12.5617 | 24 | 892 | response to cytokine |
GO:0007584 | 0.0018 | 3.841 | 2.2251 | 8 | 158 | response to nutrient |
GO:0032940 | 0.0018 | 1.8787 | 17.899 | 31 | 1271 | secretion by cell |
GO:0042102 | 0.0019 | 4.9975 | 1.2956 | 6 | 92 | positive regulation of T cell proliferation |
GO:0002677 | 0.0019 | 47.1079 | 0.0704 | 2 | 5 | negative regulation of chronic inflammatory response |
GO:0002730 | 0.0019 | 47.1079 | 0.0704 | 2 | 5 | regulation of dendritic cell cytokine production |
GO:0043903 | 0.0021 | 3.4189 | 2.8024 | 9 | 199 | regulation of symbiosis, encompassing mutualism through parasitism |
GO:0006909 | 0.0022 | 3.3829 | 2.8306 | 9 | 201 | phagocytosis |
GO:0032496 | 0.0022 | 2.9425 | 3.9713 | 11 | 282 | response to lipopolysaccharide |
GO:0002374 | 0.0023 | 13.3008 | 0.2676 | 3 | 19 | cytokine secretion involved in immune response |
GO:0009593 | 0.0024 | 2.643 | 5.2247 | 13 | 371 | detection of chemical stimulus |
GO:0070887 | 0.0026 | 1.6047 | 37.4598 | 54 | 2660 | cellular response to chemical stimulus |
GO:0002694 | 0.0027 | 2.5014 | 5.9429 | 14 | 422 | regulation of leukocyte activation |
GO:0015942 | 0.0029 | 35.3286 | 0.0845 | 2 | 6 | formate metabolic process |
GO:0097527 | 0.0029 | 35.3286 | 0.0845 | 2 | 6 | necroptotic signaling pathway |
GO:0043207 | 0.0029 | 2.1045 | 10.1395 | 20 | 720 | response to external biotic stimulus |
GO:2000145 | 0.003 | 2.1013 | 10.1536 | 20 | 721 | regulation of cell motility |
GO:0071677 | 0.0035 | 11.1984 | 0.3098 | 3 | 22 | positive regulation of mononuclear cell migration |
GO:0002480 | 0.004 | 28.261 | 0.0986 | 2 | 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent |
GO:0002887 | 0.004 | 28.261 | 0.0986 | 2 | 7 | negative regulation of myeloid leukocyte mediated immunity |
GO:0043301 | 0.004 | 28.261 | 0.0986 | 2 | 7 | negative regulation of leukocyte degranulation |
GO:0006779 | 0.004 | 10.6378 | 0.3239 | 3 | 23 | porphyrin-containing compound biosynthetic process |
GO:0045662 | 0.004 | 10.6378 | 0.3239 | 3 | 23 | negative regulation of myoblast differentiation |
GO:0060142 | 0.0045 | 10.1306 | 0.338 | 3 | 24 | regulation of syncytium formation by plasma membrane fusion |
GO:0006955 | 0.0045 | 2.4433 | 5.6626 | 13 | 459 | immune response |
GO:0003008 | 0.0046 | 1.6672 | 24.7432 | 38 | 1757 | system process |
GO:0048247 | 0.0049 | 6.3235 | 0.69 | 4 | 49 | lymphocyte chemotaxis |
GO:0002685 | 0.0054 | 3.5099 | 2.1124 | 7 | 150 | regulation of leukocyte migration |
GO:0009617 | 0.0054 | 2.2982 | 6.4358 | 14 | 457 | response to bacterium |
GO:0042110 | 0.0056 | 2.3708 | 5.788 | 13 | 411 | T cell activation |
GO:0006766 | 0.0057 | 3.9368 | 1.6195 | 6 | 115 | vitamin metabolic process |
GO:0001886 | 0.0067 | 20.1837 | 0.1267 | 2 | 9 | endothelial cell morphogenesis |
GO:0010819 | 0.0067 | 20.1837 | 0.1267 | 2 | 9 | regulation of T cell chemotaxis |
GO:0046007 | 0.0067 | 20.1837 | 0.1267 | 2 | 9 | negative regulation of activated T cell proliferation |
GO:0042168 | 0.007 | 8.5074 | 0.3943 | 3 | 28 | heme metabolic process |
GO:1900271 | 0.007 | 8.5074 | 0.3943 | 3 | 28 | regulation of long-term synaptic potentiation |
GO:0097529 | 0.0073 | 3.3001 | 2.2391 | 7 | 159 | myeloid leukocyte migration |
GO:0002521 | 0.0074 | 2.2823 | 5.9992 | 13 | 426 | leukocyte differentiation |
GO:0007154 | 0.0077 | 1.4158 | 79.3979 | 97 | 5638 | cell communication |
GO:0050906 | 0.0079 | 2.3533 | 5.3655 | 12 | 381 | detection of stimulus involved in sensory perception |
GO:0051251 | 0.0082 | 2.7321 | 3.4643 | 9 | 246 | positive regulation of lymphocyte activation |
GO:0040015 | 0.0082 | 17.6595 | 0.1408 | 2 | 10 | negative regulation of multicellular organism growth |
GO:0072672 | 0.0082 | 17.6595 | 0.1408 | 2 | 10 | neutrophil extravasation |
GO:0005996 | 0.0084 | 2.7205 | 3.4784 | 9 | 247 | monosaccharide metabolic process |
GO:0050832 | 0.0084 | 7.8761 | 0.4225 | 3 | 30 | defense response to fungus |
GO:0044419 | 0.0086 | 1.8933 | 11.1816 | 20 | 794 | interspecies interaction between organisms |
GO:0006950 | 0.0088 | 1.465 | 46.867 | 62 | 3328 | response to stress |
GO:0032946 | 0.0088 | 3.5733 | 1.7744 | 6 | 126 | positive regulation of mononuclear cell proliferation |
GO:0030595 | 0.0088 | 3.5729 | 1.7743 | 6 | 128 | leukocyte chemotaxis |
GO:0050900 | 0.0091 | 3.5472 | 1.7863 | 6 | 133 | leukocyte migration |
GO:0071346 | 0.0092 | 3.5435 | 1.7885 | 6 | 127 | cellular response to interferon-gamma |
GO:0007606 | 0.0092 | 2.3021 | 5.4781 | 12 | 389 | sensory perception of chemical stimulus |
GO:0002684 | 0.0092 | 1.849 | 12.0266 | 21 | 854 | positive regulation of immune system process |
GO:0018119 | 0.01 | 15.6963 | 0.1549 | 2 | 11 | peptidyl-cysteine S-nitrosylation |
GO:0051873 | 0.01 | 15.6963 | 0.1549 | 2 | 11 | killing by host of symbiont cells |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0021879 | 0 | 15.8973 | 1.0155 | 12 | 49 | forebrain neuron differentiation |
GO:0022008 | 0 | 3.0521 | 19.1647 | 50 | 976 | neurogenesis |
GO:0048663 | 0 | 11.6103 | 1.4093 | 13 | 68 | neuron fate commitment |
GO:0001708 | 0 | 9.092 | 1.5859 | 12 | 77 | cell fate specification |
GO:0007399 | 0 | 3.4725 | 9.8597 | 30 | 573 | nervous system development |
GO:0001764 | 0 | 6.5384 | 2.6528 | 15 | 128 | neuron migration |
GO:0032989 | 0 | 2.6421 | 19.2539 | 45 | 929 | cellular component morphogenesis |
GO:0007275 | 0 | 1.8664 | 83.133 | 123 | 4261 | multicellular organism development |
GO:0048812 | 0 | 3.0115 | 11.0466 | 30 | 533 | neuron projection morphogenesis |
GO:0048667 | 0 | 3.1457 | 9.8653 | 28 | 476 | cell morphogenesis involved in neuron differentiation |
GO:0035107 | 0 | 5.6299 | 2.8187 | 14 | 136 | appendage morphogenesis |
GO:0048858 | 0 | 2.9096 | 11.399 | 30 | 550 | cell projection morphogenesis |
GO:0061564 | 0 | 3.1792 | 8.303 | 24 | 404 | axon development |
GO:0021513 | 0 | 18.0466 | 0.456 | 6 | 22 | spinal cord dorsal/ventral patterning |
GO:0060173 | 0 | 4.6967 | 3.3161 | 14 | 160 | limb development |
GO:0061364 | 0 | Inf | 0.0622 | 3 | 3 | apoptotic process involved in luteolysis |
GO:0007411 | 0 | 4.242 | 3.9051 | 15 | 190 | axon guidance |
GO:0003002 | 0 | 3.3659 | 6.5078 | 20 | 314 | regionalization |
GO:0007156 | 0 | 4.8493 | 2.9845 | 13 | 144 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0060581 | 0 | 23.9935 | 0.3109 | 5 | 15 | cell fate commitment involved in pattern specification |
GO:0006935 | 0 | 2.7672 | 10.6736 | 27 | 515 | chemotaxis |
GO:0021983 | 0 | 10.5502 | 0.8083 | 7 | 39 | pituitary gland development |
GO:0021514 | 0 | 19.9919 | 0.3523 | 5 | 17 | ventral spinal cord interneuron differentiation |
GO:0050808 | 0 | 3.6871 | 4.7461 | 16 | 229 | synapse organization |
GO:0019098 | 0 | 12.5482 | 0.601 | 6 | 29 | reproductive behavior |
GO:0007267 | 0 | 2.1361 | 21.1299 | 41 | 1047 | cell-cell signaling |
GO:0021953 | 0 | 7.3517 | 1.2508 | 8 | 63 | central nervous system neuron differentiation |
GO:0048870 | 0 | 1.9849 | 27.2332 | 49 | 1314 | cell motility |
GO:0072001 | 0 | 4.1799 | 3.4141 | 13 | 167 | renal system development |
GO:0014031 | 0 | 7.1579 | 1.285 | 8 | 62 | mesenchymal cell development |
GO:0072132 | 0 | 8.6525 | 0.9534 | 7 | 46 | mesenchyme morphogenesis |
GO:0003205 | 1e-04 | 4.2642 | 3.0881 | 12 | 149 | cardiac chamber development |
GO:0014706 | 1e-04 | 2.9508 | 6.9637 | 19 | 336 | striated muscle tissue development |
GO:0003208 | 1e-04 | 6.4395 | 1.4093 | 8 | 68 | cardiac ventricle morphogenesis |
GO:0048934 | 1e-04 | 23.9188 | 0.2487 | 4 | 12 | peripheral nervous system neuron differentiation |
GO:0051962 | 1e-04 | 2.6992 | 8.8083 | 22 | 425 | positive regulation of nervous system development |
GO:0001709 | 1e-04 | 9.6783 | 0.7415 | 6 | 36 | cell fate determination |
GO:0001964 | 1e-04 | 13.3225 | 0.4767 | 5 | 23 | startle response |
GO:0030182 | 1e-04 | 2.4675 | 10.9859 | 25 | 585 | neuron differentiation |
GO:0007218 | 1e-04 | 5.246 | 1.9067 | 9 | 92 | neuropeptide signaling pathway |
GO:0010720 | 1e-04 | 2.5869 | 9.1606 | 22 | 442 | positive regulation of cell development |
GO:0048468 | 2e-04 | 2.2201 | 14.7159 | 30 | 795 | cell development |
GO:0021891 | 2e-04 | 47.699 | 0.1244 | 3 | 6 | olfactory bulb interneuron development |
GO:0061138 | 2e-04 | 3.8141 | 3.4197 | 12 | 165 | morphogenesis of a branching epithelium |
GO:0048709 | 2e-04 | 5.5961 | 1.5959 | 8 | 77 | oligodendrocyte differentiation |
GO:0120036 | 2e-04 | 1.8866 | 25.9896 | 45 | 1254 | plasma membrane bounded cell projection organization |
GO:0021772 | 2e-04 | 10.8972 | 0.5596 | 5 | 27 | olfactory bulb development |
GO:0009887 | 2e-04 | 2.145 | 15.6116 | 31 | 776 | animal organ morphogenesis |
GO:0007626 | 2e-04 | 4.7657 | 2.0765 | 9 | 103 | locomotory behavior |
GO:0099537 | 3e-04 | 2.3267 | 11.544 | 25 | 557 | trans-synaptic signaling |
GO:0021954 | 3e-04 | 6.2426 | 1.2642 | 7 | 61 | central nervous system neuron development |
GO:0048864 | 3e-04 | 6.1287 | 1.285 | 7 | 62 | stem cell development |
GO:0021521 | 3e-04 | 36 | 0.1442 | 3 | 7 | ventral spinal cord interneuron specification |
GO:0007420 | 3e-04 | 3.051 | 5.2885 | 15 | 275 | brain development |
GO:0035385 | 3e-04 | 35.7718 | 0.1451 | 3 | 7 | Roundabout signaling pathway |
GO:2001141 | 3e-04 | 1.5678 | 67.8549 | 94 | 3274 | regulation of RNA biosynthetic process |
GO:0045944 | 3e-04 | 1.9475 | 21.0984 | 38 | 1018 | positive regulation of transcription from RNA polymerase II promoter |
GO:0021537 | 3e-04 | 5.9086 | 1.3244 | 7 | 66 | telencephalon development |
GO:0006355 | 4e-04 | 1.559 | 67.3368 | 93 | 3249 | regulation of transcription, DNA-templated |
GO:0014033 | 4e-04 | 5.8105 | 1.3472 | 7 | 65 | neural crest cell differentiation |
GO:0060562 | 4e-04 | 2.8436 | 6.0311 | 16 | 291 | epithelial tube morphogenesis |
GO:0001569 | 4e-04 | 9.2182 | 0.6425 | 5 | 31 | branching involved in blood vessel morphogenesis |
GO:0008344 | 4e-04 | 6.9432 | 0.9838 | 6 | 48 | adult locomotory behavior |
GO:0021842 | 4e-04 | Inf | 0.0415 | 2 | 2 | chemorepulsion involved in interneuron migration from the subpallium to the cortex |
GO:0033693 | 4e-04 | Inf | 0.0415 | 2 | 2 | neurofilament bundle assembly |
GO:0043503 | 4e-04 | Inf | 0.0415 | 2 | 2 | skeletal muscle fiber adaptation |
GO:0086097 | 4e-04 | Inf | 0.0415 | 2 | 2 | phospholipase C-activating angiotensin-activated signaling pathway |
GO:0042063 | 4e-04 | 3.0587 | 4.9119 | 14 | 237 | gliogenesis |
GO:0048747 | 4e-04 | 6.8627 | 0.9948 | 6 | 48 | muscle fiber development |
GO:0002118 | 5e-04 | 28.6155 | 0.1658 | 3 | 8 | aggressive behavior |
GO:0022610 | 5e-04 | 1.8305 | 25.4301 | 43 | 1227 | biological adhesion |
GO:0030900 | 5e-04 | 4.2897 | 2.2837 | 9 | 116 | forebrain development |
GO:0050768 | 5e-04 | 6.7179 | 1.0116 | 6 | 50 | negative regulation of neurogenesis |
GO:0021515 | 5e-04 | 8.6932 | 0.6737 | 5 | 33 | cell differentiation in spinal cord |
GO:0021510 | 6e-04 | 8.2853 | 0.7002 | 5 | 35 | spinal cord development |
GO:0071804 | 6e-04 | 3.2728 | 3.9378 | 12 | 190 | cellular potassium ion transport |
GO:0019219 | 7e-04 | 1.5014 | 78.487 | 104 | 3787 | regulation of nucleobase-containing compound metabolic process |
GO:0060180 | 7e-04 | 23.8447 | 0.1865 | 3 | 9 | female mating behavior |
GO:0001755 | 7e-04 | 7.987 | 0.7254 | 5 | 35 | neural crest cell migration |
GO:0031016 | 8e-04 | 5.1034 | 1.513 | 7 | 73 | pancreas development |
GO:0021516 | 8e-04 | 11.249 | 0.4352 | 4 | 21 | dorsal spinal cord development |
GO:0021520 | 9e-04 | 20.5686 | 0.206 | 3 | 10 | spinal cord motor neuron cell fate specification |
GO:0007618 | 9e-04 | 7.4868 | 0.7668 | 5 | 37 | mating |
GO:0021903 | 9e-04 | 20.4369 | 0.2073 | 3 | 10 | rostrocaudal neural tube patterning |
GO:0060538 | 0.001 | 3.53 | 3.0466 | 10 | 147 | skeletal muscle organ development |
GO:0003272 | 0.001 | 10.6234 | 0.456 | 4 | 22 | endocardial cushion formation |
GO:0035640 | 0.001 | 10.6234 | 0.456 | 4 | 22 | exploration behavior |
GO:0007268 | 0.0011 | 2.1569 | 11.3503 | 23 | 551 | chemical synaptic transmission |
GO:0045665 | 0.0011 | 3.2286 | 3.6477 | 11 | 176 | negative regulation of neuron differentiation |
GO:0007189 | 0.0011 | 5.6482 | 1.1813 | 6 | 57 | adenylate cyclase-activating G-protein coupled receptor signaling pathway |
GO:0048596 | 0.0012 | 10.0636 | 0.4767 | 4 | 23 | embryonic camera-type eye morphogenesis |
GO:0003197 | 0.0012 | 7.0454 | 0.8083 | 5 | 39 | endocardial cushion development |
GO:0051241 | 0.0012 | 1.8406 | 20.3523 | 35 | 982 | negative regulation of multicellular organismal process |
GO:0010243 | 0.0012 | 1.9125 | 17.3057 | 31 | 835 | response to organonitrogen compound |
GO:0021524 | 0.0013 | 95.1032 | 0.0622 | 2 | 3 | visceral motor neuron differentiation |
GO:0021912 | 0.0013 | 95.1032 | 0.0622 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0048936 | 0.0013 | 95.1032 | 0.0622 | 2 | 3 | peripheral nervous system neuron axonogenesis |
GO:0060912 | 0.0013 | 95.1032 | 0.0622 | 2 | 3 | cardiac cell fate specification |
GO:0060913 | 0.0013 | 95.1032 | 0.0622 | 2 | 3 | cardiac cell fate determination |
GO:0070346 | 0.0013 | 95.1032 | 0.0622 | 2 | 3 | positive regulation of fat cell proliferation |
GO:0097659 | 0.0013 | 1.4829 | 70.7772 | 94 | 3415 | nucleic acid-templated transcription |
GO:0003044 | 0.0013 | 6.8436 | 0.829 | 5 | 40 | regulation of systemic arterial blood pressure mediated by a chemical signal |
GO:0072091 | 0.0014 | 5.4343 | 1.2228 | 6 | 59 | regulation of stem cell proliferation |
GO:0072073 | 0.0014 | 3.65 | 2.6528 | 9 | 128 | kidney epithelium development |
GO:0006874 | 0.0014 | 2.4192 | 7.4611 | 17 | 360 | cellular calcium ion homeostasis |
GO:0009888 | 0.0014 | 1.6262 | 35.9585 | 54 | 1735 | tissue development |
GO:0021987 | 0.0014 | 4.0148 | 2.1554 | 8 | 104 | cerebral cortex development |
GO:0042733 | 0.0015 | 5.3333 | 1.2435 | 6 | 60 | embryonic digit morphogenesis |
GO:0021517 | 0.0015 | 9.2466 | 0.5104 | 4 | 25 | ventral spinal cord development |
GO:0042391 | 0.0015 | 2.3977 | 7.5233 | 17 | 363 | regulation of membrane potential |
GO:0003148 | 0.0016 | 9.1039 | 0.5181 | 4 | 25 | outflow tract septum morphogenesis |
GO:0048568 | 0.0016 | 2.3202 | 8.228 | 18 | 397 | embryonic organ development |
GO:0008038 | 0.0016 | 16.0316 | 0.2466 | 3 | 12 | neuron recognition |
GO:0010454 | 0.0017 | 15.8932 | 0.2487 | 3 | 12 | negative regulation of cell fate commitment |
GO:0007628 | 0.0019 | 8.6895 | 0.5389 | 4 | 26 | adult walking behavior |
GO:0031644 | 0.0019 | 5.0516 | 1.3057 | 6 | 63 | regulation of neurological system process |
GO:0033555 | 0.0019 | 5.0516 | 1.3057 | 6 | 63 | multicellular organismal response to stress |
GO:0007187 | 0.002 | 3.1784 | 3.3575 | 10 | 162 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0007171 | 0.0022 | 14.3029 | 0.2694 | 3 | 13 | activation of transmembrane receptor protein tyrosine kinase activity |
GO:0060080 | 0.0022 | 14.3029 | 0.2694 | 3 | 13 | inhibitory postsynaptic potential |
GO:0098655 | 0.0022 | 1.9206 | 14.9223 | 27 | 720 | cation transmembrane transport |
GO:0061061 | 0.0024 | 2.0192 | 12.0622 | 23 | 582 | muscle structure development |
GO:0001992 | 0.0025 | 47.5484 | 0.0829 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0001994 | 0.0025 | 47.5484 | 0.0829 | 2 | 4 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure |
GO:0007621 | 0.0025 | 47.5484 | 0.0829 | 2 | 4 | negative regulation of female receptivity |
GO:0021523 | 0.0025 | 47.5484 | 0.0829 | 2 | 4 | somatic motor neuron differentiation |
GO:0021913 | 0.0025 | 47.5484 | 0.0829 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0042662 | 0.0025 | 47.5484 | 0.0829 | 2 | 4 | negative regulation of mesodermal cell fate specification |
GO:0050923 | 0.0025 | 47.5484 | 0.0829 | 2 | 4 | regulation of negative chemotaxis |
GO:0051414 | 0.0025 | 47.5484 | 0.0829 | 2 | 4 | response to cortisol |
GO:0060214 | 0.0025 | 47.5484 | 0.0829 | 2 | 4 | endocardium formation |
GO:1905903 | 0.0025 | 47.5484 | 0.0829 | 2 | 4 | negative regulation of mesoderm formation |
GO:0050931 | 0.0025 | 7.9643 | 0.5803 | 4 | 28 | pigment cell differentiation |
GO:0055085 | 0.0025 | 1.6799 | 26.0933 | 41 | 1259 | transmembrane transport |
GO:0000904 | 0.0025 | 3.6376 | 2.3573 | 8 | 121 | cell morphogenesis involved in differentiation |
GO:0003151 | 0.0027 | 5.7673 | 0.9632 | 5 | 47 | outflow tract morphogenesis |
GO:0042711 | 0.0027 | 13.0018 | 0.2902 | 3 | 14 | maternal behavior |
GO:0070286 | 0.0029 | 7.6452 | 0.601 | 4 | 29 | axonemal dynein complex assembly |
GO:0021915 | 0.003 | 3.2343 | 2.9665 | 9 | 144 | neural tube development |
GO:0042755 | 0.0032 | 7.3506 | 0.6218 | 4 | 30 | eating behavior |
GO:0022010 | 0.0033 | 11.9175 | 0.3109 | 3 | 15 | central nervous system myelination |
GO:0006811 | 0.0033 | 1.6234 | 28.9741 | 44 | 1398 | ion transport |
GO:0042220 | 0.0033 | 5.4405 | 1.0155 | 5 | 49 | response to cocaine |
GO:0021543 | 0.0034 | 5.4259 | 1.0167 | 5 | 50 | pallium development |
GO:0007423 | 0.0034 | 2.0617 | 10.2383 | 20 | 494 | sensory organ development |
GO:0050877 | 0.0036 | 1.7236 | 20.9634 | 34 | 1027 | nervous system process |
GO:0030879 | 0.0037 | 3.4068 | 2.5078 | 8 | 121 | mammary gland development |
GO:0050886 | 0.0037 | 4.3601 | 1.4922 | 6 | 72 | endocrine process |
GO:0002065 | 0.0038 | 3.7786 | 1.9896 | 7 | 96 | columnar/cuboidal epithelial cell differentiation |
GO:0045666 | 0.0038 | 2.3917 | 6.1762 | 14 | 298 | positive regulation of neuron differentiation |
GO:0046883 | 0.0039 | 2.5925 | 4.8912 | 12 | 236 | regulation of hormone secretion |
GO:0051963 | 0.004 | 4.2947 | 1.513 | 6 | 73 | regulation of synapse assembly |
GO:0016199 | 0.0041 | 31.6968 | 0.1036 | 2 | 5 | axon midline choice point recognition |
GO:0030240 | 0.0041 | 31.6968 | 0.1036 | 2 | 5 | skeletal muscle thin filament assembly |
GO:0051970 | 0.0041 | 31.6968 | 0.1036 | 2 | 5 | negative regulation of transmission of nerve impulse |
GO:0060012 | 0.0041 | 31.6968 | 0.1036 | 2 | 5 | synaptic transmission, glycinergic |
GO:0070100 | 0.0041 | 31.6968 | 0.1036 | 2 | 5 | negative regulation of chemokine-mediated signaling pathway |
GO:1903232 | 0.0041 | 31.6968 | 0.1036 | 2 | 5 | melanosome assembly |
GO:0001662 | 0.0041 | 6.8247 | 0.6632 | 4 | 32 | behavioral fear response |
GO:1901381 | 0.0041 | 6.8247 | 0.6632 | 4 | 32 | positive regulation of potassium ion transmembrane transport |
GO:0035637 | 0.0042 | 2.8553 | 3.7098 | 10 | 179 | multicellular organismal signaling |
GO:0072507 | 0.0042 | 2.1605 | 8.2902 | 17 | 400 | divalent inorganic cation homeostasis |
GO:2000177 | 0.0043 | 4.2313 | 1.5337 | 6 | 74 | regulation of neural precursor cell proliferation |
GO:0045823 | 0.0046 | 6.5889 | 0.6839 | 4 | 33 | positive regulation of heart contraction |
GO:0015672 | 0.0046 | 2.4247 | 5.6532 | 13 | 278 | monovalent inorganic cation transport |
GO:0021885 | 0.0047 | 4.9857 | 1.0984 | 5 | 53 | forebrain cell migration |
GO:0045669 | 0.0047 | 4.9857 | 1.0984 | 5 | 53 | positive regulation of osteoblast differentiation |
GO:0008217 | 0.0048 | 2.9902 | 3.1917 | 9 | 154 | regulation of blood pressure |
GO:0072006 | 0.005 | 3.2337 | 2.6321 | 8 | 127 | nephron development |
GO:0048598 | 0.0051 | 2.0249 | 9.8776 | 19 | 484 | embryonic morphogenesis |
GO:0097756 | 0.0052 | 4.0516 | 1.5959 | 6 | 77 | negative regulation of blood vessel diameter |
GO:0055001 | 0.0053 | 2.9491 | 3.2332 | 9 | 156 | muscle cell development |
GO:0071495 | 0.0053 | 1.6412 | 23.9171 | 37 | 1154 | cellular response to endogenous stimulus |
GO:0019935 | 0.0053 | 3.5385 | 2.114 | 7 | 102 | cyclic-nucleotide-mediated signaling |
GO:0048856 | 0.0053 | 3.544 | 2.1173 | 7 | 139 | anatomical structure development |
GO:0045595 | 0.0054 | 1.5542 | 32.2694 | 47 | 1557 | regulation of cell differentiation |
GO:0007389 | 0.0054 | 4.0204 | 1.6046 | 6 | 81 | pattern specification process |
GO:0021854 | 0.0057 | 9.532 | 0.3731 | 3 | 18 | hypothalamus development |
GO:0023019 | 0.0057 | 9.532 | 0.3731 | 3 | 18 | signal transduction involved in regulation of gene expression |
GO:0015872 | 0.0057 | 6.163 | 0.7254 | 4 | 35 | dopamine transport |
GO:0035137 | 0.0057 | 6.163 | 0.7254 | 4 | 35 | hindlimb morphogenesis |
GO:0051146 | 0.0059 | 2.4481 | 5.1606 | 12 | 249 | striated muscle cell differentiation |
GO:0006936 | 0.006 | 2.2616 | 6.5078 | 14 | 314 | muscle contraction |
GO:0019336 | 0.0061 | 23.771 | 0.1244 | 2 | 6 | phenol-containing compound catabolic process |
GO:0033504 | 0.0061 | 23.771 | 0.1244 | 2 | 6 | floor plate development |
GO:0060710 | 0.0061 | 23.771 | 0.1244 | 2 | 6 | chorio-allantoic fusion |
GO:0060956 | 0.0061 | 23.771 | 0.1244 | 2 | 6 | endocardial cell differentiation |
GO:0010470 | 0.0063 | 5.97 | 0.7461 | 4 | 36 | regulation of gastrulation |
GO:0035136 | 0.0063 | 5.97 | 0.7461 | 4 | 36 | forelimb morphogenesis |
GO:0030326 | 0.0065 | 4.5869 | 1.1837 | 5 | 58 | embryonic limb morphogenesis |
GO:0009889 | 0.0066 | 1.3664 | 84.8912 | 105 | 4096 | regulation of biosynthetic process |
GO:0002089 | 0.0067 | 8.9357 | 0.3938 | 3 | 19 | lens morphogenesis in camera-type eye |
GO:0007413 | 0.0067 | 8.9357 | 0.3938 | 3 | 19 | axonal fasciculation |
GO:0035813 | 0.0067 | 8.9357 | 0.3938 | 3 | 19 | regulation of renal sodium excretion |
GO:0048608 | 0.0068 | 2.0996 | 8 | 16 | 386 | reproductive structure development |
GO:0023061 | 0.007 | 2.0938 | 8.0207 | 16 | 387 | signal release |
GO:0009914 | 0.0072 | 2.2873 | 5.9689 | 13 | 288 | hormone transport |
GO:0034765 | 0.0073 | 2.0823 | 8.0622 | 16 | 389 | regulation of ion transmembrane transport |
GO:0098609 | 0.0074 | 1.7778 | 14.7913 | 25 | 718 | cell-cell adhesion |
GO:0048592 | 0.0074 | 3.0045 | 2.8187 | 8 | 136 | eye morphogenesis |
GO:0007588 | 0.0074 | 4.43 | 1.2228 | 5 | 59 | excretion |
GO:0035914 | 0.0074 | 4.43 | 1.2228 | 5 | 59 | skeletal muscle cell differentiation |
GO:0022612 | 0.0076 | 3.2941 | 2.2591 | 7 | 109 | gland morphogenesis |
GO:0001504 | 0.0077 | 8.4095 | 0.4145 | 3 | 20 | neurotransmitter uptake |
GO:0002052 | 0.0077 | 8.4095 | 0.4145 | 3 | 20 | positive regulation of neuroblast proliferation |
GO:0031290 | 0.0077 | 8.4095 | 0.4145 | 3 | 20 | retinal ganglion cell axon guidance |
GO:0042471 | 0.0079 | 3.2619 | 2.2798 | 7 | 110 | ear morphogenesis |
GO:0034654 | 0.008 | 1.3619 | 79.7927 | 99 | 3850 | nucleobase-containing compound biosynthetic process |
GO:0098660 | 0.0081 | 1.7632 | 14.9016 | 25 | 719 | inorganic ion transmembrane transport |
GO:0001826 | 0.0084 | 19.0155 | 0.1451 | 2 | 7 | inner cell mass cell differentiation |
GO:0021826 | 0.0084 | 19.0155 | 0.1451 | 2 | 7 | substrate-independent telencephalic tangential migration |
GO:0021830 | 0.0084 | 19.0155 | 0.1451 | 2 | 7 | interneuron migration from the subpallium to the cortex |
GO:0021860 | 0.0084 | 19.0155 | 0.1451 | 2 | 7 | pyramidal neuron development |
GO:0060013 | 0.0084 | 19.0155 | 0.1451 | 2 | 7 | righting reflex |
GO:0071863 | 0.0084 | 19.0155 | 0.1451 | 2 | 7 | regulation of cell proliferation in bone marrow |
GO:2000035 | 0.0084 | 19.0155 | 0.1451 | 2 | 7 | regulation of stem cell division |
GO:0000003 | 0.0085 | 1.5765 | 25.4922 | 38 | 1230 | reproduction |
GO:0060411 | 0.0088 | 5.3673 | 0.8197 | 4 | 40 | cardiac septum morphogenesis |
GO:0019233 | 0.0089 | 3.5936 | 1.7824 | 6 | 86 | sensory perception of pain |
GO:0061326 | 0.0089 | 3.5936 | 1.7824 | 6 | 86 | renal tubule development |
GO:0014821 | 0.0089 | 7.9417 | 0.4352 | 3 | 21 | phasic smooth muscle contraction |
GO:0032098 | 0.0089 | 7.9417 | 0.4352 | 3 | 21 | regulation of appetite |
GO:0051093 | 0.0089 | 1.7097 | 16.601 | 27 | 801 | negative regulation of developmental process |
GO:0007129 | 0.0092 | 5.3052 | 0.829 | 4 | 40 | synapsis |
GO:1901379 | 0.0097 | 5.2194 | 0.8406 | 4 | 41 | regulation of potassium ion transmembrane transport |
GO:0006873 | 0.0097 | 1.8585 | 11.2746 | 20 | 544 | cellular ion homeostasis |
GO:0003341 | 0.0098 | 4.1233 | 1.3057 | 5 | 63 | cilium movement |
GO:0051937 | 0.0099 | 7.6059 | 0.4512 | 3 | 22 | catecholamine transport |
GO:0006814 | 0.0099 | 2.4961 | 4.2073 | 10 | 203 | sodium ion transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005549 | 1e-04 | 7.9232 | 0.9944 | 7 | 72 | odorant binding |
GO:0008147 | 2e-04 | Inf | 0.0276 | 2 | 2 | structural constituent of bone |
GO:0004930 | 5e-04 | 2.4265 | 9.3635 | 21 | 678 | G-protein coupled receptor activity |
GO:0004984 | 9e-04 | 3.1184 | 4.1155 | 12 | 298 | olfactory receptor activity |
GO:0015238 | 0.001 | 18.0988 | 0.2072 | 3 | 15 | drug transmembrane transporter activity |
GO:0016638 | 0.0013 | 16.7054 | 0.221 | 3 | 16 | oxidoreductase activity, acting on the CH-NH2 group of donors |
GO:0019825 | 0.0018 | 8.5461 | 0.5248 | 4 | 38 | oxygen binding |
GO:0042605 | 0.0021 | 13.5704 | 0.2624 | 3 | 19 | peptide antigen binding |
GO:0004465 | 0.0027 | 36.0413 | 0.0829 | 2 | 6 | lipoprotein lipase activity |
GO:0004866 | 0.0032 | 3.8839 | 1.9197 | 7 | 139 | endopeptidase inhibitor activity |
GO:0016176 | 0.0038 | 28.8311 | 0.0967 | 2 | 7 | superoxide-generating NADPH oxidase activator activity |
GO:0004950 | 0.0042 | 10.3359 | 0.3315 | 3 | 24 | chemokine receptor activity |
GO:0020037 | 0.0044 | 4.172 | 1.533 | 6 | 111 | heme binding |
GO:0005164 | 0.0053 | 9.4358 | 0.3591 | 3 | 26 | tumor necrosis factor receptor binding |
GO:0019957 | 0.0064 | 20.5908 | 0.1243 | 2 | 9 | C-C chemokine binding |
GO:0060089 | 0.0067 | 1.7179 | 18.7409 | 30 | 1357 | molecular transducer activity |
GO:0099600 | 0.007 | 1.7996 | 14.8187 | 25 | 1073 | transmembrane receptor activity |
GO:0038023 | 0.0071 | 1.7774 | 15.6197 | 26 | 1131 | signaling receptor activity |
GO:0019955 | 0.0085 | 4.2293 | 1.2568 | 5 | 91 | cytokine binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000981 | 0 | 3.1902 | 13.9298 | 39 | 697 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0043565 | 0 | 4.4734 | 5.03 | 20 | 267 | sequence-specific DNA binding |
GO:0022836 | 0 | 3.6572 | 5.7158 | 19 | 286 | gated channel activity |
GO:1990837 | 0 | 2.4186 | 13.5101 | 30 | 676 | sequence-specific double-stranded DNA binding |
GO:0001067 | 0 | 2.3066 | 15.6086 | 33 | 781 | regulatory region nucleic acid binding |
GO:0001077 | 0 | 3.5155 | 4.9564 | 16 | 248 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
GO:0071837 | 2e-04 | 18.0582 | 0.2998 | 4 | 15 | HMG box domain binding |
GO:0022838 | 2e-04 | 2.6798 | 7.6144 | 19 | 381 | substrate-specific channel activity |
GO:0005509 | 3e-04 | 2.2667 | 12.331 | 26 | 617 | calcium ion binding |
GO:0015075 | 3e-04 | 2.1307 | 15.1689 | 30 | 759 | ion transmembrane transporter activity |
GO:0036461 | 4e-04 | Inf | 0.04 | 2 | 2 | BLOC-2 complex binding |
GO:0008013 | 5e-04 | 5.4673 | 1.419 | 7 | 71 | beta-catenin binding |
GO:0015276 | 6e-04 | 4.1429 | 2.3583 | 9 | 118 | ligand-gated ion channel activity |
GO:0022803 | 6e-04 | 2.4695 | 8.214 | 19 | 411 | passive transmembrane transporter activity |
GO:0003700 | 7e-04 | 2.527 | 7.6243 | 18 | 418 | DNA binding transcription factor activity |
GO:0035240 | 9e-04 | 21.2172 | 0.1999 | 3 | 10 | dopamine binding |
GO:0000978 | 0.001 | 2.5912 | 6.5752 | 16 | 329 | RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0016934 | 0.0012 | 98.7224 | 0.06 | 2 | 3 | extracellularly glycine-gated chloride channel activity |
GO:0035651 | 0.0012 | 98.7224 | 0.06 | 2 | 3 | AP-3 adaptor complex binding |
GO:0005231 | 0.0013 | 6.9088 | 0.8194 | 5 | 41 | excitatory extracellular ligand-gated ion channel activity |
GO:0001159 | 0.0016 | 2.4702 | 6.875 | 16 | 344 | core promoter proximal region DNA binding |
GO:0000977 | 0.002 | 2.8166 | 4.5269 | 12 | 234 | RNA polymerase II regulatory region sequence-specific DNA binding |
GO:0001653 | 0.0023 | 3.7042 | 2.3183 | 8 | 116 | peptide receptor activity |
GO:0005329 | 0.0023 | 49.3579 | 0.0799 | 2 | 4 | dopamine transmembrane transporter activity |
GO:0015333 | 0.0023 | 49.3579 | 0.0799 | 2 | 4 | peptide:proton symporter activity |
GO:0035650 | 0.0023 | 49.3579 | 0.0799 | 2 | 4 | AP-1 adaptor complex binding |
GO:0015294 | 0.0035 | 3.838 | 1.9586 | 7 | 98 | solute:cation symporter activity |
GO:0043237 | 0.0038 | 32.903 | 0.0999 | 2 | 5 | laminin-1 binding |
GO:0048495 | 0.0038 | 32.903 | 0.0999 | 2 | 5 | Roundabout binding |
GO:0005328 | 0.0044 | 10.6035 | 0.3398 | 3 | 17 | neurotransmitter:sodium symporter activity |
GO:0008569 | 0.0044 | 10.6035 | 0.3398 | 3 | 17 | ATP-dependent microtubule motor activity, minus-end-directed |
GO:0044212 | 0.0049 | 2.1267 | 8.4239 | 17 | 435 | transcription regulatory region DNA binding |
GO:0004653 | 0.0052 | 9.896 | 0.3597 | 3 | 18 | polypeptide N-acetylgalactosaminyltransferase activity |
GO:0042562 | 0.0055 | 4.7778 | 1.1392 | 5 | 57 | hormone binding |
GO:0022892 | 0.0059 | 1.6893 | 20.0453 | 32 | 1003 | substrate-specific transporter activity |
GO:0015077 | 0.0066 | 2.2369 | 6.5752 | 14 | 329 | monovalent inorganic cation transmembrane transporter activity |
GO:0043169 | 0.0069 | 1.3817 | 74.8453 | 94 | 3745 | cation binding |
GO:0046873 | 0.0069 | 2.0961 | 8.0141 | 16 | 401 | metal ion transmembrane transporter activity |
GO:0042923 | 0.007 | 8.7306 | 0.3997 | 3 | 20 | neuropeptide binding |
GO:0030297 | 0.0078 | 19.7391 | 0.1399 | 2 | 7 | transmembrane receptor protein tyrosine kinase activator activity |
GO:0005272 | 0.0081 | 5.5084 | 0.7994 | 4 | 40 | sodium channel activity |
GO:0008188 | 0.0089 | 5.3592 | 0.8194 | 4 | 41 | neuropeptide receptor activity |
GO:0099600 | 0.0089 | 1.6244 | 21.4443 | 33 | 1073 | transmembrane receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002263 | 0 | 2.7432 | 17.0586 | 42 | 600 | cell activation involved in immune response |
GO:0002275 | 0 | 2.9609 | 13.5331 | 36 | 476 | myeloid cell activation involved in immune response |
GO:0050911 | 0 | 3.5666 | 8.4724 | 27 | 298 | detection of chemical stimulus involved in sensory perception of smell |
GO:0042119 | 0 | 3.0301 | 12.4812 | 34 | 439 | neutrophil activation |
GO:0043312 | 0 | 3.0021 | 12.1969 | 33 | 429 | neutrophil degranulation |
GO:0009593 | 0 | 3.1577 | 10.5479 | 30 | 371 | detection of chemical stimulus |
GO:0002444 | 0 | 2.8315 | 13.6753 | 35 | 481 | myeloid leukocyte mediated immunity |
GO:0050906 | 0 | 3.0655 | 10.8322 | 30 | 381 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 2.9955 | 11.0597 | 30 | 389 | sensory perception of chemical stimulus |
GO:0045055 | 0 | 2.4426 | 18.4517 | 41 | 649 | regulated exocytosis |
GO:0050877 | 0 | 2.0217 | 30.9898 | 57 | 1090 | nervous system process |
GO:0045321 | 0 | 2.4111 | 16.7872 | 37 | 605 | leukocyte activation |
GO:0045087 | 0 | 2.2455 | 20.9252 | 43 | 736 | innate immune response |
GO:0070268 | 0 | 4.9487 | 2.9853 | 13 | 105 | cornification |
GO:0007186 | 0 | 1.9404 | 31.53 | 56 | 1109 | G-protein coupled receptor signaling pathway |
GO:0006968 | 0 | 7.9407 | 1.2225 | 8 | 43 | cellular defense response |
GO:0060326 | 0 | 3.1434 | 6.596 | 19 | 232 | cell chemotaxis |
GO:0032501 | 0 | 1.4753 | 183.8063 | 224 | 6465 | multicellular organismal process |
GO:1903039 | 1e-04 | 3.2112 | 5.7715 | 17 | 203 | positive regulation of leukocyte cell-cell adhesion |
GO:0032571 | 1e-04 | 103.2353 | 0.1137 | 3 | 4 | response to vitamin K |
GO:0016192 | 1e-04 | 1.6867 | 46.5699 | 72 | 1638 | vesicle-mediated transport |
GO:0032940 | 1e-04 | 1.7696 | 36.1358 | 59 | 1271 | secretion by cell |
GO:0070098 | 2e-04 | 4.9652 | 2.047 | 9 | 72 | chemokine-mediated signaling pathway |
GO:0045785 | 2e-04 | 2.4375 | 10.1214 | 23 | 356 | positive regulation of cell adhesion |
GO:2000406 | 3e-04 | 10.7934 | 0.5971 | 5 | 21 | positive regulation of T cell migration |
GO:0002523 | 3e-04 | 17.2382 | 0.3412 | 4 | 12 | leukocyte migration involved in inflammatory response |
GO:0002237 | 3e-04 | 2.5487 | 8.4156 | 20 | 296 | response to molecule of bacterial origin |
GO:0019730 | 4e-04 | 4.5316 | 2.2176 | 9 | 78 | antimicrobial humoral response |
GO:0009991 | 4e-04 | 2.2526 | 11.8557 | 25 | 417 | response to extracellular stimulus |
GO:0030855 | 4e-04 | 1.9622 | 19.0488 | 35 | 670 | epithelial cell differentiation |
GO:0045730 | 4e-04 | 9.5929 | 0.6539 | 5 | 23 | respiratory burst |
GO:0048247 | 4e-04 | 5.7736 | 1.3931 | 7 | 49 | lymphocyte chemotaxis |
GO:0044130 | 5e-04 | 13.7887 | 0.398 | 4 | 14 | negative regulation of growth of symbiont in host |
GO:0007584 | 6e-04 | 3.1284 | 4.4921 | 13 | 158 | response to nutrient |
GO:0007154 | 6e-04 | 1.3848 | 160.2939 | 193 | 5638 | cell communication |
GO:0097529 | 6e-04 | 3.1068 | 4.5205 | 13 | 159 | myeloid leukocyte migration |
GO:0030216 | 7e-04 | 2.5246 | 7.6195 | 18 | 268 | keratinocyte differentiation |
GO:0022610 | 8e-04 | 1.6559 | 34.8848 | 54 | 1227 | biological adhesion |
GO:2000401 | 9e-04 | 6.102 | 1.1372 | 6 | 40 | regulation of lymphocyte migration |
GO:0044144 | 9e-04 | 11.489 | 0.4549 | 4 | 16 | modulation of growth of symbiont involved in interaction with host |
GO:0006950 | 0.001 | 1.4202 | 94.6183 | 122 | 3328 | response to stress |
GO:0071346 | 0.001 | 3.2996 | 3.6107 | 11 | 127 | cellular response to interferon-gamma |
GO:0044282 | 0.001 | 2.2562 | 9.894 | 21 | 348 | small molecule catabolic process |
GO:0071222 | 0.0012 | 3.0284 | 4.2646 | 12 | 150 | cellular response to lipopolysaccharide |
GO:0042102 | 0.0012 | 3.7636 | 2.6157 | 9 | 92 | positive regulation of T cell proliferation |
GO:0002684 | 0.0013 | 1.7493 | 24.2801 | 40 | 854 | positive regulation of immune system process |
GO:0050867 | 0.0014 | 2.361 | 8.1028 | 18 | 285 | positive regulation of cell activation |
GO:0044110 | 0.0014 | 9.8464 | 0.5118 | 4 | 18 | growth involved in symbiotic interaction |
GO:2000145 | 0.0014 | 1.8097 | 20.4987 | 35 | 721 | regulation of cell motility |
GO:0051716 | 0.0015 | 1.3513 | 172.0031 | 202 | 6166 | cellular response to stimulus |
GO:0031295 | 0.0017 | 4.4868 | 1.7343 | 7 | 61 | T cell costimulation |
GO:0071216 | 0.0017 | 2.7624 | 5.0323 | 13 | 177 | cellular response to biotic stimulus |
GO:0010819 | 0.0017 | 17.2 | 0.2559 | 3 | 9 | regulation of T cell chemotaxis |
GO:0051251 | 0.0018 | 2.4307 | 6.994 | 16 | 246 | positive regulation of lymphocyte activation |
GO:0023052 | 0.0019 | 1.3393 | 159.7537 | 189 | 5619 | signaling |
GO:0050900 | 0.0022 | 2.5638 | 5.8098 | 14 | 209 | leukocyte migration |
GO:0045603 | 0.0022 | 8.6144 | 0.5686 | 4 | 20 | positive regulation of endothelial cell differentiation |
GO:0031640 | 0.0023 | 4.937 | 1.3647 | 6 | 48 | killing of cells of other organism |
GO:0010951 | 0.0023 | 2.5422 | 5.8568 | 14 | 206 | negative regulation of endopeptidase activity |
GO:0072672 | 0.0024 | 14.7418 | 0.2843 | 3 | 10 | neutrophil extravasation |
GO:0002407 | 0.0026 | 8.1071 | 0.5971 | 4 | 21 | dendritic cell chemotaxis |
GO:0002449 | 0.0028 | 2.5868 | 5.345 | 13 | 188 | lymphocyte mediated immunity |
GO:0032094 | 0.0029 | 5.751 | 0.9951 | 5 | 35 | response to food |
GO:0002544 | 0.0031 | 13.0163 | 0.31 | 3 | 11 | chronic inflammatory response |
GO:0071677 | 0.0031 | 7.6562 | 0.6255 | 4 | 22 | positive regulation of mononuclear cell migration |
GO:0051873 | 0.0032 | 12.8982 | 0.3127 | 3 | 11 | killing by host of symbiont cells |
GO:0070234 | 0.0032 | 12.8982 | 0.3127 | 3 | 11 | positive regulation of T cell apoptotic process |
GO:0032946 | 0.0032 | 2.9925 | 3.5823 | 10 | 126 | positive regulation of mononuclear cell proliferation |
GO:0051216 | 0.0034 | 2.6414 | 4.8333 | 12 | 170 | cartilage development |
GO:0035821 | 0.0036 | 2.9414 | 3.6392 | 10 | 128 | modification of morphology or physiology of other organism |
GO:0030335 | 0.0036 | 2.0103 | 11.0028 | 21 | 387 | positive regulation of cell migration |
GO:0072677 | 0.0041 | 11.4643 | 0.3412 | 3 | 12 | eosinophil migration |
GO:0019835 | 0.0042 | 5.2271 | 1.0804 | 5 | 38 | cytolysis |
GO:0070663 | 0.0042 | 2.4587 | 5.6009 | 13 | 197 | regulation of leukocyte proliferation |
GO:0002676 | 0.0046 | 34.4835 | 0.1132 | 2 | 4 | regulation of chronic inflammatory response |
GO:0008588 | 0.0047 | 34.3286 | 0.1137 | 2 | 4 | release of cytoplasmic sequestered NF-kappaB |
GO:0072679 | 0.0047 | 34.3286 | 0.1137 | 2 | 4 | thymocyte migration |
GO:1901668 | 0.0047 | 34.3286 | 0.1137 | 2 | 4 | regulation of superoxide dismutase activity |
GO:0002526 | 0.0047 | 2.8208 | 3.7813 | 10 | 133 | acute inflammatory response |
GO:0046006 | 0.0047 | 5.073 | 1.1088 | 5 | 39 | regulation of activated T cell proliferation |
GO:0002694 | 0.0047 | 1.9272 | 11.9979 | 22 | 422 | regulation of leukocyte activation |
GO:0007166 | 0.0048 | 1.3888 | 69.4569 | 90 | 2443 | cell surface receptor signaling pathway |
GO:0034097 | 0.005 | 1.6188 | 25.3604 | 39 | 892 | response to cytokine |
GO:0006909 | 0.005 | 2.4057 | 5.7146 | 13 | 201 | phagocytosis |
GO:2000108 | 0.0051 | 6.5611 | 0.7108 | 4 | 25 | positive regulation of leukocyte apoptotic process |
GO:0045214 | 0.0053 | 4.9277 | 1.1372 | 5 | 40 | sarcomere organization |
GO:0046850 | 0.0053 | 4.9277 | 1.1372 | 5 | 40 | regulation of bone remodeling |
GO:0045780 | 0.0053 | 10.3172 | 0.3696 | 3 | 13 | positive regulation of bone resorption |
GO:0006766 | 0.0055 | 2.9423 | 3.2696 | 9 | 115 | vitamin metabolic process |
GO:0022407 | 0.0056 | 1.9649 | 10.69 | 20 | 376 | regulation of cell-cell adhesion |
GO:0040017 | 0.0057 | 1.8931 | 12.1969 | 22 | 429 | positive regulation of locomotion |
GO:0051384 | 0.0058 | 2.7312 | 3.895 | 10 | 137 | response to glucocorticoid |
GO:0042345 | 0.0059 | 4.7905 | 1.1657 | 5 | 41 | regulation of NF-kappaB import into nucleus |
GO:0061756 | 0.0059 | 6.2624 | 0.7392 | 4 | 26 | leukocyte adhesion to vascular endothelial cell |
GO:0048525 | 0.0062 | 3.4575 | 2.1892 | 7 | 77 | negative regulation of viral process |
GO:0003417 | 0.0066 | 9.3786 | 0.398 | 3 | 14 | growth plate cartilage development |
GO:0030593 | 0.0067 | 3.4086 | 2.2176 | 7 | 78 | neutrophil chemotaxis |
GO:0042330 | 0.0067 | 1.7896 | 14.642 | 25 | 515 | taxis |
GO:0008284 | 0.0067 | 1.6271 | 22.5742 | 35 | 794 | positive regulation of cell proliferation |
GO:0048870 | 0.007 | 1.7431 | 16.2596 | 27 | 593 | cell motility |
GO:0009620 | 0.0072 | 4.5378 | 1.2225 | 5 | 43 | response to fungus |
GO:0046395 | 0.0072 | 2.2144 | 6.6528 | 14 | 234 | carboxylic acid catabolic process |
GO:0008544 | 0.0075 | 1.8736 | 11.742 | 21 | 413 | epidermis development |
GO:0051272 | 0.0075 | 1.8736 | 11.742 | 21 | 413 | positive regulation of cellular component movement |
GO:0050829 | 0.0076 | 3.7667 | 1.7343 | 6 | 61 | defense response to Gram-negative bacterium |
GO:0002677 | 0.0076 | 22.8842 | 0.1422 | 2 | 5 | negative regulation of chronic inflammatory response |
GO:0002730 | 0.0076 | 22.8842 | 0.1422 | 2 | 5 | regulation of dendritic cell cytokine production |
GO:0042866 | 0.0076 | 22.8842 | 0.1422 | 2 | 5 | pyruvate biosynthetic process |
GO:1901509 | 0.0076 | 22.8842 | 0.1422 | 2 | 5 | regulation of endothelial tube morphogenesis |
GO:2000110 | 0.0076 | 22.8842 | 0.1422 | 2 | 5 | negative regulation of macrophage apoptotic process |
GO:0006955 | 0.0078 | 1.8701 | 11.7888 | 21 | 459 | immune response |
GO:0052547 | 0.0078 | 1.9344 | 10.292 | 19 | 362 | regulation of peptidase activity |
GO:0098581 | 0.008 | 8.5965 | 0.4265 | 3 | 15 | detection of external biotic stimulus |
GO:0010469 | 0.0087 | 1.7698 | 14.1871 | 24 | 499 | regulation of receptor activity |
GO:0010594 | 0.0094 | 2.6868 | 3.5539 | 9 | 125 | regulation of endothelial cell migration |
GO:0032103 | 0.0095 | 2.1355 | 6.8803 | 14 | 242 | positive regulation of response to external stimulus |
GO:0045071 | 0.0095 | 4.2049 | 1.3078 | 5 | 46 | negative regulation of viral genome replication |
GO:0098542 | 0.0096 | 1.8578 | 11.2587 | 20 | 396 | defense response to other organism |
GO:0002076 | 0.0097 | 7.9347 | 0.4549 | 3 | 16 | osteoblast development |
GO:0003159 | 0.0097 | 7.9347 | 0.4549 | 3 | 16 | morphogenesis of an endothelium |
GO:0051818 | 0.0097 | 7.9347 | 0.4549 | 3 | 16 | disruption of cells of other organism involved in symbiotic interaction |
GO:0060575 | 0.0097 | 7.9347 | 0.4549 | 3 | 16 | intestinal epithelial cell differentiation |
GO:1900017 | 0.0097 | 7.9347 | 0.4549 | 3 | 16 | positive regulation of cytokine production involved in inflammatory response |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007156 | 0 | 6.4325 | 5.8924 | 30 | 144 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0060173 | 0 | 5.8779 | 6.5471 | 31 | 160 | limb development |
GO:0035107 | 0 | 6.3183 | 5.565 | 28 | 136 | appendage morphogenesis |
GO:0007275 | 0 | 2.1056 | 78.9377 | 136 | 2224 | multicellular organism development |
GO:0009790 | 0 | 2.6041 | 31.0781 | 71 | 774 | embryo development |
GO:0048663 | 0 | 9.7727 | 2.4039 | 17 | 59 | neuron fate commitment |
GO:0007399 | 0 | 2.6938 | 24.9712 | 59 | 718 | nervous system development |
GO:0010720 | 0 | 2.9366 | 18.0864 | 47 | 442 | positive regulation of cell development |
GO:0045944 | 0 | 2.2151 | 41.6559 | 82 | 1018 | positive regulation of transcription from RNA polymerase II promoter |
GO:0090596 | 0 | 3.8043 | 9.6979 | 32 | 237 | sensory organ morphogenesis |
GO:0007267 | 0 | 2.7857 | 20.261 | 50 | 533 | cell-cell signaling |
GO:0001708 | 0 | 7.1949 | 3.0145 | 17 | 74 | cell fate specification |
GO:0048729 | 0 | 2.5879 | 23.8151 | 55 | 582 | tissue morphogenesis |
GO:0048699 | 0 | 2.6698 | 21.901 | 52 | 578 | generation of neurons |
GO:0051962 | 0 | 3.0664 | 15.1022 | 41 | 372 | positive regulation of nervous system development |
GO:0099537 | 0 | 2.6026 | 22.7921 | 53 | 557 | trans-synaptic signaling |
GO:0001655 | 0 | 3.6241 | 9.7787 | 31 | 241 | urogenital system development |
GO:0050767 | 0 | 2.5935 | 21.9625 | 51 | 543 | regulation of neurogenesis |
GO:0007218 | 0 | 5.8427 | 3.7646 | 18 | 92 | neuropeptide signaling pathway |
GO:0045666 | 0 | 6.2737 | 3.1497 | 16 | 78 | positive regulation of neuron differentiation |
GO:0006355 | 0 | 1.6195 | 132.947 | 187 | 3249 | regulation of transcription, DNA-templated |
GO:2001141 | 0 | 1.6158 | 133.97 | 188 | 3274 | regulation of RNA biosynthetic process |
GO:0061138 | 0 | 3.9048 | 6.7517 | 23 | 165 | morphogenesis of a branching epithelium |
GO:0009952 | 0 | 5.5407 | 3.4735 | 16 | 87 | anterior/posterior pattern specification |
GO:0021983 | 0 | 9.3571 | 1.5959 | 11 | 39 | pituitary gland development |
GO:0060562 | 0 | 2.9997 | 11.9075 | 32 | 291 | epithelial tube morphogenesis |
GO:0019219 | 0 | 1.5586 | 154.9616 | 209 | 3787 | regulation of nucleobase-containing compound metabolic process |
GO:0032989 | 0 | 2.0267 | 38.0141 | 70 | 929 | cellular component morphogenesis |
GO:0048812 | 0 | 2.3713 | 21.81 | 47 | 533 | neuron projection morphogenesis |
GO:0048858 | 0 | 2.346 | 22.5056 | 48 | 550 | cell projection morphogenesis |
GO:0009887 | 0 | 3.3343 | 8.7467 | 26 | 231 | animal organ morphogenesis |
GO:0060485 | 0 | 3.3154 | 8.8122 | 26 | 216 | mesenchyme development |
GO:0030900 | 0 | 4.4835 | 4.6615 | 18 | 118 | forebrain development |
GO:0060581 | 0 | 20.7328 | 0.6138 | 7 | 15 | cell fate commitment involved in pattern specification |
GO:0051961 | 0 | 3.1062 | 10.0662 | 28 | 246 | negative regulation of nervous system development |
GO:0014031 | 0 | 6.3308 | 2.537 | 13 | 62 | mesenchymal cell development |
GO:0007268 | 0 | 2.3498 | 21.013 | 45 | 519 | chemical synaptic transmission |
GO:0021513 | 0 | 13.5564 | 0.9002 | 8 | 22 | spinal cord dorsal/ventral patterning |
GO:0001764 | 0 | 4.2504 | 4.889 | 18 | 120 | neuron migration |
GO:1903508 | 0 | 1.7993 | 53.6862 | 88 | 1312 | positive regulation of nucleic acid-templated transcription |
GO:0021514 | 0 | 16.5839 | 0.6956 | 7 | 17 | ventral spinal cord interneuron differentiation |
GO:0007187 | 0 | 3.5787 | 6.6289 | 21 | 162 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0048709 | 0 | 6.9363 | 1.9925 | 11 | 49 | oligodendrocyte differentiation |
GO:0001822 | 0 | 3.5841 | 6.2929 | 20 | 156 | kidney development |
GO:0061564 | 0 | 2.3997 | 17.3089 | 38 | 423 | axon development |
GO:0048864 | 0 | 5.7171 | 2.537 | 12 | 62 | stem cell development |
GO:0006935 | 0 | 2.2205 | 21.0735 | 43 | 515 | chemotaxis |
GO:0045595 | 0 | 1.7129 | 59.4207 | 93 | 1470 | regulation of cell differentiation |
GO:0001755 | 0 | 8.2187 | 1.4322 | 9 | 35 | neural crest cell migration |
GO:0007411 | 0 | 3.1637 | 7.7345 | 22 | 190 | axon guidance |
GO:0030154 | 0 | 1.6348 | 76.3739 | 112 | 2046 | cell differentiation |
GO:0060042 | 0 | 6.6016 | 1.8823 | 10 | 46 | retina morphogenesis in camera-type eye |
GO:0048667 | 0 | 2.2302 | 19.4776 | 40 | 476 | cell morphogenesis involved in neuron differentiation |
GO:0003203 | 0 | 9.0332 | 1.1867 | 8 | 29 | endocardial cushion morphogenesis |
GO:0009954 | 0 | 9.0332 | 1.1867 | 8 | 29 | proximal/distal pattern formation |
GO:0051254 | 0 | 1.6929 | 56.5506 | 88 | 1382 | positive regulation of RNA metabolic process |
GO:0034654 | 0 | 1.4544 | 157.5395 | 203 | 3850 | nucleobase-containing compound biosynthetic process |
GO:0048704 | 0 | 6.3114 | 1.9471 | 10 | 48 | embryonic skeletal system morphogenesis |
GO:0042472 | 0 | 4.3374 | 3.7237 | 14 | 91 | inner ear morphogenesis |
GO:0043583 | 0 | 3.0186 | 8.0611 | 22 | 197 | ear development |
GO:0055123 | 0 | 3.6302 | 5.2786 | 17 | 129 | digestive system development |
GO:0031328 | 0 | 1.6307 | 67.5579 | 101 | 1651 | positive regulation of cellular biosynthetic process |
GO:0021953 | 0 | 4.2738 | 3.7579 | 14 | 95 | central nervous system neuron differentiation |
GO:0071805 | 0 | 3.2954 | 6.4264 | 19 | 158 | potassium ion transmembrane transport |
GO:0016331 | 0 | 10.5095 | 0.9286 | 7 | 23 | morphogenesis of embryonic epithelium |
GO:0021520 | 0 | 23.6979 | 0.4079 | 5 | 10 | spinal cord motor neuron cell fate specification |
GO:0030324 | 0 | 3.2739 | 6.4653 | 19 | 158 | lung development |
GO:1905114 | 0 | 4.135 | 3.8694 | 14 | 97 | cell surface receptor signaling pathway involved in cell-cell signaling |
GO:0010721 | 0 | 2.6405 | 10.7618 | 26 | 263 | negative regulation of cell development |
GO:0014033 | 0 | 5.2486 | 2.4886 | 11 | 61 | neural crest cell differentiation |
GO:0071773 | 0 | 3.3388 | 6.0151 | 18 | 147 | cellular response to BMP stimulus |
GO:0021915 | 0 | 3.2622 | 6.1379 | 18 | 150 | neural tube development |
GO:0061326 | 0 | 4.2424 | 3.5191 | 13 | 86 | renal tubule development |
GO:0098900 | 0 | 6.2814 | 1.7595 | 9 | 43 | regulation of action potential |
GO:0071542 | 1e-04 | 7.2935 | 1.3913 | 8 | 34 | dopaminergic neuron differentiation |
GO:0098609 | 1e-04 | 1.8887 | 29.6256 | 52 | 724 | cell-cell adhesion |
GO:0023019 | 1e-04 | 11.8246 | 0.7365 | 6 | 18 | signal transduction involved in regulation of gene expression |
GO:0010557 | 1e-04 | 1.6051 | 62.7294 | 93 | 1533 | positive regulation of macromolecule biosynthetic process |
GO:0007626 | 1e-04 | 3.8159 | 4.1461 | 14 | 103 | locomotory behavior |
GO:0097756 | 1e-04 | 4.3932 | 3.1508 | 12 | 77 | negative regulation of blood vessel diameter |
GO:0061364 | 1e-04 | Inf | 0.1228 | 3 | 3 | apoptotic process involved in luteolysis |
GO:0048870 | 1e-04 | 1.646 | 53.768 | 82 | 1314 | cell motility |
GO:0001657 | 1e-04 | 4.0209 | 3.6827 | 13 | 90 | ureteric bud development |
GO:0021884 | 1e-04 | 10.9659 | 0.774 | 6 | 19 | forebrain neuron development |
GO:0072163 | 1e-04 | 3.969 | 3.7237 | 13 | 91 | mesonephric epithelium development |
GO:0021521 | 1e-04 | 31.6015 | 0.2851 | 4 | 7 | ventral spinal cord interneuron specification |
GO:0060075 | 1e-04 | 31.4488 | 0.2864 | 4 | 7 | regulation of resting membrane potential |
GO:0070848 | 1e-04 | 1.9422 | 24.879 | 45 | 608 | response to growth factor |
GO:0048645 | 1e-04 | 5.0527 | 2.3324 | 10 | 57 | animal organ formation |
GO:0060537 | 1e-04 | 2.391 | 12.2165 | 27 | 301 | muscle tissue development |
GO:0021988 | 1e-04 | 7.8911 | 1.1457 | 7 | 28 | olfactory lobe development |
GO:0009889 | 1e-04 | 1.3939 | 167.6057 | 209 | 4096 | regulation of biosynthetic process |
GO:0001656 | 1e-04 | 4.1373 | 3.3145 | 12 | 81 | metanephros development |
GO:0060080 | 1e-04 | 14.7606 | 0.532 | 5 | 13 | inhibitory postsynaptic potential |
GO:0120036 | 1e-04 | 1.635 | 51.3129 | 78 | 1254 | plasma membrane bounded cell projection organization |
GO:0006811 | 1e-04 | 1.6001 | 57.2053 | 85 | 1398 | ion transport |
GO:0035637 | 1e-04 | 2.8401 | 7.3246 | 19 | 179 | multicellular organismal signaling |
GO:0048608 | 1e-04 | 2.2577 | 13.8363 | 29 | 341 | reproductive structure development |
GO:0048066 | 2e-04 | 6.115 | 1.5959 | 8 | 39 | developmental pigmentation |
GO:0042391 | 2e-04 | 2.5229 | 9.8815 | 23 | 246 | regulation of membrane potential |
GO:0035148 | 2e-04 | 3.1553 | 5.606 | 16 | 137 | tube formation |
GO:0072028 | 2e-04 | 4.2852 | 2.9462 | 11 | 72 | nephron morphogenesis |
GO:0035115 | 2e-04 | 7.2039 | 1.2276 | 7 | 30 | embryonic forelimb morphogenesis |
GO:0048562 | 2e-04 | 2.9951 | 6.2337 | 17 | 156 | embryonic organ morphogenesis |
GO:0030916 | 2e-04 | 23.585 | 0.3274 | 4 | 8 | otic vesicle formation |
GO:0010811 | 2e-04 | 3.6404 | 4.0101 | 13 | 98 | positive regulation of cell-substrate adhesion |
GO:0098655 | 2e-04 | 1.8153 | 29.4619 | 50 | 720 | cation transmembrane transport |
GO:0030326 | 2e-04 | 7.0422 | 1.2448 | 7 | 31 | embryonic limb morphogenesis |
GO:0072009 | 2e-04 | 3.5978 | 4.051 | 13 | 99 | nephron epithelium development |
GO:0008038 | 2e-04 | 6.9033 | 1.2685 | 7 | 31 | neuron recognition |
GO:0010628 | 2e-04 | 1.5286 | 68.3353 | 97 | 1670 | positive regulation of gene expression |
GO:0035295 | 2e-04 | 2.2982 | 12.1729 | 26 | 308 | tube development |
GO:0071294 | 2e-04 | 11.8069 | 0.6138 | 5 | 15 | cellular response to zinc ion |
GO:0015844 | 3e-04 | 4.3956 | 2.6188 | 10 | 64 | monoamine transport |
GO:0019935 | 3e-04 | 3.4758 | 4.1738 | 13 | 102 | cyclic-nucleotide-mediated signaling |
GO:0072359 | 3e-04 | 1.6997 | 37.0729 | 59 | 906 | circulatory system development |
GO:0060079 | 3e-04 | 3.7054 | 3.6418 | 12 | 89 | excitatory postsynaptic potential |
GO:0007198 | 3e-04 | 70.6542 | 0.1637 | 3 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0021913 | 3e-04 | 70.6542 | 0.1637 | 3 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0042662 | 3e-04 | 70.6542 | 0.1637 | 3 | 4 | negative regulation of mesodermal cell fate specification |
GO:0071504 | 3e-04 | 70.6542 | 0.1637 | 3 | 4 | cellular response to heparin |
GO:0090244 | 3e-04 | 70.6542 | 0.1637 | 3 | 4 | Wnt signaling pathway involved in somitogenesis |
GO:1905903 | 3e-04 | 70.6542 | 0.1637 | 3 | 4 | negative regulation of mesoderm formation |
GO:0007200 | 3e-04 | 3.6698 | 3.6713 | 12 | 90 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0021515 | 3e-04 | 6.441 | 1.3365 | 7 | 33 | cell differentiation in spinal cord |
GO:0043009 | 3e-04 | 2.2211 | 13.0476 | 27 | 328 | chordate embryonic development |
GO:0046877 | 3e-04 | 18.8667 | 0.3683 | 4 | 9 | regulation of saliva secretion |
GO:0000122 | 3e-04 | 1.7731 | 29.4619 | 49 | 720 | negative regulation of transcription from RNA polymerase II promoter |
GO:0060740 | 3e-04 | 7.8798 | 0.9821 | 6 | 24 | prostate gland epithelium morphogenesis |
GO:0003208 | 3e-04 | 4.6668 | 2.2379 | 9 | 55 | cardiac ventricle morphogenesis |
GO:0006813 | 3e-04 | 3.0369 | 5.4266 | 15 | 134 | potassium ion transport |
GO:0071229 | 3e-04 | 2.7032 | 7.2427 | 18 | 177 | cellular response to acid chemical |
GO:0055085 | 4e-04 | 1.5769 | 51.5175 | 76 | 1259 | transmembrane transport |
GO:0007416 | 4e-04 | 3.8184 | 3.2478 | 11 | 80 | synapse assembly |
GO:0035725 | 4e-04 | 3.0032 | 5.4832 | 15 | 134 | sodium ion transmembrane transport |
GO:0021517 | 4e-04 | 7.546 | 1.0125 | 6 | 25 | ventral spinal cord development |
GO:0045137 | 4e-04 | 2.579 | 7.9793 | 19 | 195 | development of primary sexual characteristics |
GO:0003148 | 4e-04 | 7.4645 | 1.023 | 6 | 25 | outflow tract septum morphogenesis |
GO:0072078 | 4e-04 | 4.0913 | 2.7825 | 10 | 68 | nephron tubule morphogenesis |
GO:0048546 | 4e-04 | 5.1213 | 1.8414 | 8 | 45 | digestive tract morphogenesis |
GO:0030879 | 4e-04 | 3.1148 | 4.9512 | 14 | 121 | mammary gland development |
GO:0003279 | 4e-04 | 3.4783 | 3.8464 | 12 | 94 | cardiac septum development |
GO:0007189 | 5e-04 | 4.445 | 2.3324 | 9 | 57 | adenylate cyclase-activating G-protein coupled receptor signaling pathway |
GO:0021559 | 5e-04 | 15.7211 | 0.4092 | 4 | 10 | trigeminal nerve development |
GO:0021903 | 5e-04 | 15.7211 | 0.4092 | 4 | 10 | rostrocaudal neural tube patterning |
GO:0048666 | 5e-04 | 1.9952 | 17.1074 | 32 | 435 | neuron development |
GO:0003407 | 5e-04 | 4.354 | 2.3733 | 9 | 58 | neural retina development |
GO:0098660 | 6e-04 | 1.7338 | 29.421 | 48 | 719 | inorganic ion transmembrane transport |
GO:2000026 | 6e-04 | 1.5414 | 54.0836 | 78 | 1362 | regulation of multicellular organismal development |
GO:0072091 | 6e-04 | 4.2666 | 2.4142 | 9 | 59 | regulation of stem cell proliferation |
GO:0001759 | 6e-04 | 9.0803 | 0.7365 | 5 | 18 | organ induction |
GO:0021889 | 6e-04 | 35.491 | 0.2037 | 3 | 5 | olfactory bulb interneuron differentiation |
GO:0008344 | 6e-04 | 4.7685 | 1.9516 | 8 | 48 | adult locomotory behavior |
GO:0032229 | 6e-04 | 35.3246 | 0.2046 | 3 | 5 | negative regulation of synaptic transmission, GABAergic |
GO:1904956 | 6e-04 | 35.3246 | 0.2046 | 3 | 5 | regulation of midbrain dopaminergic neuron differentiation |
GO:0060021 | 7e-04 | 3.5292 | 3.4781 | 11 | 85 | palate development |
GO:0045995 | 7e-04 | 3.5061 | 3.4963 | 11 | 86 | regulation of embryonic development |
GO:0046883 | 7e-04 | 2.3348 | 9.657 | 21 | 236 | regulation of hormone secretion |
GO:0003157 | 7e-04 | 13.4743 | 0.4501 | 4 | 11 | endocardium development |
GO:0060019 | 7e-04 | 13.4743 | 0.4501 | 4 | 11 | radial glial cell differentiation |
GO:0021879 | 8e-04 | 8.5893 | 0.7638 | 5 | 19 | forebrain neuron differentiation |
GO:0022414 | 8e-04 | 1.5446 | 50.2899 | 73 | 1229 | reproductive process |
GO:0050808 | 8e-04 | 4.1116 | 2.4863 | 9 | 62 | synapse organization |
GO:0001654 | 8e-04 | 2.0982 | 13.217 | 26 | 323 | eye development |
GO:0030278 | 8e-04 | 2.6657 | 6.5062 | 16 | 159 | regulation of ossification |
GO:0050789 | 9e-04 | 1.3489 | 337.5117 | 372 | 8684 | regulation of biological process |
GO:0007517 | 9e-04 | 2.3525 | 9.1232 | 20 | 227 | muscle organ development |
GO:0008015 | 9e-04 | 2.116 | 12.6014 | 25 | 312 | blood circulation |
GO:0021537 | 9e-04 | 2.8605 | 5.3317 | 14 | 133 | telencephalon development |
GO:0019098 | 0.001 | 6.1646 | 1.1867 | 6 | 29 | reproductive behavior |
GO:0007389 | 0.001 | 3.5726 | 3.1103 | 10 | 81 | pattern specification process |
GO:0002052 | 0.001 | 7.8685 | 0.8184 | 5 | 20 | positive regulation of neuroblast proliferation |
GO:0010454 | 0.0011 | 11.7892 | 0.491 | 4 | 12 | negative regulation of cell fate commitment |
GO:0048934 | 0.0011 | 11.7892 | 0.491 | 4 | 12 | peripheral nervous system neuron differentiation |
GO:0001838 | 0.0011 | 2.9429 | 4.8285 | 13 | 118 | embryonic epithelial tube formation |
GO:0021987 | 0.0011 | 3.098 | 4.2556 | 12 | 104 | cerebral cortex development |
GO:0014855 | 0.0011 | 3.8774 | 2.6188 | 9 | 64 | striated muscle cell proliferation |
GO:0042755 | 0.0012 | 5.9074 | 1.2276 | 6 | 30 | eating behavior |
GO:0051954 | 0.0012 | 5.9074 | 1.2276 | 6 | 30 | positive regulation of amine transport |
GO:0006936 | 0.0012 | 2.071 | 12.8487 | 25 | 314 | muscle contraction |
GO:0010648 | 0.0012 | 1.5275 | 48.6122 | 70 | 1188 | negative regulation of cell communication |
GO:0048701 | 0.0012 | 4.8695 | 1.6777 | 7 | 41 | embryonic cranial skeleton morphogenesis |
GO:0021891 | 0.0012 | 23.5481 | 0.2455 | 3 | 6 | olfactory bulb interneuron development |
GO:0032808 | 0.0012 | 23.5481 | 0.2455 | 3 | 6 | lacrimal gland development |
GO:0046533 | 0.0012 | 23.5481 | 0.2455 | 3 | 6 | negative regulation of photoreceptor cell differentiation |
GO:0008016 | 0.0013 | 2.3246 | 8.7567 | 19 | 214 | regulation of heart contraction |
GO:0023061 | 0.0013 | 1.943 | 15.8358 | 29 | 387 | signal release |
GO:0045669 | 0.0013 | 4.2085 | 2.1687 | 8 | 53 | positive regulation of osteoblast differentiation |
GO:0023057 | 0.0013 | 1.5216 | 48.7759 | 70 | 1192 | negative regulation of signaling |
GO:0021516 | 0.0013 | 7.3762 | 0.8593 | 5 | 21 | dorsal spinal cord development |
GO:0042475 | 0.0014 | 3.4364 | 3.2326 | 10 | 79 | odontogenesis of dentin-containing tooth |
GO:0021675 | 0.0014 | 3.7408 | 2.7007 | 9 | 66 | nerve development |
GO:0001569 | 0.0014 | 5.6707 | 1.2685 | 6 | 31 | branching involved in blood vessel morphogenesis |
GO:0048639 | 0.0014 | 2.6053 | 6.2197 | 15 | 152 | positive regulation of developmental growth |
GO:0003214 | 0.0015 | 10.4786 | 0.532 | 4 | 13 | cardiac left ventricle morphogenesis |
GO:0015812 | 0.0015 | 10.4786 | 0.532 | 4 | 13 | gamma-aminobutyric acid transport |
GO:0007611 | 0.0015 | 2.2889 | 8.8795 | 19 | 217 | learning or memory |
GO:0046660 | 0.0015 | 2.9681 | 4.4193 | 12 | 108 | female sex differentiation |
GO:0003205 | 0.0015 | 4.0865 | 2.2206 | 8 | 55 | cardiac chamber development |
GO:0008589 | 0.0016 | 3.6761 | 2.7416 | 9 | 67 | regulation of smoothened signaling pathway |
GO:0070252 | 0.0016 | 3.1446 | 3.8464 | 11 | 94 | actin-mediated cell contraction |
GO:0035640 | 0.0017 | 6.9419 | 0.9002 | 5 | 22 | exploration behavior |
GO:0055026 | 0.0017 | 5.4522 | 1.3094 | 6 | 32 | negative regulation of cardiac muscle tissue development |
GO:0019229 | 0.0017 | 4.0288 | 2.2506 | 8 | 55 | regulation of vasoconstriction |
GO:0021842 | 0.0017 | Inf | 0.0818 | 2 | 2 | chemorepulsion involved in interneuron migration from the subpallium to the cortex |
GO:0033693 | 0.0017 | Inf | 0.0818 | 2 | 2 | neurofilament bundle assembly |
GO:0043503 | 0.0017 | Inf | 0.0818 | 2 | 2 | skeletal muscle fiber adaptation |
GO:0070352 | 0.0017 | Inf | 0.0818 | 2 | 2 | positive regulation of white fat cell proliferation |
GO:0086097 | 0.0017 | Inf | 0.0818 | 2 | 2 | phospholipase C-activating angiotensin-activated signaling pathway |
GO:2000041 | 0.0017 | Inf | 0.0818 | 2 | 2 | negative regulation of planar cell polarity pathway involved in axis elongation |
GO:2001055 | 0.0017 | Inf | 0.0818 | 2 | 2 | positive regulation of mesenchymal cell apoptotic process |
GO:0001942 | 0.0017 | 3.3391 | 3.3145 | 10 | 81 | hair follicle development |
GO:0044057 | 0.0017 | 1.8821 | 16.872 | 30 | 416 | regulation of system process |
GO:0042063 | 0.0017 | 2.6535 | 5.703 | 14 | 141 | gliogenesis |
GO:0009914 | 0.0018 | 2.0744 | 11.7848 | 23 | 288 | hormone transport |
GO:0040008 | 0.0018 | 1.723 | 23.8969 | 39 | 584 | regulation of growth |
GO:0014013 | 0.0019 | 3.0702 | 3.9283 | 11 | 96 | regulation of gliogenesis |
GO:1903507 | 0.0019 | 1.5293 | 43.5382 | 63 | 1064 | negative regulation of nucleic acid-templated transcription |
GO:0007519 | 0.0019 | 2.6206 | 5.7696 | 14 | 141 | skeletal muscle tissue development |
GO:0022404 | 0.002 | 3.2472 | 3.3963 | 10 | 83 | molting cycle process |
GO:0001964 | 0.0021 | 6.5557 | 0.9411 | 5 | 23 | startle response |
GO:0042733 | 0.0021 | 3.8763 | 2.3253 | 8 | 57 | embryonic digit morphogenesis |
GO:0071495 | 0.0021 | 1.5427 | 40.3962 | 59 | 1007 | cellular response to endogenous stimulus |
GO:0021798 | 0.0021 | 17.6599 | 0.2864 | 3 | 7 | forebrain dorsal/ventral pattern formation |
GO:0035385 | 0.0021 | 17.6599 | 0.2864 | 3 | 7 | Roundabout signaling pathway |
GO:0021766 | 0.0021 | 3.4946 | 2.8644 | 9 | 70 | hippocampus development |
GO:0030850 | 0.0022 | 4.3557 | 1.8414 | 7 | 45 | prostate gland development |
GO:0086002 | 0.0022 | 4.3557 | 1.8414 | 7 | 45 | cardiac muscle cell action potential involved in contraction |
GO:0048593 | 0.0022 | 3.84 | 2.342 | 8 | 58 | camera-type eye morphogenesis |
GO:0007417 | 0.0023 | 2.8071 | 4.6212 | 12 | 125 | central nervous system development |
GO:0086091 | 0.0023 | 5.0621 | 1.3913 | 6 | 34 | regulation of heart rate by cardiac conduction |
GO:0007420 | 0.0023 | 2.1 | 10.6143 | 21 | 275 | brain development |
GO:0046661 | 0.0023 | 2.5596 | 5.8924 | 14 | 144 | male sex differentiation |
GO:0035019 | 0.0023 | 3.438 | 2.9053 | 9 | 71 | somatic stem cell population maintenance |
GO:0003002 | 0.0024 | 2.962 | 4.0426 | 11 | 104 | regionalization |
GO:0048878 | 0.0025 | 1.5411 | 38.9961 | 57 | 953 | chemical homeostasis |
GO:0035235 | 0.0025 | 6.2103 | 0.9821 | 5 | 24 | ionotropic glutamate receptor signaling pathway |
GO:0019233 | 0.0026 | 3.1184 | 3.5191 | 10 | 86 | sensory perception of pain |
GO:0071599 | 0.0026 | 8.5722 | 0.6138 | 4 | 15 | otic vesicle development |
GO:0003151 | 0.0027 | 4.173 | 1.9076 | 7 | 47 | outflow tract morphogenesis |
GO:0031076 | 0.0027 | 4.8872 | 1.4322 | 6 | 35 | embryonic camera-type eye development |
GO:0055074 | 0.0028 | 1.8781 | 15.1811 | 27 | 371 | calcium ion homeostasis |
GO:0046620 | 0.0029 | 3.0777 | 3.56 | 10 | 87 | regulation of organ growth |
GO:0035282 | 0.0029 | 5.9755 | 1.0106 | 5 | 25 | segmentation |
GO:0090101 | 0.003 | 2.8665 | 4.1738 | 11 | 102 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0045992 | 0.003 | 5.8993 | 1.023 | 5 | 25 | negative regulation of embryonic development |
GO:0060441 | 0.003 | 5.8993 | 1.023 | 5 | 25 | epithelial tube branching involved in lung morphogenesis |
GO:2000177 | 0.0031 | 3.2786 | 3.028 | 9 | 74 | regulation of neural precursor cell proliferation |
GO:0032941 | 0.0031 | 4.7239 | 1.4731 | 6 | 36 | secretion by tissue |
GO:0035137 | 0.0032 | 14.2214 | 0.3253 | 3 | 8 | hindlimb morphogenesis |
GO:0055008 | 0.0033 | 3.5713 | 2.4961 | 8 | 61 | cardiac muscle tissue morphogenesis |
GO:0002118 | 0.0033 | 14.1269 | 0.3274 | 3 | 8 | aggressive behavior |
GO:0021603 | 0.0033 | 14.1269 | 0.3274 | 3 | 8 | cranial nerve formation |
GO:0021859 | 0.0033 | 14.1269 | 0.3274 | 3 | 8 | pyramidal neuron differentiation |
GO:2001223 | 0.0033 | 14.1269 | 0.3274 | 3 | 8 | negative regulation of neuron migration |
GO:0032332 | 0.0034 | 7.8573 | 0.6547 | 4 | 16 | positive regulation of chondrocyte differentiation |
GO:2000380 | 0.0034 | 7.8573 | 0.6547 | 4 | 16 | regulation of mesoderm development |
GO:0016055 | 0.0035 | 1.7829 | 17.7179 | 30 | 435 | Wnt signaling pathway |
GO:0051253 | 0.0035 | 1.4738 | 46.4435 | 65 | 1135 | negative regulation of RNA metabolic process |
GO:0061448 | 0.0036 | 2.1538 | 8.8795 | 18 | 217 | connective tissue development |
GO:0042220 | 0.0036 | 3.9398 | 2.005 | 7 | 49 | response to cocaine |
GO:0048635 | 0.0036 | 3.9398 | 2.005 | 7 | 49 | negative regulation of muscle organ development |
GO:1901862 | 0.0036 | 3.9398 | 2.005 | 7 | 49 | negative regulation of muscle tissue development |
GO:0007628 | 0.0036 | 5.618 | 1.0639 | 5 | 26 | adult walking behavior |
GO:0043266 | 0.0037 | 2.9616 | 3.6827 | 10 | 90 | regulation of potassium ion transport |
GO:0007167 | 0.0037 | 1.5246 | 37.2366 | 54 | 910 | enzyme linked receptor protein signaling pathway |
GO:0048705 | 0.0039 | 2.9341 | 3.7076 | 10 | 93 | skeletal system morphogenesis |
GO:0031644 | 0.004 | 3.4409 | 2.5779 | 8 | 63 | regulation of neurological system process |
GO:0033555 | 0.004 | 3.4409 | 2.5779 | 8 | 63 | multicellular organismal response to stress |
GO:0022029 | 0.004 | 3.8479 | 2.046 | 7 | 50 | telencephalon cell migration |
GO:0045665 | 0.0041 | 2.3109 | 6.9252 | 15 | 170 | negative regulation of neuron differentiation |
GO:0003073 | 0.0041 | 3.1333 | 3.1508 | 9 | 77 | regulation of systemic arterial blood pressure |
GO:0072503 | 0.0042 | 1.8185 | 15.6312 | 27 | 382 | cellular divalent inorganic cation homeostasis |
GO:0035296 | 0.0043 | 2.5878 | 4.9922 | 12 | 122 | regulation of tube diameter |
GO:0035116 | 0.0043 | 5.3623 | 1.1048 | 5 | 27 | embryonic hindlimb morphogenesis |
GO:0008585 | 0.0043 | 2.889 | 3.7646 | 10 | 92 | female gonad development |
GO:0003198 | 0.0043 | 7.2524 | 0.6956 | 4 | 17 | epithelial to mesenchymal transition involved in endocardial cushion formation |
GO:0008584 | 0.0045 | 2.5643 | 5.0331 | 12 | 123 | male gonad development |
GO:0021781 | 0.0047 | 11.8085 | 0.3672 | 3 | 9 | glial cell fate commitment |
GO:0001754 | 0.0047 | 4.2936 | 1.5959 | 6 | 39 | eye photoreceptor cell differentiation |
GO:0048664 | 0.0048 | 11.7716 | 0.3683 | 3 | 9 | neuron fate determination |
GO:0060174 | 0.0048 | 11.7716 | 0.3683 | 3 | 9 | limb bud formation |
GO:0060180 | 0.0048 | 11.7716 | 0.3683 | 3 | 9 | female mating behavior |
GO:1905770 | 0.0048 | 11.7716 | 0.3683 | 3 | 9 | regulation of mesodermal cell differentiation |
GO:2000543 | 0.0048 | 11.7716 | 0.3683 | 3 | 9 | positive regulation of gastrulation |
GO:1903524 | 0.0049 | 3.3197 | 2.6598 | 8 | 65 | positive regulation of blood circulation |
GO:0010717 | 0.0049 | 3.0434 | 3.2326 | 9 | 79 | regulation of epithelial to mesenchymal transition |
GO:0030510 | 0.0049 | 3.0434 | 3.2326 | 9 | 79 | regulation of BMP signaling pathway |
GO:0021524 | 0.0049 | 47.0261 | 0.1228 | 2 | 3 | visceral motor neuron differentiation |
GO:0021912 | 0.0049 | 47.0261 | 0.1228 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0035880 | 0.0049 | 47.0261 | 0.1228 | 2 | 3 | embryonic nail plate morphogenesis |
GO:0042126 | 0.0049 | 47.0261 | 0.1228 | 2 | 3 | nitrate metabolic process |
GO:0048807 | 0.0049 | 47.0261 | 0.1228 | 2 | 3 | female genitalia morphogenesis |
GO:0048936 | 0.0049 | 47.0261 | 0.1228 | 2 | 3 | peripheral nervous system neuron axonogenesis |
GO:0060221 | 0.0049 | 47.0261 | 0.1228 | 2 | 3 | retinal rod cell differentiation |
GO:0060594 | 0.0049 | 47.0261 | 0.1228 | 2 | 3 | mammary gland specification |
GO:0060912 | 0.0049 | 47.0261 | 0.1228 | 2 | 3 | cardiac cell fate specification |
GO:0060913 | 0.0049 | 47.0261 | 0.1228 | 2 | 3 | cardiac cell fate determination |
GO:0070384 | 0.0049 | 47.0261 | 0.1228 | 2 | 3 | Harderian gland development |
GO:0072034 | 0.0049 | 47.0261 | 0.1228 | 2 | 3 | renal vesicle induction |
GO:0072197 | 0.0049 | 47.0261 | 0.1228 | 2 | 3 | ureter morphogenesis |
GO:0090427 | 0.0049 | 47.0261 | 0.1228 | 2 | 3 | activation of meiosis |
GO:0031016 | 0.0049 | 5.1656 | 1.138 | 5 | 28 | pancreas development |
GO:0051966 | 0.005 | 3.6764 | 2.1278 | 7 | 52 | regulation of synaptic transmission, glutamatergic |
GO:0003401 | 0.0051 | 5.1288 | 1.1457 | 5 | 28 | axis elongation |
GO:0048713 | 0.0051 | 5.1288 | 1.1457 | 5 | 28 | regulation of oligodendrocyte differentiation |
GO:0060045 | 0.0051 | 5.1288 | 1.1457 | 5 | 28 | positive regulation of cardiac muscle cell proliferation |
GO:0022612 | 0.0051 | 3.0201 | 3.2532 | 9 | 80 | gland morphogenesis |
GO:0003015 | 0.0051 | 2.0287 | 9.9025 | 19 | 242 | heart process |
GO:0007193 | 0.0052 | 3.2782 | 2.6882 | 8 | 66 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
GO:0008284 | 0.0052 | 1.5486 | 31.1477 | 46 | 766 | positive regulation of cell proliferation |
GO:0048644 | 0.0053 | 3.0003 | 3.2735 | 9 | 80 | muscle organ morphogenesis |
GO:0060421 | 0.0054 | 4.167 | 1.6368 | 6 | 40 | positive regulation of heart growth |
GO:0030318 | 0.0054 | 6.7339 | 0.7365 | 4 | 18 | melanocyte differentiation |
GO:0097094 | 0.0054 | 6.7339 | 0.7365 | 4 | 18 | craniofacial suture morphogenesis |
GO:0051965 | 0.0056 | 3.5962 | 2.1687 | 7 | 53 | positive regulation of synapse assembly |
GO:0050807 | 0.0057 | 2.6069 | 4.542 | 11 | 111 | regulation of synapse organization |
GO:2000027 | 0.0058 | 2.0461 | 9.3012 | 18 | 228 | regulation of organ morphogenesis |
GO:0002065 | 0.0058 | 2.7539 | 3.9283 | 10 | 96 | columnar/cuboidal epithelial cell differentiation |
GO:0030814 | 0.0059 | 2.4745 | 5.1968 | 12 | 127 | regulation of cAMP metabolic process |
GO:0007435 | 0.0059 | 4.9148 | 1.1867 | 5 | 29 | salivary gland morphogenesis |
GO:0086019 | 0.0059 | 4.9148 | 1.1867 | 5 | 29 | cell-cell signaling involved in cardiac conduction |
GO:0051270 | 0.0061 | 1.5268 | 32.2445 | 47 | 788 | regulation of cellular component movement |
GO:0001658 | 0.0062 | 3.5194 | 2.2096 | 7 | 54 | branching involved in ureteric bud morphogenesis |
GO:0045600 | 0.0062 | 3.5194 | 2.2096 | 7 | 54 | positive regulation of fat cell differentiation |
GO:0050880 | 0.0062 | 2.453 | 5.2377 | 12 | 128 | regulation of blood vessel size |
GO:0051094 | 0.0064 | 1.6203 | 23.2878 | 36 | 609 | positive regulation of developmental process |
GO:0033993 | 0.0064 | 1.5146 | 33.1856 | 48 | 811 | response to lipid |
GO:0060828 | 0.0065 | 2.0198 | 9.4115 | 18 | 230 | regulation of canonical Wnt signaling pathway |
GO:0016202 | 0.0066 | 3.4762 | 2.232 | 7 | 55 | regulation of striated muscle tissue development |
GO:0035646 | 0.0066 | 10.0893 | 0.4092 | 3 | 10 | endosome to melanosome transport |
GO:0048757 | 0.0066 | 10.0893 | 0.4092 | 3 | 10 | pigment granule maturation |
GO:0060900 | 0.0066 | 10.0893 | 0.4092 | 3 | 10 | embryonic camera-type eye formation |
GO:0070344 | 0.0066 | 10.0893 | 0.4092 | 3 | 10 | regulation of fat cell proliferation |
GO:2000095 | 0.0066 | 10.0893 | 0.4092 | 3 | 10 | regulation of Wnt signaling pathway, planar cell polarity pathway |
GO:0001892 | 0.0067 | 2.878 | 3.3963 | 9 | 83 | embryonic placenta development |
GO:0009187 | 0.0068 | 2.1723 | 7.3246 | 15 | 179 | cyclic nucleotide metabolic process |
GO:0009948 | 0.0069 | 3.935 | 1.7186 | 6 | 42 | anterior/posterior axis specification |
GO:0010243 | 0.0069 | 1.501 | 34.1677 | 49 | 835 | response to organonitrogen compound |
GO:0008285 | 0.0075 | 1.5698 | 25.9838 | 39 | 635 | negative regulation of cell proliferation |
GO:0035094 | 0.0077 | 3.8284 | 1.7595 | 6 | 43 | response to nicotine |
GO:0022600 | 0.0078 | 2.8019 | 3.4781 | 9 | 85 | digestive system process |
GO:0090277 | 0.0078 | 2.8019 | 3.4781 | 9 | 85 | positive regulation of peptide hormone secretion |
GO:0000578 | 0.0079 | 4.5361 | 1.2685 | 5 | 31 | embryonic axis specification |
GO:0003209 | 0.0079 | 4.5361 | 1.2685 | 5 | 31 | cardiac atrium morphogenesis |
GO:0048048 | 0.0079 | 4.5361 | 1.2685 | 5 | 31 | embryonic eye morphogenesis |
GO:0001502 | 0.008 | 5.8913 | 0.8184 | 4 | 20 | cartilage condensation |
GO:0021544 | 0.008 | 5.8913 | 0.8184 | 4 | 20 | subpallium development |
GO:0031290 | 0.008 | 5.8913 | 0.8184 | 4 | 20 | retinal ganglion cell axon guidance |
GO:0043586 | 0.008 | 5.8913 | 0.8184 | 4 | 20 | tongue development |
GO:0050951 | 0.008 | 5.8913 | 0.8184 | 4 | 20 | sensory perception of temperature stimulus |
GO:0060039 | 0.008 | 5.8913 | 0.8184 | 4 | 20 | pericardium development |
GO:0086012 | 0.008 | 5.8913 | 0.8184 | 4 | 20 | membrane depolarization during cardiac muscle cell action potential |
GO:0040012 | 0.008 | 1.5067 | 31.9171 | 46 | 780 | regulation of locomotion |
GO:0051480 | 0.0081 | 1.8967 | 11.0891 | 20 | 271 | regulation of cytosolic calcium ion concentration |
GO:0015850 | 0.0082 | 2.0658 | 8.1839 | 16 | 200 | organic hydroxy compound transport |
GO:0007155 | 0.0082 | 1.6526 | 19.6396 | 31 | 499 | cell adhesion |
GO:0000904 | 0.0084 | 2.4588 | 4.7809 | 11 | 121 | cell morphogenesis involved in differentiation |
GO:0051899 | 0.0085 | 2.7653 | 3.5191 | 9 | 86 | membrane depolarization |
GO:0003207 | 0.0088 | 8.8275 | 0.4501 | 3 | 11 | cardiac chamber formation |
GO:0043476 | 0.0088 | 8.8275 | 0.4501 | 3 | 11 | pigment accumulation |
GO:0061029 | 0.0088 | 8.8275 | 0.4501 | 3 | 11 | eyelid development in camera-type eye |
GO:0048856 | 0.0088 | 1.8269 | 12.7261 | 22 | 424 | anatomical structure development |
GO:0042633 | 0.0089 | 2.5732 | 4.1738 | 10 | 102 | hair cycle |
GO:0051932 | 0.0089 | 4.3887 | 1.3035 | 5 | 32 | synaptic transmission, GABAergic |
GO:0007492 | 0.009 | 2.9552 | 2.9462 | 8 | 72 | endoderm development |
GO:0045844 | 0.009 | 2.9552 | 2.9462 | 8 | 72 | positive regulation of striated muscle tissue development |
GO:0001662 | 0.0091 | 4.3678 | 1.3094 | 5 | 32 | behavioral fear response |
GO:1901381 | 0.0091 | 4.3678 | 1.3094 | 5 | 32 | positive regulation of potassium ion transmembrane transport |
GO:0010976 | 0.0091 | 1.9901 | 9.0023 | 17 | 220 | positive regulation of neuron projection development |
GO:0055021 | 0.0091 | 3.2425 | 2.3733 | 7 | 58 | regulation of cardiac muscle tissue growth |
GO:0060348 | 0.0092 | 2.1571 | 6.8745 | 14 | 168 | bone development |
GO:0001837 | 0.0092 | 3.6682 | 1.8239 | 6 | 45 | epithelial to mesenchymal transition |
GO:0006873 | 0.0095 | 1.5954 | 22.2601 | 34 | 544 | cellular ion homeostasis |
GO:0048589 | 0.0095 | 1.7351 | 15.0835 | 25 | 374 | developmental growth |
GO:0001992 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0001994 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure |
GO:0003164 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | His-Purkinje system development |
GO:0003308 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | negative regulation of Wnt signaling pathway involved in heart development |
GO:0007621 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | negative regulation of female receptivity |
GO:0014034 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | neural crest cell fate commitment |
GO:0014054 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | positive regulation of gamma-aminobutyric acid secretion |
GO:0021523 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | somatic motor neuron differentiation |
GO:0032430 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | positive regulation of phospholipase A2 activity |
GO:0034287 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | detection of monosaccharide stimulus |
GO:0048866 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | stem cell fate specification |
GO:0050923 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | regulation of negative chemotaxis |
GO:0051414 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | response to cortisol |
GO:0051594 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | detection of glucose |
GO:0060018 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | astrocyte fate commitment |
GO:0060214 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | endocardium formation |
GO:0060364 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | frontal suture morphogenesis |
GO:0061009 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | common bile duct development |
GO:0061056 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | sclerotome development |
GO:0072086 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | specification of loop of Henle identity |
GO:0072289 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | metanephric nephron tubule formation |
GO:0097118 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | neuroligin clustering involved in postsynaptic membrane assembly |
GO:1901078 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | negative regulation of relaxation of muscle |
GO:1901843 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | positive regulation of high voltage-gated calcium channel activity |
GO:2000809 | 0.0095 | 23.5114 | 0.1637 | 2 | 4 | positive regulation of synaptic vesicle clustering |
GO:0014821 | 0.0095 | 5.5444 | 0.8593 | 4 | 21 | phasic smooth muscle contraction |
GO:0032925 | 0.0095 | 5.5444 | 0.8593 | 4 | 21 | regulation of activin receptor signaling pathway |
GO:0060487 | 0.0095 | 5.5444 | 0.8593 | 4 | 21 | lung epithelial cell differentiation |
GO:0031018 | 0.0096 | 3.6315 | 1.8414 | 6 | 45 | endocrine pancreas development |
GO:0050432 | 0.0096 | 3.6315 | 1.8414 | 6 | 45 | catecholamine secretion |
GO:0001756 | 0.0098 | 3.1954 | 2.4031 | 7 | 59 | somitogenesis |
GO:0034765 | 0.0099 | 1.7087 | 15.9176 | 26 | 389 | regulation of ion transmembrane transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 3.643 | 8.3102 | 27 | 298 | olfactory receptor activity |
GO:0004930 | 0 | 2.3103 | 18.9071 | 40 | 678 | G-protein coupled receptor activity |
GO:0005549 | 0 | 5.7352 | 2.0078 | 10 | 72 | odorant binding |
GO:0060089 | 1e-04 | 1.7496 | 37.8421 | 61 | 1357 | molecular transducer activity |
GO:0099600 | 2e-04 | 1.7989 | 29.9223 | 50 | 1073 | transmembrane receptor activity |
GO:0038023 | 2e-04 | 1.7761 | 31.5397 | 52 | 1131 | signaling receptor activity |
GO:0004727 | 8e-04 | Inf | 0.0558 | 2 | 2 | prenylated protein tyrosine phosphatase activity |
GO:0008147 | 8e-04 | Inf | 0.0558 | 2 | 2 | structural constituent of bone |
GO:0061134 | 0.0012 | 2.8727 | 4.8523 | 13 | 174 | peptidase regulator activity |
GO:0004866 | 0.0014 | 3.1637 | 3.7478 | 11 | 135 | endopeptidase inhibitor activity |
GO:0005125 | 0.0022 | 2.6712 | 5.1869 | 13 | 186 | cytokine activity |
GO:0019956 | 0.0024 | 8.2715 | 0.5856 | 4 | 21 | chemokine binding |
GO:0030545 | 0.0035 | 1.9833 | 11.6845 | 22 | 419 | receptor regulator activity |
GO:0019825 | 0.0039 | 5.3333 | 1.0597 | 5 | 38 | oxygen binding |
GO:0004950 | 0.0041 | 7.0293 | 0.6693 | 4 | 24 | chemokine receptor activity |
GO:0019828 | 0.0045 | 35.0215 | 0.1115 | 2 | 4 | aspartic-type endopeptidase inhibitor activity |
GO:0005504 | 0.0047 | 6.6941 | 0.6972 | 4 | 25 | fatty acid binding |
GO:0005200 | 0.005 | 3.2483 | 2.6492 | 8 | 95 | structural constituent of cytoskeleton |
GO:0008201 | 0.0051 | 2.7874 | 3.8205 | 10 | 137 | heparin binding |
GO:0031406 | 0.0055 | 2.5982 | 4.4897 | 11 | 161 | carboxylic acid binding |
GO:0050544 | 0.0073 | 23.3461 | 0.1394 | 2 | 5 | arachidonic acid binding |
GO:0015238 | 0.0076 | 8.7704 | 0.4183 | 3 | 15 | drug transmembrane transporter activity |
GO:0005509 | 0.008 | 1.7041 | 17.206 | 28 | 617 | calcium ion binding |
GO:0008308 | 0.0092 | 8.0952 | 0.4462 | 3 | 16 | voltage-gated anion channel activity |
GO:0016638 | 0.0092 | 8.0952 | 0.4462 | 3 | 16 | oxidoreductase activity, acting on the CH-NH2 group of donors |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002275 | 0 | 4.3172 | 4.4583 | 17 | 476 | myeloid cell activation involved in immune response |
GO:0002263 | 0 | 3.8417 | 5.6198 | 19 | 600 | cell activation involved in immune response |
GO:0043312 | 0 | 4.1693 | 4.0181 | 15 | 429 | neutrophil degranulation |
GO:0042119 | 0 | 4.0681 | 4.1118 | 15 | 439 | neutrophil activation |
GO:0032094 | 0 | 18.239 | 0.3278 | 5 | 35 | response to food |
GO:0045321 | 0 | 3.0756 | 8.1571 | 22 | 895 | leukocyte activation |
GO:0009991 | 0 | 3.9691 | 3.9057 | 14 | 417 | response to extracellular stimulus |
GO:0045730 | 1e-04 | 22.8874 | 0.2154 | 4 | 23 | respiratory burst |
GO:0002676 | 1e-04 | 54.0109 | 0.0843 | 3 | 9 | regulation of chronic inflammatory response |
GO:0002444 | 1e-04 | 3.5178 | 4.3787 | 14 | 474 | myeloid leukocyte mediated immunity |
GO:0032496 | 3e-04 | 4.1089 | 2.6413 | 10 | 282 | response to lipopolysaccharide |
GO:0060326 | 3e-04 | 4.4914 | 2.173 | 9 | 232 | cell chemotaxis |
GO:0045055 | 4e-04 | 2.8876 | 6.0787 | 16 | 649 | regulated exocytosis |
GO:0050900 | 5e-04 | 4.7892 | 1.8095 | 8 | 201 | leukocyte migration |
GO:0006955 | 5e-04 | 2.527 | 8.8795 | 20 | 1052 | immune response |
GO:0016192 | 5e-04 | 2.1409 | 15.342 | 29 | 1638 | vesicle-mediated transport |
GO:0006968 | 7e-04 | 11.1353 | 0.4028 | 4 | 43 | cellular defense response |
GO:0051716 | 0.001 | 1.709 | 59.4103 | 78 | 6343 | cellular response to stimulus |
GO:0071677 | 0.0011 | 17.0412 | 0.2061 | 3 | 22 | positive regulation of mononuclear cell migration |
GO:0048247 | 0.0011 | 9.6467 | 0.4589 | 4 | 49 | lymphocyte chemotaxis |
GO:2000145 | 0.0012 | 2.5796 | 6.7531 | 16 | 721 | regulation of cell motility |
GO:0097527 | 0.0013 | 53.6295 | 0.0562 | 2 | 6 | necroptotic signaling pathway |
GO:0060142 | 0.0014 | 15.4161 | 0.2248 | 3 | 24 | regulation of syncytium formation by plasma membrane fusion |
GO:0002480 | 0.0018 | 42.9007 | 0.0656 | 2 | 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent |
GO:0002887 | 0.0018 | 42.9007 | 0.0656 | 2 | 7 | negative regulation of myeloid leukocyte mediated immunity |
GO:0043301 | 0.0018 | 42.9007 | 0.0656 | 2 | 7 | negative regulation of leukocyte degranulation |
GO:0034341 | 0.0024 | 4.7239 | 1.3581 | 6 | 145 | response to interferon-gamma |
GO:0031295 | 0.0025 | 7.6097 | 0.5713 | 4 | 61 | T cell costimulation |
GO:0050832 | 0.0027 | 11.9855 | 0.281 | 3 | 30 | defense response to fungus |
GO:0006909 | 0.0029 | 3.9634 | 1.8826 | 7 | 201 | phagocytosis |
GO:0002685 | 0.0029 | 4.5583 | 1.4049 | 6 | 150 | regulation of leukocyte migration |
GO:0010819 | 0.003 | 30.6393 | 0.0843 | 2 | 9 | regulation of T cell chemotaxis |
GO:1903039 | 0.003 | 3.9224 | 1.9014 | 7 | 203 | positive regulation of leukocyte cell-cell adhesion |
GO:0042592 | 0.003 | 1.9679 | 14.0213 | 25 | 1497 | homeostatic process |
GO:0007584 | 0.0035 | 4.3774 | 1.4602 | 6 | 157 | response to nutrient |
GO:0002478 | 0.0035 | 4.3742 | 1.4611 | 6 | 156 | antigen processing and presentation of exogenous peptide antigen |
GO:0002479 | 0.0036 | 6.8822 | 0.6275 | 4 | 67 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent |
GO:0040015 | 0.0037 | 26.8076 | 0.0937 | 2 | 10 | negative regulation of multicellular organism growth |
GO:0009617 | 0.0038 | 2.7447 | 4.2804 | 11 | 457 | response to bacterium |
GO:0033280 | 0.0042 | 10.1094 | 0.3278 | 3 | 35 | response to vitamin D |
GO:0002544 | 0.0044 | 24.3431 | 0.1009 | 2 | 11 | chronic inflammatory response |
GO:0018119 | 0.0045 | 23.8273 | 0.103 | 2 | 11 | peptidyl-cysteine S-nitrosylation |
GO:0070098 | 0.0046 | 6.374 | 0.6744 | 4 | 72 | chemokine-mediated signaling pathway |
GO:0006094 | 0.0049 | 6.2812 | 0.6837 | 4 | 73 | gluconeogenesis |
GO:0022610 | 0.005 | 1.989 | 11.4924 | 21 | 1227 | biological adhesion |
GO:0046903 | 0.0051 | 1.9299 | 13.0285 | 23 | 1391 | secretion |
GO:0030029 | 0.0053 | 2.4061 | 5.779 | 13 | 617 | actin filament-based process |
GO:0032099 | 0.0054 | 21.4432 | 0.1124 | 2 | 12 | negative regulation of appetite |
GO:0051798 | 0.0054 | 21.4432 | 0.1124 | 2 | 12 | positive regulation of hair follicle development |
GO:0048870 | 0.0056 | 2.4907 | 5.1716 | 12 | 593 | cell motility |
GO:0007010 | 0.0061 | 2.0189 | 10.1811 | 19 | 1087 | cytoskeleton organization |
GO:0019730 | 0.0062 | 5.8548 | 0.7306 | 4 | 78 | antimicrobial humoral response |
GO:0045785 | 0.0064 | 2.8621 | 3.3344 | 9 | 356 | positive regulation of cell adhesion |
GO:0006952 | 0.0064 | 1.9442 | 11.7551 | 21 | 1288 | defense response |
GO:0046364 | 0.0067 | 5.7 | 0.7493 | 4 | 80 | monosaccharide biosynthetic process |
GO:0060333 | 0.0067 | 5.7 | 0.7493 | 4 | 80 | interferon-gamma-mediated signaling pathway |
GO:0007186 | 0.0069 | 1.9933 | 10.3049 | 19 | 1108 | G-protein coupled receptor signaling pathway |
GO:0050911 | 0.007 | 3.033 | 2.7912 | 8 | 298 | detection of chemical stimulus involved in sensory perception of smell |
GO:0003417 | 0.0074 | 17.8669 | 0.1311 | 2 | 14 | growth plate cartilage development |
GO:0032108 | 0.0074 | 17.8669 | 0.1311 | 2 | 14 | negative regulation of response to nutrient levels |
GO:0044130 | 0.0074 | 17.8669 | 0.1311 | 2 | 14 | negative regulation of growth of symbiont in host |
GO:0055114 | 0.0075 | 2.1046 | 8.158 | 16 | 871 | oxidation-reduction process |
GO:2001239 | 0.0076 | 8.0832 | 0.4028 | 3 | 43 | regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO:0002474 | 0.008 | 5.4135 | 0.7868 | 4 | 84 | antigen processing and presentation of peptide antigen via MHC class I |
GO:0002695 | 0.008 | 4.2803 | 1.2363 | 5 | 132 | negative regulation of leukocyte activation |
GO:0048010 | 0.0083 | 5.3463 | 0.7961 | 4 | 85 | vascular endothelial growth factor receptor signaling pathway |
GO:0010043 | 0.0086 | 7.6972 | 0.4215 | 3 | 45 | response to zinc ion |
GO:0043244 | 0.0087 | 5.2808 | 0.8055 | 4 | 86 | regulation of protein complex disassembly |
GO:0009612 | 0.009 | 3.5577 | 1.7796 | 6 | 190 | response to mechanical stimulus |
GO:0071356 | 0.009 | 3.1669 | 2.3322 | 7 | 249 | cellular response to tumor necrosis factor |
GO:0006949 | 0.0091 | 7.5177 | 0.4308 | 3 | 46 | syncytium formation |
GO:0030834 | 0.0091 | 7.5177 | 0.4308 | 3 | 46 | regulation of actin filament depolymerization |
GO:0045123 | 0.0091 | 7.5177 | 0.4308 | 3 | 46 | cellular extravasation |
GO:0042330 | 0.0091 | 2.4191 | 4.8236 | 11 | 515 | taxis |
GO:0051384 | 0.0094 | 4.1168 | 1.2832 | 5 | 137 | response to glucocorticoid |
GO:0002149 | 0.0094 | Inf | 0.0094 | 1 | 1 | hypochlorous acid biosynthetic process |
GO:0002881 | 0.0094 | Inf | 0.0094 | 1 | 1 | negative regulation of chronic inflammatory response to non-antigenic stimulus |
GO:0003421 | 0.0094 | Inf | 0.0094 | 1 | 1 | growth plate cartilage axis specification |
GO:0006218 | 0.0094 | Inf | 0.0094 | 1 | 1 | uridine catabolic process |
GO:0010722 | 0.0094 | Inf | 0.0094 | 1 | 1 | regulation of ferrochelatase activity |
GO:0015689 | 0.0094 | Inf | 0.0094 | 1 | 1 | molybdate ion transport |
GO:0015728 | 0.0094 | Inf | 0.0094 | 1 | 1 | mevalonate transport |
GO:0019442 | 0.0094 | Inf | 0.0094 | 1 | 1 | tryptophan catabolic process to acetyl-CoA |
GO:0032685 | 0.0094 | Inf | 0.0094 | 1 | 1 | negative regulation of granulocyte macrophage colony-stimulating factor production |
GO:0034120 | 0.0094 | Inf | 0.0094 | 1 | 1 | positive regulation of erythrocyte aggregation |
GO:0035238 | 0.0094 | Inf | 0.0094 | 1 | 1 | vitamin A biosynthetic process |
GO:0038192 | 0.0094 | Inf | 0.0094 | 1 | 1 | gastric inhibitory peptide signaling pathway |
GO:0051780 | 0.0094 | Inf | 0.0094 | 1 | 1 | behavioral response to nutrient |
GO:0061048 | 0.0094 | Inf | 0.0094 | 1 | 1 | negative regulation of branching involved in lung morphogenesis |
GO:0098974 | 0.0094 | Inf | 0.0094 | 1 | 1 | postsynaptic actin cytoskeleton organization |
GO:1901810 | 0.0094 | Inf | 0.0094 | 1 | 1 | beta-carotene metabolic process |
GO:1903403 | 0.0094 | Inf | 0.0094 | 1 | 1 | negative regulation of renal phosphate excretion |
GO:1990268 | 0.0094 | Inf | 0.0094 | 1 | 1 | response to gold nanoparticle |
GO:1990539 | 0.0094 | Inf | 0.0094 | 1 | 1 | fructose import across plasma membrane |
GO:0000185 | 0.0096 | 15.3124 | 0.1499 | 2 | 16 | activation of MAPKKK activity |
GO:0044144 | 0.0096 | 15.3124 | 0.1499 | 2 | 16 | modulation of growth of symbiont involved in interaction with host |
GO:0045661 | 0.0097 | 7.3463 | 0.4402 | 3 | 47 | regulation of myoblast differentiation |
GO:0042113 | 0.0097 | 3.4999 | 1.8077 | 6 | 193 | B cell activation |
GO:1901606 | 0.0097 | 5.0933 | 0.8336 | 4 | 89 | alpha-amino acid catabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007420 | 0 | 4.018 | 8.0626 | 28 | 613 | brain development |
GO:0048663 | 0 | 13.5712 | 0.8944 | 10 | 68 | neuron fate commitment |
GO:0001764 | 0 | 8.9022 | 1.5632 | 12 | 120 | neuron migration |
GO:0060284 | 0 | 3.201 | 9.9303 | 28 | 755 | regulation of cell development |
GO:0001708 | 0 | 10.4658 | 1.0027 | 9 | 77 | cell fate specification |
GO:0051960 | 0 | 3.2269 | 9.4699 | 27 | 720 | regulation of nervous system development |
GO:0022008 | 0 | 3.1691 | 10.1286 | 28 | 831 | neurogenesis |
GO:0019098 | 0 | 20.1535 | 0.3814 | 6 | 29 | reproductive behavior |
GO:0021953 | 0 | 6.803 | 1.8191 | 11 | 141 | central nervous system neuron differentiation |
GO:0032989 | 0 | 2.7723 | 12.2188 | 30 | 929 | cellular component morphogenesis |
GO:0048812 | 0 | 3.3239 | 7.0104 | 21 | 533 | neuron projection morphogenesis |
GO:0021513 | 0 | 22.6135 | 0.2894 | 5 | 22 | spinal cord dorsal/ventral patterning |
GO:0021872 | 0 | 10.6391 | 0.7629 | 7 | 58 | forebrain generation of neurons |
GO:0048858 | 0 | 3.2133 | 7.234 | 21 | 550 | cell projection morphogenesis |
GO:0032502 | 0 | 2.0814 | 38.1491 | 62 | 3250 | developmental process |
GO:0048667 | 0 | 3.3444 | 6.2607 | 19 | 476 | cell morphogenesis involved in neuron differentiation |
GO:0045665 | 0 | 5.2374 | 2.3149 | 11 | 176 | negative regulation of neuron differentiation |
GO:0003002 | 0 | 4.1554 | 3.6988 | 14 | 285 | regionalization |
GO:0007411 | 0 | 4.7761 | 2.7621 | 12 | 210 | axon guidance |
GO:0060581 | 0 | 27.8257 | 0.1973 | 4 | 15 | cell fate commitment involved in pattern specification |
GO:0045596 | 0 | 2.952 | 7.8258 | 21 | 595 | negative regulation of cell differentiation |
GO:0048870 | 0 | 2.2794 | 17.2826 | 35 | 1314 | cell motility |
GO:0061564 | 0 | 3.3428 | 5.5636 | 17 | 423 | axon development |
GO:0021514 | 1e-04 | 23.5416 | 0.2236 | 4 | 17 | ventral spinal cord interneuron differentiation |
GO:0007399 | 1e-04 | 3.0922 | 6.4668 | 18 | 591 | nervous system development |
GO:0035295 | 1e-04 | 2.9499 | 7.0367 | 19 | 535 | tube development |
GO:0007189 | 1e-04 | 9.0717 | 0.7497 | 6 | 57 | adenylate cyclase-activating G-protein coupled receptor signaling pathway |
GO:0007618 | 1e-04 | 12.0013 | 0.4866 | 5 | 37 | mating |
GO:0072091 | 1e-04 | 8.7282 | 0.776 | 6 | 59 | regulation of stem cell proliferation |
GO:0014706 | 1e-04 | 3.4343 | 4.4193 | 14 | 336 | striated muscle tissue development |
GO:0021537 | 2e-04 | 4.1224 | 2.8936 | 11 | 220 | telencephalon development |
GO:0021842 | 2e-04 | Inf | 0.0263 | 2 | 2 | chemorepulsion involved in interneuron migration from the subpallium to the cortex |
GO:0043503 | 2e-04 | Inf | 0.0263 | 2 | 2 | skeletal muscle fiber adaptation |
GO:0060180 | 2e-04 | 38.0769 | 0.1184 | 3 | 9 | female mating behavior |
GO:0051241 | 2e-04 | 2.2983 | 12.9159 | 27 | 982 | negative regulation of multicellular organismal process |
GO:0021903 | 3e-04 | 32.6352 | 0.1315 | 3 | 10 | rostrocaudal neural tube patterning |
GO:0048468 | 3e-04 | 2.3156 | 12.4596 | 26 | 1048 | cell development |
GO:0021517 | 3e-04 | 14.8591 | 0.3225 | 4 | 25 | ventral spinal cord development |
GO:0003148 | 3e-04 | 14.5655 | 0.3288 | 4 | 25 | outflow tract septum morphogenesis |
GO:0072132 | 3e-04 | 9.3612 | 0.605 | 5 | 46 | mesenchyme morphogenesis |
GO:0050793 | 4e-04 | 1.8455 | 28.8175 | 47 | 2191 | regulation of developmental process |
GO:1901379 | 4e-04 | 6.8979 | 0.9601 | 6 | 73 | regulation of potassium ion transmembrane transport |
GO:0048709 | 4e-04 | 8.8439 | 0.6359 | 5 | 49 | oligodendrocyte differentiation |
GO:0008344 | 4e-04 | 6.796 | 0.9733 | 6 | 74 | adult locomotory behavior |
GO:0035107 | 4e-04 | 4.8447 | 1.7888 | 8 | 136 | appendage morphogenesis |
GO:0048935 | 5e-04 | 25.3795 | 0.1578 | 3 | 12 | peripheral nervous system neuron development |
GO:0021524 | 5e-04 | 151.5816 | 0.0395 | 2 | 3 | visceral motor neuron differentiation |
GO:0021912 | 5e-04 | 151.5816 | 0.0395 | 2 | 3 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification |
GO:0060912 | 5e-04 | 151.5816 | 0.0395 | 2 | 3 | cardiac cell fate specification |
GO:0060913 | 5e-04 | 151.5816 | 0.0395 | 2 | 3 | cardiac cell fate determination |
GO:0072001 | 5e-04 | 3.5523 | 3.3276 | 11 | 253 | renal system development |
GO:0007171 | 6e-04 | 22.84 | 0.171 | 3 | 13 | activation of transmembrane receptor protein tyrosine kinase activity |
GO:0009887 | 6e-04 | 2.7202 | 6.3496 | 16 | 511 | animal organ morphogenesis |
GO:0060538 | 7e-04 | 4.458 | 1.9334 | 8 | 147 | skeletal muscle organ development |
GO:0042711 | 7e-04 | 20.7622 | 0.1841 | 3 | 14 | maternal behavior |
GO:0021515 | 8e-04 | 10.7543 | 0.4257 | 4 | 33 | cell differentiation in spinal cord |
GO:0030182 | 9e-04 | 2.3111 | 9.8839 | 21 | 832 | neuron differentiation |
GO:0051937 | 9e-04 | 7.3754 | 0.7497 | 5 | 57 | catecholamine transport |
GO:0022010 | 9e-04 | 19.0308 | 0.1973 | 3 | 15 | central nervous system myelination |
GO:0048562 | 9e-04 | 3.3152 | 3.5512 | 11 | 270 | embryonic organ morphogenesis |
GO:0071804 | 9e-04 | 3.8608 | 2.499 | 9 | 190 | cellular potassium ion transport |
GO:0014032 | 0.001 | 7.2358 | 0.7629 | 5 | 58 | neural crest cell development |
GO:0009790 | 0.001 | 2.2829 | 9.945 | 21 | 774 | embryo development |
GO:0001992 | 0.001 | 75.7857 | 0.0526 | 2 | 4 | regulation of systemic arterial blood pressure by vasopressin |
GO:0001994 | 0.001 | 75.7857 | 0.0526 | 2 | 4 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure |
GO:0007621 | 0.001 | 75.7857 | 0.0526 | 2 | 4 | negative regulation of female receptivity |
GO:0021913 | 0.001 | 75.7857 | 0.0526 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0007268 | 0.0011 | 2.4948 | 7.3129 | 17 | 556 | chemical synaptic transmission |
GO:0099537 | 0.0011 | 2.49 | 7.326 | 17 | 557 | trans-synaptic signaling |
GO:0001709 | 0.0012 | 9.6504 | 0.4688 | 4 | 36 | cell fate determination |
GO:0060173 | 0.0013 | 4.0731 | 2.1044 | 8 | 160 | limb development |
GO:0006935 | 0.0013 | 2.5294 | 6.7736 | 16 | 515 | chemotaxis |
GO:0007187 | 0.0014 | 4.0197 | 2.1307 | 8 | 162 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0003279 | 0.0015 | 5.2443 | 1.2363 | 6 | 94 | cardiac septum development |
GO:0021884 | 0.0015 | 15.3741 | 0.2345 | 3 | 18 | forebrain neuron development |
GO:0023019 | 0.0016 | 15.2215 | 0.2367 | 3 | 18 | signal transduction involved in regulation of gene expression |
GO:0003197 | 0.0017 | 8.7311 | 0.513 | 4 | 39 | endocardial cushion development |
GO:0021983 | 0.0017 | 8.7311 | 0.513 | 4 | 39 | pituitary gland development |
GO:0014013 | 0.0017 | 5.1271 | 1.2627 | 6 | 96 | regulation of gliogenesis |
GO:0021510 | 0.0018 | 8.587 | 0.5193 | 4 | 41 | spinal cord development |
GO:0061061 | 0.0018 | 2.3757 | 7.6548 | 17 | 582 | muscle structure development |
GO:0050768 | 0.0018 | 8.5182 | 0.5225 | 4 | 42 | negative regulation of neurogenesis |
GO:0098742 | 0.0019 | 6.1555 | 0.8839 | 5 | 69 | cell-cell adhesion via plasma-membrane adhesion molecules |
GO:0008306 | 0.002 | 6.0831 | 0.8944 | 5 | 68 | associative learning |
GO:0007626 | 0.0021 | 4.8856 | 1.3202 | 6 | 103 | locomotory behavior |
GO:0048592 | 0.0021 | 4.184 | 1.7888 | 7 | 136 | eye morphogenesis |
GO:0002052 | 0.0022 | 13.429 | 0.2631 | 3 | 20 | positive regulation of neuroblast proliferation |
GO:0019935 | 0.0023 | 4.8047 | 1.3416 | 6 | 102 | cyclic-nucleotide-mediated signaling |
GO:0019219 | 0.0023 | 1.5664 | 49.8091 | 68 | 3787 | regulation of nucleobase-containing compound metabolic process |
GO:0006355 | 0.0024 | 1.5907 | 42.733 | 60 | 3249 | regulation of transcription, DNA-templated |
GO:0019336 | 0.0025 | 37.8878 | 0.0789 | 2 | 6 | phenol-containing compound catabolic process |
GO:0033504 | 0.0025 | 37.8878 | 0.0789 | 2 | 6 | floor plate development |
GO:0060956 | 0.0025 | 37.8878 | 0.0789 | 2 | 6 | endocardial cell differentiation |
GO:0021987 | 0.0025 | 4.706 | 1.3679 | 6 | 104 | cerebral cortex development |
GO:0031016 | 0.0027 | 5.634 | 0.9601 | 5 | 73 | pancreas development |
GO:0007275 | 0.0028 | 1.6295 | 39.9646 | 56 | 3491 | multicellular organism development |
GO:0003272 | 0.0029 | 12.0138 | 0.2894 | 3 | 22 | endocardial cushion formation |
GO:0035640 | 0.0029 | 12.0138 | 0.2894 | 3 | 22 | exploration behavior |
GO:2000177 | 0.0029 | 5.5519 | 0.9733 | 5 | 74 | regulation of neural precursor cell proliferation |
GO:2001141 | 0.0029 | 1.5749 | 43.0618 | 60 | 3274 | regulation of RNA biosynthetic process |
GO:0007156 | 0.003 | 3.9375 | 1.894 | 7 | 144 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0007389 | 0.0032 | 5.4138 | 0.9946 | 5 | 81 | pattern specification process |
GO:0048596 | 0.0033 | 11.4123 | 0.3025 | 3 | 23 | embryonic camera-type eye morphogenesis |
GO:0021521 | 0.0034 | 30.6165 | 0.0912 | 2 | 7 | ventral spinal cord interneuron specification |
GO:0001826 | 0.0035 | 30.3082 | 0.0921 | 2 | 7 | inner cell mass cell differentiation |
GO:0021826 | 0.0035 | 30.3082 | 0.0921 | 2 | 7 | substrate-independent telencephalic tangential migration |
GO:0021830 | 0.0035 | 30.3082 | 0.0921 | 2 | 7 | interneuron migration from the subpallium to the cortex |
GO:0021860 | 0.0035 | 30.3082 | 0.0921 | 2 | 7 | pyramidal neuron development |
GO:0045995 | 0.0035 | 4.3902 | 1.4599 | 6 | 111 | regulation of embryonic development |
GO:0042220 | 0.0039 | 6.7863 | 0.6445 | 4 | 49 | response to cocaine |
GO:0030030 | 0.0039 | 10.5621 | 0.3222 | 3 | 26 | cell projection organization |
GO:0001993 | 0.0046 | 25.2551 | 0.1052 | 2 | 8 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine |
GO:0002118 | 0.0046 | 25.2551 | 0.1052 | 2 | 8 | aggressive behavior |
GO:0061303 | 0.0046 | 25.2551 | 0.1052 | 2 | 8 | cornea development in camera-type eye |
GO:2001223 | 0.0046 | 25.2551 | 0.1052 | 2 | 8 | negative regulation of neuron migration |
GO:0030326 | 0.0047 | 4.1138 | 1.552 | 6 | 118 | embryonic limb morphogenesis |
GO:0045597 | 0.005 | 2.0435 | 9.9063 | 19 | 766 | positive regulation of cell differentiation |
GO:0030278 | 0.0051 | 3.5453 | 2.0913 | 7 | 159 | regulation of ossification |
GO:0021885 | 0.0051 | 6.2306 | 0.6971 | 4 | 53 | forebrain cell migration |
GO:0045669 | 0.0051 | 6.2306 | 0.6971 | 4 | 53 | positive regulation of osteoblast differentiation |
GO:0060562 | 0.0052 | 2.759 | 3.8274 | 10 | 291 | epithelial tube morphogenesis |
GO:0051240 | 0.0057 | 1.7605 | 17.7459 | 29 | 1362 | positive regulation of multicellular organismal process |
GO:0048713 | 0.0058 | 9.1268 | 0.3683 | 3 | 28 | regulation of oligodendrocyte differentiation |
GO:0007423 | 0.0058 | 2.2788 | 6.4974 | 14 | 494 | sensory organ development |
GO:0003344 | 0.0058 | 21.6458 | 0.1184 | 2 | 9 | pericardium morphogenesis |
GO:0035330 | 0.0058 | 21.6458 | 0.1184 | 2 | 9 | regulation of hippo signaling |
GO:0046549 | 0.0058 | 21.6458 | 0.1184 | 2 | 9 | retinal cone cell development |
GO:0046877 | 0.0058 | 21.6458 | 0.1184 | 2 | 9 | regulation of saliva secretion |
GO:0071670 | 0.0058 | 21.6458 | 0.1184 | 2 | 9 | smooth muscle cell chemotaxis |
GO:2000543 | 0.0058 | 21.6458 | 0.1184 | 2 | 9 | positive regulation of gastrulation |
GO:0050905 | 0.0061 | 4.6111 | 1.1574 | 5 | 88 | neuromuscular process |
GO:0009954 | 0.0064 | 8.7751 | 0.3814 | 3 | 29 | proximal/distal pattern formation |
GO:0043524 | 0.0064 | 3.8375 | 1.6572 | 6 | 126 | negative regulation of neuron apoptotic process |
GO:0050769 | 0.0064 | 2.5341 | 4.5786 | 11 | 353 | positive regulation of neurogenesis |
GO:0000122 | 0.0068 | 2.0162 | 9.4699 | 18 | 720 | negative regulation of transcription from RNA polymerase II promoter |
GO:0048741 | 0.007 | 8.4496 | 0.3946 | 3 | 30 | skeletal muscle fiber development |
GO:0021520 | 0.0071 | 19.1327 | 0.1302 | 2 | 10 | spinal cord motor neuron cell fate specification |
GO:0021559 | 0.0072 | 18.9388 | 0.1315 | 2 | 10 | trigeminal nerve development |
GO:0007200 | 0.0073 | 4.3979 | 1.21 | 5 | 92 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0120036 | 0.0075 | 1.7538 | 16.4934 | 27 | 1254 | plasma membrane bounded cell projection organization |
GO:1900006 | 0.0075 | 5.5486 | 0.776 | 4 | 59 | positive regulation of dendrite development |
GO:0097659 | 0.0077 | 1.4904 | 44.9163 | 60 | 3415 | nucleic acid-templated transcription |
GO:0001569 | 0.0077 | 8.1473 | 0.4077 | 3 | 31 | branching involved in blood vessel morphogenesis |
GO:0008038 | 0.0077 | 8.1473 | 0.4077 | 3 | 31 | neuron recognition |
GO:0045944 | 0.0078 | 1.8309 | 13.3894 | 23 | 1018 | positive regulation of transcription from RNA polymerase II promoter |
GO:0007611 | 0.0081 | 2.9508 | 2.8541 | 8 | 217 | learning or memory |
GO:0048762 | 0.0082 | 3.2236 | 2.2886 | 7 | 174 | mesenchymal cell differentiation |
GO:0007416 | 0.0083 | 3.6243 | 1.7493 | 6 | 133 | synapse assembly |
GO:0007605 | 0.0083 | 3.6243 | 1.7493 | 6 | 133 | sensory perception of sound |
GO:0003207 | 0.0088 | 16.8333 | 0.1447 | 2 | 11 | cardiac chamber formation |
GO:0031643 | 0.0088 | 16.8333 | 0.1447 | 2 | 11 | positive regulation of myelination |
GO:0035815 | 0.0088 | 16.8333 | 0.1447 | 2 | 11 | positive regulation of renal sodium excretion |
GO:0060379 | 0.0088 | 16.8333 | 0.1447 | 2 | 11 | cardiac muscle cell myoblast differentiation |
GO:2001053 | 0.0088 | 16.8333 | 0.1447 | 2 | 11 | regulation of mesenchymal cell apoptotic process |
GO:0045687 | 0.0091 | 7.6031 | 0.434 | 3 | 33 | positive regulation of glial cell differentiation |
GO:0050877 | 0.0092 | 1.8552 | 12.0431 | 21 | 945 | nervous system process |
GO:0031644 | 0.0095 | 5.1711 | 0.8286 | 4 | 63 | regulation of neurological system process |
GO:0033555 | 0.0095 | 5.1711 | 0.8286 | 4 | 63 | multicellular organismal response to stress |
GO:0003007 | 0.0099 | 2.8405 | 2.9593 | 8 | 225 | heart morphogenesis |
GO enrichment analysis was also performed for differentially variable regions.
comparison | |
Hypermethylation/hypomethylation | |
ontology | |
regions | |
differential methylation measure |
Workclouds for GO enrichment terms (Differential Variability)
comparison | |
Hypermethylation/hypomethylation | |
ontology | |
regions | |
differential methylation measure |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002305 | 0.0024 | Inf | 0.0024 | 1 | 1 | CD8-positive, gamma-delta intraepithelial T cell differentiation |
GO:0018979 | 0.0024 | Inf | 0.0024 | 1 | 1 | trichloroethylene metabolic process |
GO:0007181 | 0.0048 | 429.0571 | 0.0048 | 1 | 2 | transforming growth factor beta receptor complex assembly |
GO:0018931 | 0.0048 | 429.0571 | 0.0048 | 1 | 2 | naphthalene metabolic process |
GO:0042197 | 0.0048 | 429.0571 | 0.0048 | 1 | 2 | halogenated hydrocarbon metabolic process |
GO:0031338 | 0.0076 | 16.6093 | 0.1315 | 2 | 55 | regulation of vesicle fusion |
GO:0006432 | 0.0095 | 143 | 0.0096 | 1 | 4 | phenylalanyl-tRNA aminoacylation |
GO:0006682 | 0.0095 | 143 | 0.0096 | 1 | 4 | galactosylceramide biosynthetic process |
GO:0044537 | 0.0095 | 143 | 0.0096 | 1 | 4 | regulation of circulating fibrinogen levels |
GO:0097039 | 0.0095 | 143 | 0.0096 | 1 | 4 | protein linear polyubiquitination |
GO:0099590 | 0.0095 | 143 | 0.0096 | 1 | 4 | neurotransmitter receptor internalization |
GO:0032088 | 0.0096 | 14.6647 | 0.1483 | 2 | 62 | negative regulation of NF-kappaB transcription factor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004181 | 0.0016 | 38.4615 | 0.0599 | 2 | 22 | metallocarboxypeptidase activity |
GO:0018455 | 0.0027 | Inf | 0.0027 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
GO:0047275 | 0.0054 | 375.475 | 0.0054 | 1 | 2 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity |
GO:0004090 | 0.0081 | 187.725 | 0.0082 | 1 | 3 | carbonyl reductase (NADPH) activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008528 | 2e-04 | 10.912 | 0.5116 | 5 | 115 | G-protein coupled peptide receptor activity |
GO:0042577 | 0.001 | 51.2308 | 0.0489 | 2 | 11 | lipid phosphatase activity |
GO:0008195 | 0.0015 | 41.9105 | 0.0578 | 2 | 13 | phosphatidate phosphatase activity |
GO:0022857 | 0.0018 | 3.1353 | 3.9815 | 11 | 895 | transmembrane transporter activity |
GO:0017075 | 0.0025 | 30.7262 | 0.0756 | 2 | 17 | syntaxin-1 binding |
GO:0004653 | 0.0028 | 28.8038 | 0.0801 | 2 | 18 | polypeptide N-acetylgalactosaminyltransferase activity |
GO:0004871 | 0.0035 | 2.5468 | 6.3303 | 14 | 1423 | signal transducer activity |
GO:0042923 | 0.0035 | 25.6 | 0.089 | 2 | 20 | neuropeptide binding |
GO:0015081 | 0.0036 | 6.8854 | 0.6272 | 4 | 141 | sodium ion transmembrane transporter activity |
GO:0005326 | 0.0039 | 24.251 | 0.0934 | 2 | 21 | neurotransmitter transporter activity |
GO:0004419 | 0.0044 | Inf | 0.0044 | 1 | 1 | hydroxymethylglutaryl-CoA lyase activity |
GO:0005334 | 0.0044 | Inf | 0.0044 | 1 | 1 | norepinephrine:sodium symporter activity |
GO:0038046 | 0.0044 | Inf | 0.0044 | 1 | 1 | enkephalin receptor activity |
GO:0038048 | 0.0044 | Inf | 0.0044 | 1 | 1 | dynorphin receptor activity |
GO:0005509 | 0.0059 | 3.2028 | 2.7448 | 8 | 617 | calcium ion binding |
GO:0015075 | 0.0062 | 2.947 | 3.3765 | 9 | 759 | ion transmembrane transporter activity |
GO:0004963 | 0.0089 | 227.1667 | 0.0089 | 1 | 2 | follicle-stimulating hormone receptor activity |
GO:0005152 | 0.0089 | 227.1667 | 0.0089 | 1 | 2 | interleukin-1 receptor antagonist activity |
GO:0047322 | 0.0089 | 227.1667 | 0.0089 | 1 | 2 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity |
GO:0050405 | 0.0089 | 227.1667 | 0.0089 | 1 | 2 | [acetyl-CoA carboxylase] kinase activity |
GO:0015294 | 0.0095 | 7.3515 | 0.436 | 3 | 98 | solute:cation symporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0044419 | 0 | 2.6783 | 10.7597 | 26 | 794 | interspecies interaction between organisms |
GO:0050690 | 5e-04 | 12.893 | 0.3659 | 4 | 27 | regulation of defense response to virus by virus |
GO:0006342 | 5e-04 | 5.5188 | 1.3822 | 7 | 102 | chromatin silencing |
GO:0042110 | 5e-04 | 2.8968 | 5.5695 | 15 | 411 | T cell activation |
GO:0072679 | 0.0011 | 73.505 | 0.0542 | 2 | 4 | thymocyte migration |
GO:0035456 | 0.002 | 13.8377 | 0.2575 | 3 | 19 | response to interferon-beta |
GO:0097300 | 0.002 | 8.23 | 0.542 | 4 | 40 | programmed necrotic cell death |
GO:0043900 | 0.0025 | 2.7415 | 4.6481 | 12 | 343 | regulation of multi-organism process |
GO:0002740 | 0.0026 | 36.7475 | 0.0813 | 2 | 6 | negative regulation of cytokine secretion involved in immune response |
GO:0019064 | 0.0026 | 36.7475 | 0.0813 | 2 | 6 | fusion of virus membrane with host plasma membrane |
GO:0044800 | 0.0026 | 36.7475 | 0.0813 | 2 | 6 | multi-organism membrane fusion |
GO:0097527 | 0.0026 | 36.7475 | 0.0813 | 2 | 6 | necroptotic signaling pathway |
GO:0001817 | 0.0028 | 2.3268 | 7.3177 | 16 | 540 | regulation of cytokine production |
GO:0002366 | 0.0031 | 2.2407 | 8.0765 | 17 | 596 | leukocyte activation involved in immune response |
GO:0032608 | 0.0034 | 7.0514 | 0.6234 | 4 | 46 | interferon-beta production |
GO:0042346 | 0.0036 | 11.0672 | 0.3117 | 3 | 23 | positive regulation of NF-kappaB import into nucleus |
GO:0048007 | 0.0037 | 29.396 | 0.0949 | 2 | 7 | antigen processing and presentation, exogenous lipid antigen via MHC class Ib |
GO:0051707 | 0.0041 | 2.0792 | 9.7298 | 19 | 718 | response to other organism |
GO:0002701 | 0.0045 | 10.0597 | 0.3388 | 3 | 25 | negative regulation of production of molecular mediator of immune response |
GO:0010803 | 0.0046 | 6.4365 | 0.6776 | 4 | 50 | regulation of tumor necrosis factor-mediated signaling pathway |
GO:0034371 | 0.0048 | 24.495 | 0.1084 | 2 | 8 | chylomicron remodeling |
GO:0071550 | 0.0048 | 24.495 | 0.1084 | 2 | 8 | death-inducing signaling complex assembly |
GO:1901033 | 0.0048 | 24.495 | 0.1084 | 2 | 8 | positive regulation of response to reactive oxygen species |
GO:0002521 | 0.0054 | 2.3792 | 5.7728 | 13 | 426 | leukocyte differentiation |
GO:0042742 | 0.0056 | 3.1493 | 2.6831 | 8 | 198 | defense response to bacterium |
GO:0046632 | 0.0057 | 4.6979 | 1.1383 | 5 | 84 | alpha-beta T cell differentiation |
GO:0016032 | 0.0058 | 2.2786 | 6.5043 | 14 | 503 | viral process |
GO:0015867 | 0.0062 | 20.9943 | 0.122 | 2 | 9 | ATP transport |
GO:0016998 | 0.0062 | 20.9943 | 0.122 | 2 | 9 | cell wall macromolecule catabolic process |
GO:0051006 | 0.0062 | 20.9943 | 0.122 | 2 | 9 | positive regulation of lipoprotein lipase activity |
GO:0070328 | 0.0063 | 8.8507 | 0.3794 | 3 | 28 | triglyceride homeostasis |
GO:0042108 | 0.0065 | 5.8035 | 0.7453 | 4 | 55 | positive regulation of cytokine biosynthetic process |
GO:0075733 | 0.0065 | 5.8035 | 0.7453 | 4 | 55 | intracellular transport of virus |
GO:1903039 | 0.0065 | 3.0675 | 2.7509 | 8 | 203 | positive regulation of leukocyte cell-cell adhesion |
GO:0002252 | 0.0071 | 1.8447 | 13.2802 | 23 | 980 | immune effector process |
GO:0009607 | 0.0074 | 1.9583 | 10.2854 | 19 | 759 | response to biotic stimulus |
GO:0002475 | 0.0077 | 18.3688 | 0.1355 | 2 | 10 | antigen processing and presentation via MHC class Ib |
GO:0060766 | 0.0077 | 18.3688 | 0.1355 | 2 | 10 | negative regulation of androgen receptor signaling pathway |
GO:0071801 | 0.0077 | 18.3688 | 0.1355 | 2 | 10 | regulation of podosome assembly |
GO:0098792 | 0.0077 | 18.3688 | 0.1355 | 2 | 10 | xenophagy |
GO:0001775 | 0.0078 | 1.765 | 15.733 | 26 | 1161 | cell activation |
GO:0061024 | 0.0083 | 1.9335 | 10.4073 | 19 | 768 | membrane organization |
GO:0043122 | 0.0091 | 2.8873 | 2.9135 | 8 | 215 | regulation of I-kappaB kinase/NF-kappaB signaling |
GO:0006656 | 0.0091 | 7.6279 | 0.4336 | 3 | 32 | phosphatidylcholine biosynthetic process |
GO:0019081 | 0.0093 | 16.3267 | 0.1491 | 2 | 11 | viral translation |
GO:0071223 | 0.0093 | 16.3267 | 0.1491 | 2 | 11 | cellular response to lipoteichoic acid |
GO:0071554 | 0.0093 | 16.3267 | 0.1491 | 2 | 11 | cell wall organization or biogenesis |
GO:0072567 | 0.0093 | 16.3267 | 0.1491 | 2 | 11 | chemokine (C-X-C motif) ligand 2 production |
GO:1903140 | 0.0093 | 16.3267 | 0.1491 | 2 | 11 | regulation of establishment of endothelial barrier |
GO:0050792 | 0.0093 | 3.1432 | 2.3444 | 7 | 173 | regulation of viral process |
GO:0045785 | 0.0094 | 2.3963 | 4.8242 | 11 | 356 | positive regulation of cell adhesion |
GO:0006906 | 0.0099 | 3.4853 | 1.8159 | 6 | 134 | vesicle fusion |
GO:0097352 | 0.0099 | 7.3731 | 0.4472 | 3 | 33 | autophagosome maturation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007399 | 0 | 2.9253 | 29.7895 | 71 | 1497 | nervous system development |
GO:0007156 | 0 | 6.4968 | 3.0418 | 17 | 144 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0007275 | 0 | 1.9995 | 65.3537 | 104 | 3370 | multicellular organism development |
GO:0099537 | 0 | 3.1405 | 11.766 | 33 | 557 | trans-synaptic signaling |
GO:0048699 | 0 | 2.9268 | 11.3933 | 30 | 578 | generation of neurons |
GO:0007267 | 0 | 2.9737 | 10.8438 | 29 | 557 | cell-cell signaling |
GO:0007420 | 0 | 2.7259 | 12.949 | 32 | 613 | brain development |
GO:0098609 | 0 | 2.5214 | 15.2937 | 35 | 724 | cell-cell adhesion |
GO:0021953 | 0 | 6.5897 | 1.558 | 9 | 75 | central nervous system neuron differentiation |
GO:0048608 | 0 | 2.9346 | 8.1538 | 22 | 386 | reproductive structure development |
GO:0032990 | 0 | 2.5431 | 11.9773 | 28 | 567 | cell part morphogenesis |
GO:0030154 | 0 | 1.6817 | 69.258 | 100 | 3372 | cell differentiation |
GO:0120039 | 0 | 2.5366 | 11.5548 | 27 | 547 | plasma membrane bounded cell projection morphogenesis |
GO:0031175 | 0 | 2.2432 | 17.0048 | 35 | 805 | neuron projection development |
GO:0032502 | 0 | 1.7566 | 58.5894 | 86 | 3175 | developmental process |
GO:0045987 | 0 | 10.8802 | 0.676 | 6 | 32 | positive regulation of smooth muscle contraction |
GO:0015844 | 1e-04 | 6.765 | 1.3519 | 8 | 64 | monoamine transport |
GO:0042391 | 1e-04 | 2.8947 | 7.4763 | 20 | 356 | regulation of membrane potential |
GO:0000904 | 1e-04 | 2.404 | 12.611 | 28 | 597 | cell morphogenesis involved in differentiation |
GO:0021537 | 1e-04 | 3.5091 | 4.6473 | 15 | 220 | telencephalon development |
GO:0035295 | 1e-04 | 2.4888 | 11.3013 | 26 | 535 | tube development |
GO:0060157 | 1e-04 | 70.1619 | 0.1056 | 3 | 5 | urinary bladder development |
GO:0007389 | 1e-04 | 2.7152 | 8.344 | 21 | 395 | pattern specification process |
GO:0030030 | 1e-04 | 1.896 | 27.0809 | 47 | 1282 | cell projection organization |
GO:0007218 | 1e-04 | 5.142 | 1.9434 | 9 | 92 | neuropeptide signaling pathway |
GO:1905114 | 2e-04 | 2.3752 | 11.3224 | 25 | 536 | cell surface receptor signaling pathway involved in cell-cell signaling |
GO:0023061 | 2e-04 | 2.6277 | 8.175 | 20 | 387 | signal release |
GO:0042698 | 3e-04 | 4.6361 | 2.1335 | 9 | 101 | ovulation cycle |
GO:0021826 | 3e-04 | 35.0762 | 0.1479 | 3 | 7 | substrate-independent telencephalic tangential migration |
GO:0021830 | 3e-04 | 35.0762 | 0.1479 | 3 | 7 | interneuron migration from the subpallium to the cortex |
GO:0042755 | 4e-04 | 9.4 | 0.6337 | 5 | 30 | eating behavior |
GO:0001655 | 4e-04 | 2.8386 | 6.0415 | 16 | 286 | urogenital system development |
GO:0050804 | 4e-04 | 2.8386 | 6.0415 | 16 | 286 | modulation of chemical synaptic transmission |
GO:0021842 | 4e-04 | Inf | 0.0422 | 2 | 2 | chemorepulsion involved in interneuron migration from the subpallium to the cortex |
GO:0046660 | 5e-04 | 4.3063 | 2.2814 | 9 | 108 | female sex differentiation |
GO:0010720 | 5e-04 | 2.4042 | 9.3368 | 21 | 442 | positive regulation of cell development |
GO:0007210 | 6e-04 | 12.5019 | 0.4014 | 4 | 19 | serotonin receptor signaling pathway |
GO:0021515 | 6e-04 | 6.4213 | 1.0562 | 6 | 50 | cell differentiation in spinal cord |
GO:0048754 | 7e-04 | 3.7348 | 2.894 | 10 | 137 | branching morphogenesis of an epithelial tube |
GO:0009887 | 7e-04 | 1.9247 | 18.9532 | 34 | 905 | animal organ morphogenesis |
GO:0006836 | 7e-04 | 3.4379 | 3.4432 | 11 | 163 | neurotransmitter transport |
GO:0042428 | 7e-04 | 23.381 | 0.1901 | 3 | 9 | serotonin metabolic process |
GO:0046877 | 7e-04 | 23.381 | 0.1901 | 3 | 9 | regulation of saliva secretion |
GO:0031290 | 7e-04 | 11.7197 | 0.4225 | 4 | 20 | retinal ganglion cell axon guidance |
GO:0008585 | 7e-04 | 4.5014 | 1.9434 | 8 | 92 | female gonad development |
GO:0051962 | 7e-04 | 2.3748 | 8.9777 | 20 | 425 | positive regulation of nervous system development |
GO:0060485 | 8e-04 | 2.9916 | 4.6473 | 13 | 220 | mesenchyme development |
GO:0003206 | 8e-04 | 3.945 | 2.4715 | 9 | 117 | cardiac chamber morphogenesis |
GO:0045669 | 8e-04 | 6.0102 | 1.1196 | 6 | 53 | positive regulation of osteoblast differentiation |
GO:0050808 | 9e-04 | 4.3718 | 1.9945 | 8 | 96 | synapse organization |
GO:0007268 | 9e-04 | 2.8381 | 5.2677 | 14 | 260 | chemical synaptic transmission |
GO:0045137 | 9e-04 | 3.1186 | 4.1192 | 12 | 195 | development of primary sexual characteristics |
GO:0003013 | 9e-04 | 2.276 | 9.8226 | 21 | 465 | circulatory system process |
GO:0007155 | 9e-04 | 2.2753 | 9.8546 | 21 | 499 | cell adhesion |
GO:0008344 | 9e-04 | 4.9279 | 1.5632 | 7 | 74 | adult locomotory behavior |
GO:0060415 | 9e-04 | 4.9279 | 1.5632 | 7 | 74 | muscle tissue morphogenesis |
GO:0090092 | 0.001 | 3.1014 | 4.1403 | 12 | 196 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0030432 | 0.001 | 20.0395 | 0.2112 | 3 | 10 | peristalsis |
GO:0006937 | 0.001 | 3.5115 | 3.063 | 10 | 145 | regulation of muscle contraction |
GO:0071773 | 0.0011 | 3.4598 | 3.1052 | 10 | 147 | cellular response to BMP stimulus |
GO:0009653 | 0.0012 | 1.7899 | 23.554 | 39 | 1198 | anatomical structure morphogenesis |
GO:0009914 | 0.0012 | 2.6227 | 6.0837 | 15 | 288 | hormone transport |
GO:0001964 | 0.0013 | 9.8672 | 0.4859 | 4 | 23 | startle response |
GO:0015820 | 0.0013 | 93.2595 | 0.0634 | 2 | 3 | leucine transport |
GO:0021524 | 0.0013 | 93.2595 | 0.0634 | 2 | 3 | visceral motor neuron differentiation |
GO:0048936 | 0.0013 | 93.2595 | 0.0634 | 2 | 3 | peripheral nervous system neuron axonogenesis |
GO:0061364 | 0.0013 | 93.2595 | 0.0634 | 2 | 3 | apoptotic process involved in luteolysis |
GO:1904349 | 0.0013 | 93.2595 | 0.0634 | 2 | 3 | positive regulation of small intestine smooth muscle contraction |
GO:2000721 | 0.0013 | 93.2595 | 0.0634 | 2 | 3 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation |
GO:0060379 | 0.0014 | 17.5333 | 0.2324 | 3 | 11 | cardiac muscle cell myoblast differentiation |
GO:0060573 | 0.0014 | 17.5333 | 0.2324 | 3 | 11 | cell fate specification involved in pattern specification |
GO:0001763 | 0.0014 | 3.1449 | 3.7389 | 11 | 177 | morphogenesis of a branching structure |
GO:0010717 | 0.0014 | 4.5841 | 1.6688 | 7 | 79 | regulation of epithelial to mesenchymal transition |
GO:0051674 | 0.0015 | 1.7027 | 27.7569 | 44 | 1314 | localization of cell |
GO:0021511 | 0.0015 | 9.3732 | 0.507 | 4 | 24 | spinal cord patterning |
GO:0060740 | 0.0015 | 9.3732 | 0.507 | 4 | 24 | prostate gland epithelium morphogenesis |
GO:0046883 | 0.0016 | 2.7739 | 4.9853 | 13 | 236 | regulation of hormone secretion |
GO:0042063 | 0.0016 | 2.7614 | 5.0064 | 13 | 237 | gliogenesis |
GO:0045666 | 0.0017 | 2.5283 | 6.2949 | 15 | 298 | positive regulation of neuron differentiation |
GO:0003148 | 0.0017 | 8.9263 | 0.5281 | 4 | 25 | outflow tract septum morphogenesis |
GO:0006929 | 0.0017 | 8.9263 | 0.5281 | 4 | 25 | substrate-dependent cell migration |
GO:0045165 | 0.0018 | 2.7365 | 5.0486 | 13 | 239 | cell fate commitment |
GO:0021954 | 0.0018 | 5.1332 | 1.2886 | 6 | 61 | central nervous system neuron development |
GO:0032354 | 0.0018 | 15.5841 | 0.2535 | 3 | 12 | response to follicle-stimulating hormone |
GO:0048934 | 0.0018 | 15.5841 | 0.2535 | 3 | 12 | peripheral nervous system neuron differentiation |
GO:0021517 | 0.0018 | 6.3462 | 0.8872 | 5 | 42 | ventral spinal cord development |
GO:0055085 | 0.0021 | 1.6904 | 26.5951 | 42 | 1259 | transmembrane transport |
GO:0031644 | 0.0021 | 4.9524 | 1.3308 | 6 | 63 | regulation of neurological system process |
GO:0022600 | 0.0021 | 4.2298 | 1.7955 | 7 | 85 | digestive system process |
GO:0003012 | 0.0022 | 2.2546 | 8.4496 | 18 | 400 | muscle system process |
GO:0009952 | 0.0022 | 2.9472 | 3.9713 | 11 | 188 | anterior/posterior pattern specification |
GO:0007171 | 0.0023 | 14.0248 | 0.2746 | 3 | 13 | activation of transmembrane receptor protein tyrosine kinase activity |
GO:0035112 | 0.0023 | 14.0248 | 0.2746 | 3 | 13 | genitalia morphogenesis |
GO:0016339 | 0.0023 | 8.149 | 0.5703 | 4 | 27 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0021772 | 0.0023 | 8.149 | 0.5703 | 4 | 27 | olfactory bulb development |
GO:0071805 | 0.0024 | 2.9139 | 4.0136 | 11 | 190 | potassium ion transmembrane transport |
GO:0050767 | 0.0025 | 2.2274 | 8.5508 | 18 | 413 | regulation of neurogenesis |
GO:0003231 | 0.0026 | 3.6308 | 2.3659 | 8 | 112 | cardiac ventricle development |
GO:0007198 | 0.0026 | 46.6266 | 0.0845 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0021555 | 0.0026 | 46.6266 | 0.0845 | 2 | 4 | midbrain-hindbrain boundary morphogenesis |
GO:0021913 | 0.0026 | 46.6266 | 0.0845 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0051414 | 0.0026 | 46.6266 | 0.0845 | 2 | 4 | response to cortisol |
GO:0071504 | 0.0026 | 46.6266 | 0.0845 | 2 | 4 | cellular response to heparin |
GO:0021675 | 0.0027 | 4.7038 | 1.3942 | 6 | 66 | nerve development |
GO:0043114 | 0.0027 | 7.8089 | 0.5915 | 4 | 28 | regulation of vascular permeability |
GO:0030514 | 0.0027 | 5.7255 | 0.9717 | 5 | 46 | negative regulation of BMP signaling pathway |
GO:0055010 | 0.0027 | 5.7255 | 0.9717 | 5 | 46 | ventricular cardiac muscle tissue morphogenesis |
GO:0060079 | 0.0028 | 4.0224 | 1.88 | 7 | 89 | excitatory postsynaptic potential |
GO:0042711 | 0.0029 | 12.7489 | 0.2957 | 3 | 14 | maternal behavior |
GO:0001657 | 0.0029 | 3.9736 | 1.9012 | 7 | 90 | ureteric bud development |
GO:0003203 | 0.0031 | 7.4961 | 0.6126 | 4 | 29 | endocardial cushion morphogenesis |
GO:0019098 | 0.0031 | 7.4961 | 0.6126 | 4 | 29 | reproductive behavior |
GO:0048666 | 0.0031 | 3.9346 | 1.9152 | 7 | 97 | neuron development |
GO:0008306 | 0.0031 | 4.5515 | 1.4364 | 6 | 68 | associative learning |
GO:0072163 | 0.0031 | 3.926 | 1.9223 | 7 | 91 | mesonephric epithelium development |
GO:0007167 | 0.0032 | 1.766 | 19.2228 | 32 | 910 | enzyme linked receptor protein signaling pathway |
GO:0007200 | 0.0033 | 3.8796 | 1.9434 | 7 | 92 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:1903522 | 0.0034 | 2.521 | 5.45 | 13 | 258 | regulation of blood circulation |
GO:0030501 | 0.0035 | 7.2073 | 0.6337 | 4 | 30 | positive regulation of bone mineralization |
GO:0022010 | 0.0035 | 11.6857 | 0.3169 | 3 | 15 | central nervous system myelination |
GO:0060579 | 0.0035 | 11.6857 | 0.3169 | 3 | 15 | ventral spinal cord interneuron fate commitment |
GO:0015850 | 0.0036 | 2.7578 | 4.2248 | 11 | 200 | organic hydroxy compound transport |
GO:0021879 | 0.0036 | 5.334 | 1.0351 | 5 | 49 | forebrain neuron differentiation |
GO:0009953 | 0.0037 | 3.7899 | 1.9857 | 7 | 94 | dorsal/ventral pattern formation |
GO:0061333 | 0.0038 | 4.3405 | 1.4998 | 6 | 71 | renal tubule morphogenesis |
GO:0030336 | 0.0039 | 2.5875 | 4.9008 | 12 | 232 | negative regulation of cell migration |
GO:0009790 | 0.004 | 1.7558 | 18.6947 | 31 | 885 | embryo development |
GO:0072028 | 0.0041 | 4.2745 | 1.5209 | 6 | 72 | nephron morphogenesis |
GO:0045110 | 0.0043 | 31.0823 | 0.1056 | 2 | 5 | intermediate filament bundle assembly |
GO:0060012 | 0.0043 | 31.0823 | 0.1056 | 2 | 5 | synaptic transmission, glycinergic |
GO:0070100 | 0.0043 | 31.0823 | 0.1056 | 2 | 5 | negative regulation of chemokine-mediated signaling pathway |
GO:1904304 | 0.0043 | 31.0823 | 0.1056 | 2 | 5 | regulation of gastro-intestinal system smooth muscle contraction |
GO:0030111 | 0.0044 | 2.3519 | 6.2738 | 14 | 297 | regulation of Wnt signaling pathway |
GO:0007190 | 0.0044 | 6.6915 | 0.676 | 4 | 32 | activation of adenylate cyclase activity |
GO:0030198 | 0.0046 | 2.3351 | 6.3161 | 14 | 299 | extracellular matrix organization |
GO:0040013 | 0.0047 | 2.4205 | 5.6612 | 13 | 268 | negative regulation of locomotion |
GO:1905207 | 0.0047 | 4.9925 | 1.0984 | 5 | 52 | regulation of cardiocyte differentiation |
GO:0010811 | 0.0047 | 3.6223 | 2.0701 | 7 | 98 | positive regulation of cell-substrate adhesion |
GO:0035637 | 0.0048 | 2.7985 | 3.7812 | 10 | 179 | multicellular organismal signaling |
GO:0050877 | 0.0049 | 1.6856 | 21.3744 | 34 | 1027 | nervous system process |
GO:0048665 | 0.0049 | 6.4604 | 0.6971 | 4 | 33 | neuron fate specification |
GO:0021885 | 0.0051 | 4.8882 | 1.1196 | 5 | 53 | forebrain cell migration |
GO:0014706 | 0.0053 | 2.2231 | 7.0976 | 15 | 336 | striated muscle tissue development |
GO:0050850 | 0.0055 | 6.2446 | 0.7182 | 4 | 34 | positive regulation of calcium-mediated signaling |
GO:0097485 | 0.0055 | 2.591 | 4.4783 | 11 | 212 | neuron projection guidance |
GO:0098655 | 0.0055 | 1.8016 | 15.2092 | 26 | 720 | cation transmembrane transport |
GO:2000145 | 0.0056 | 1.7989 | 15.2304 | 26 | 721 | regulation of cell motility |
GO:0007626 | 0.0056 | 3.4954 | 2.1384 | 7 | 103 | locomotory behavior |
GO:0015837 | 0.0057 | 3.9721 | 1.6265 | 6 | 77 | amine transport |
GO:0048709 | 0.0057 | 3.9721 | 1.6265 | 6 | 77 | oligodendrocyte differentiation |
GO:0001764 | 0.0058 | 3.1432 | 2.7039 | 8 | 128 | neuron migration |
GO:0055123 | 0.0061 | 3.117 | 2.725 | 8 | 129 | digestive system development |
GO:0015872 | 0.0061 | 6.0427 | 0.7393 | 4 | 35 | dopamine transport |
GO:0007160 | 0.0062 | 2.686 | 3.9291 | 10 | 186 | cell-matrix adhesion |
GO:0016576 | 0.0063 | 23.3101 | 0.1267 | 2 | 6 | histone dephosphorylation |
GO:0021891 | 0.0063 | 23.3101 | 0.1267 | 2 | 6 | olfactory bulb interneuron development |
GO:0021957 | 0.0063 | 23.3101 | 0.1267 | 2 | 6 | corticospinal tract morphogenesis |
GO:0060687 | 0.0063 | 23.3101 | 0.1267 | 2 | 6 | regulation of branching involved in prostate gland morphogenesis |
GO:0007611 | 0.0065 | 2.5273 | 4.5839 | 11 | 217 | learning or memory |
GO:0010648 | 0.0067 | 1.6033 | 25.0953 | 38 | 1188 | negative regulation of cell communication |
GO:0030278 | 0.0067 | 2.8322 | 3.3587 | 9 | 159 | regulation of ossification |
GO:0055024 | 0.0069 | 3.8103 | 1.6899 | 6 | 80 | regulation of cardiac muscle tissue development |
GO:0003215 | 0.007 | 8.7619 | 0.4014 | 3 | 19 | cardiac right ventricle morphogenesis |
GO:0007413 | 0.007 | 8.7619 | 0.4014 | 3 | 19 | axonal fasciculation |
GO:0023057 | 0.007 | 1.5973 | 25.1798 | 38 | 1192 | negative regulation of signaling |
GO:0007416 | 0.0073 | 3.0165 | 2.8095 | 8 | 133 | synapse assembly |
GO:0007605 | 0.0073 | 3.0165 | 2.8095 | 8 | 133 | sensory perception of sound |
GO:0021782 | 0.0073 | 3.7592 | 1.711 | 6 | 81 | glial cell development |
GO:0007618 | 0.0075 | 5.6757 | 0.7816 | 4 | 37 | mating |
GO:0051932 | 0.0075 | 5.6757 | 0.7816 | 4 | 37 | synaptic transmission, GABAergic |
GO:0048813 | 0.0076 | 3.2943 | 2.2603 | 7 | 107 | dendrite morphogenesis |
GO:0009725 | 0.0077 | 1.7302 | 16.4133 | 27 | 777 | response to hormone |
GO:0043269 | 0.0078 | 1.8696 | 11.7872 | 21 | 558 | regulation of ion transport |
GO:0050796 | 0.0078 | 2.7579 | 3.4432 | 9 | 163 | regulation of insulin secretion |
GO:0007409 | 0.0079 | 2.0649 | 8.1252 | 16 | 387 | axonogenesis |
GO:0007588 | 0.008 | 4.3433 | 1.2463 | 5 | 59 | excretion |
GO:0007214 | 0.0082 | 8.2459 | 0.4225 | 3 | 20 | gamma-aminobutyric acid signaling pathway |
GO:0015874 | 0.0082 | 8.2459 | 0.4225 | 3 | 20 | norepinephrine transport |
GO:0033688 | 0.0082 | 8.2459 | 0.4225 | 3 | 20 | regulation of osteoblast proliferation |
GO:0051968 | 0.0082 | 8.2459 | 0.4225 | 3 | 20 | positive regulation of synaptic transmission, glutamatergic |
GO:0060039 | 0.0082 | 8.2459 | 0.4225 | 3 | 20 | pericardium development |
GO:0043268 | 0.0082 | 5.5084 | 0.8027 | 4 | 38 | positive regulation of potassium ion transport |
GO:1903115 | 0.0082 | 5.5084 | 0.8027 | 4 | 38 | regulation of actin filament-based movement |
GO:0035108 | 0.0083 | 2.9452 | 2.8729 | 8 | 136 | limb morphogenesis |
GO:0051271 | 0.0086 | 2.3195 | 5.4289 | 12 | 257 | negative regulation of cellular component movement |
GO:0014827 | 0.0087 | 18.6468 | 0.1479 | 2 | 7 | intestine smooth muscle contraction |
GO:0035385 | 0.0087 | 18.6468 | 0.1479 | 2 | 7 | Roundabout signaling pathway |
GO:0060075 | 0.0087 | 18.6468 | 0.1479 | 2 | 7 | regulation of resting membrane potential |
GO:0071420 | 0.0087 | 18.6468 | 0.1479 | 2 | 7 | cellular response to histamine |
GO:1902513 | 0.0087 | 18.6468 | 0.1479 | 2 | 7 | regulation of organelle transport along microtubule |
GO:0030072 | 0.0087 | 2.42 | 4.774 | 11 | 226 | peptide hormone secretion |
GO:0050768 | 0.0087 | 2.42 | 4.774 | 11 | 226 | negative regulation of neurogenesis |
GO:0032879 | 0.0087 | 1.4227 | 49.7892 | 66 | 2357 | regulation of localization |
GO:0098661 | 0.0088 | 3.1977 | 2.3236 | 7 | 110 | inorganic anion transmembrane transport |
GO:0007423 | 0.0089 | 1.9078 | 10.4352 | 19 | 494 | sensory organ development |
GO:0021983 | 0.009 | 5.3507 | 0.8238 | 4 | 39 | pituitary gland development |
GO:0060491 | 0.009 | 2.8995 | 2.9151 | 8 | 138 | regulation of cell projection assembly |
GO:0001975 | 0.0094 | 7.7873 | 0.4436 | 3 | 21 | response to amphetamine |
GO:0007188 | 0.0094 | 2.8771 | 2.9362 | 8 | 139 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0006357 | 0.0096 | 1.4697 | 37.6429 | 52 | 1782 | regulation of transcription from RNA polymerase II promoter |
GO:0072359 | 0.0098 | 1.6481 | 19.1383 | 30 | 906 | circulatory system development |
GO:0048729 | 0.0099 | 1.8869 | 10.5466 | 19 | 508 | tissue morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0016493 | 6e-04 | 23.554 | 0.1697 | 3 | 12 | C-C chemokine receptor activity |
GO:0030676 | 9e-04 | 19.2688 | 0.198 | 3 | 14 | Rac guanyl-nucleotide exchange factor activity |
GO:0001637 | 0.0045 | 10.0864 | 0.3394 | 3 | 24 | G-protein coupled chemoattractant receptor activity |
GO:0004896 | 0.0052 | 4.7992 | 1.1173 | 5 | 79 | cytokine receptor activity |
GO:0008035 | 0.0053 | 23.4471 | 0.1131 | 2 | 8 | high-density lipoprotein particle binding |
GO:0052650 | 0.0053 | 23.4471 | 0.1131 | 2 | 8 | NADP-retinol dehydrogenase activity |
GO:0019957 | 0.0067 | 20.0961 | 0.1273 | 2 | 9 | C-C chemokine binding |
GO:0003796 | 0.0083 | 17.5829 | 0.1414 | 2 | 10 | lysozyme activity |
GO:0071723 | 0.0083 | 17.5829 | 0.1414 | 2 | 10 | lipopeptide binding |
GO:0016491 | 0.0089 | 1.9971 | 8.9805 | 17 | 635 | oxidoreductase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 0 | 2.6957 | 12.6587 | 31 | 617 | calcium ion binding |
GO:0022838 | 0 | 3.0732 | 7.8168 | 22 | 381 | substrate-specific channel activity |
GO:0022803 | 0 | 2.9772 | 8.4323 | 23 | 411 | passive transmembrane transporter activity |
GO:0004888 | 0 | 2.1822 | 20.1438 | 40 | 992 | transmembrane signaling receptor activity |
GO:0004872 | 0 | 2.0041 | 27.0203 | 49 | 1317 | receptor activity |
GO:0030594 | 0 | 5.9505 | 1.7029 | 9 | 83 | neurotransmitter receptor activity |
GO:0004871 | 1e-04 | 1.9058 | 28.8768 | 50 | 1416 | signal transducer activity |
GO:0022890 | 2e-04 | 2.4819 | 9.9711 | 23 | 486 | inorganic cation transmembrane transporter activity |
GO:0008504 | 3e-04 | 36.1471 | 0.1436 | 3 | 7 | monoamine transmembrane transporter activity |
GO:0005328 | 3e-04 | 14.8691 | 0.3488 | 4 | 17 | neurotransmitter:sodium symporter activity |
GO:0022836 | 3e-04 | 4.5112 | 2.1823 | 9 | 109 | gated channel activity |
GO:0015276 | 4e-04 | 4.3363 | 2.2637 | 9 | 111 | ligand-gated ion channel activity |
GO:0004993 | 5e-04 | 12.8848 | 0.3898 | 4 | 19 | G-protein coupled serotonin receptor activity |
GO:0015075 | 9e-04 | 2.2742 | 9.844 | 21 | 492 | ion transmembrane transporter activity |
GO:0022832 | 0.0011 | 3.2434 | 3.6314 | 11 | 177 | voltage-gated channel activity |
GO:0042577 | 0.0012 | 18.0686 | 0.2257 | 3 | 11 | lipid phosphatase activity |
GO:0022892 | 0.0014 | 1.8189 | 20.5781 | 35 | 1003 | substrate-specific transporter activity |
GO:0016594 | 0.0016 | 16.0599 | 0.2462 | 3 | 12 | glycine binding |
GO:0004890 | 0.0021 | 14.4529 | 0.2667 | 3 | 13 | GABA-A receptor activity |
GO:0008195 | 0.0021 | 14.4529 | 0.2667 | 3 | 13 | phosphatidate phosphatase activity |
GO:0005237 | 0.0024 | 48.0456 | 0.0821 | 2 | 4 | inhibitory extracellular ligand-gated ion channel activity |
GO:0008013 | 0.0033 | 4.4743 | 1.4567 | 6 | 71 | beta-catenin binding |
GO:0022843 | 0.0035 | 3.4432 | 2.4825 | 8 | 121 | voltage-gated cation channel activity |
GO:0008509 | 0.0036 | 2.5068 | 5.4779 | 13 | 267 | anion transmembrane transporter activity |
GO:0015079 | 0.0036 | 3.1311 | 3.057 | 9 | 149 | potassium ion transmembrane transporter activity |
GO:0008528 | 0.0039 | 4.3223 | 1.5027 | 6 | 74 | G-protein coupled peptide receptor activity |
GO:0043237 | 0.004 | 32.0282 | 0.1026 | 2 | 5 | laminin-1 binding |
GO:0048495 | 0.004 | 32.0282 | 0.1026 | 2 | 5 | Roundabout binding |
GO:0005262 | 0.0048 | 3.6144 | 2.0722 | 7 | 101 | calcium channel activity |
GO:0000981 | 0.0049 | 1.8444 | 14.3 | 25 | 697 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:1901618 | 0.0055 | 6.2278 | 0.7181 | 4 | 35 | organic hydroxy compound transmembrane transporter activity |
GO:0019903 | 0.0059 | 3.4659 | 2.1542 | 7 | 105 | protein phosphatase binding |
GO:0019894 | 0.0061 | 6.0328 | 0.7386 | 4 | 36 | kinesin binding |
GO:0042562 | 0.0062 | 4.6495 | 1.1694 | 5 | 57 | hormone binding |
GO:0005242 | 0.0065 | 9.0294 | 0.3898 | 3 | 19 | inward rectifier potassium channel activity |
GO:0008201 | 0.0073 | 3.0128 | 2.8108 | 8 | 137 | heparin binding |
GO:0043169 | 0.0074 | 1.3743 | 75.9052 | 95 | 3733 | cation binding |
GO:0004714 | 0.0077 | 4.395 | 1.231 | 5 | 60 | transmembrane receptor protein tyrosine kinase activity |
GO:0001105 | 0.0081 | 5.5146 | 0.8001 | 4 | 39 | RNA polymerase II transcription coactivator activity |
GO:0005004 | 0.0082 | 19.2143 | 0.1436 | 2 | 7 | GPI-linked ephrin receptor activity |
GO:0030297 | 0.0082 | 19.2143 | 0.1436 | 2 | 7 | transmembrane receptor protein tyrosine kinase activator activity |
GO:0099095 | 0.0082 | 19.2143 | 0.1436 | 2 | 7 | ligand-gated anion channel activity |
GO:0015081 | 0.0086 | 2.9214 | 2.8928 | 8 | 141 | sodium ion transmembrane transporter activity |
GO:0005231 | 0.0097 | 5.2158 | 0.8412 | 4 | 41 | excitatory extracellular ligand-gated ion channel activity |
GO:0008188 | 0.0097 | 5.2158 | 0.8412 | 4 | 41 | neuropeptide receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007156 | 0 | 7.0339 | 5.8733 | 32 | 144 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0007275 | 0 | 1.8902 | 136.4844 | 207 | 3517 | multicellular organism development |
GO:0007267 | 0 | 3.1592 | 20.487 | 56 | 533 | cell-cell signaling |
GO:0099537 | 0 | 2.9144 | 22.7181 | 58 | 557 | trans-synaptic signaling |
GO:0007268 | 0 | 3.5668 | 10.5727 | 33 | 265 | chemical synaptic transmission |
GO:0032502 | 0 | 1.7455 | 116.434 | 169 | 3175 | developmental process |
GO:0022008 | 0 | 2.3546 | 28.4276 | 60 | 724 | neurogenesis |
GO:0007399 | 0 | 2.6003 | 21.1198 | 49 | 583 | nervous system development |
GO:0021953 | 0 | 3.9086 | 6.4443 | 22 | 158 | central nervous system neuron differentiation |
GO:0007218 | 0 | 5.0569 | 3.7524 | 16 | 92 | neuropeptide signaling pathway |
GO:0044057 | 0 | 2.4928 | 16.7332 | 38 | 416 | regulation of system process |
GO:0098609 | 0 | 2.0691 | 29.5294 | 56 | 724 | cell-cell adhesion |
GO:0007420 | 0 | 2.1337 | 25.0021 | 49 | 613 | brain development |
GO:0098900 | 0 | 7.2281 | 1.7538 | 10 | 43 | regulation of action potential |
GO:0120039 | 0 | 2.1388 | 22.3102 | 44 | 547 | plasma membrane bounded cell projection morphogenesis |
GO:0032990 | 0 | 2.1087 | 23.1259 | 45 | 567 | cell part morphogenesis |
GO:0007626 | 0 | 4.1276 | 4.1599 | 15 | 103 | locomotory behavior |
GO:0003012 | 0 | 2.331 | 16.3146 | 35 | 400 | muscle system process |
GO:0023061 | 0 | 2.3393 | 15.7844 | 34 | 387 | signal release |
GO:0042391 | 0 | 2.5071 | 12.5977 | 29 | 314 | regulation of membrane potential |
GO:0007389 | 0 | 2.2862 | 16.1107 | 34 | 395 | pattern specification process |
GO:0030182 | 0 | 1.9346 | 28.4675 | 51 | 732 | neuron differentiation |
GO:0031644 | 0 | 5.0475 | 2.5695 | 11 | 63 | regulation of neurological system process |
GO:0061138 | 0 | 3.1263 | 6.7298 | 19 | 165 | morphogenesis of a branching epithelium |
GO:0009914 | 1e-04 | 2.4988 | 11.7465 | 27 | 288 | hormone transport |
GO:0086091 | 1e-04 | 7.3186 | 1.3867 | 8 | 34 | regulation of heart rate by cardiac conduction |
GO:0016339 | 1e-04 | 8.3147 | 1.1012 | 7 | 27 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0070252 | 1e-04 | 3.8345 | 3.8339 | 13 | 94 | actin-mediated cell contraction |
GO:0048608 | 1e-04 | 2.1878 | 15.7436 | 32 | 386 | reproductive structure development |
GO:0050796 | 1e-04 | 2.9774 | 6.6482 | 18 | 163 | regulation of insulin secretion |
GO:1903115 | 1e-04 | 6.341 | 1.5499 | 8 | 38 | regulation of actin filament-based movement |
GO:0086019 | 1e-04 | 7.5577 | 1.1828 | 7 | 29 | cell-cell signaling involved in cardiac conduction |
GO:0007416 | 1e-04 | 4.807 | 2.4271 | 10 | 60 | synapse assembly |
GO:0045137 | 1e-04 | 2.7446 | 7.9534 | 20 | 195 | development of primary sexual characteristics |
GO:0035637 | 2e-04 | 3.3777 | 4.609 | 14 | 114 | multicellular organismal signaling |
GO:0098911 | 2e-04 | 11.8473 | 0.6118 | 5 | 15 | regulation of ventricular cardiac muscle cell action potential |
GO:0030534 | 2e-04 | 4.9184 | 2.1405 | 9 | 53 | adult behavior |
GO:0097756 | 3e-04 | 3.9729 | 3.1406 | 11 | 77 | negative regulation of blood vessel diameter |
GO:0007155 | 3e-04 | 1.9824 | 19.4307 | 36 | 499 | cell adhesion |
GO:0009887 | 3e-04 | 1.7795 | 29.3849 | 49 | 737 | animal organ morphogenesis |
GO:0051962 | 3e-04 | 2.0355 | 17.3343 | 33 | 425 | positive regulation of nervous system development |
GO:0021675 | 3e-04 | 4.2526 | 2.6919 | 10 | 66 | nerve development |
GO:0006939 | 3e-04 | 4.212 | 2.7118 | 10 | 67 | smooth muscle contraction |
GO:0008585 | 3e-04 | 3.5781 | 3.7524 | 12 | 92 | female gonad development |
GO:0030072 | 4e-04 | 2.4591 | 9.2177 | 21 | 226 | peptide hormone secretion |
GO:0006937 | 4e-04 | 4.0775 | 2.7871 | 10 | 69 | regulation of muscle contraction |
GO:0009953 | 4e-04 | 3.4903 | 3.8339 | 12 | 94 | dorsal/ventral pattern formation |
GO:0046660 | 4e-04 | 3.2662 | 4.4049 | 13 | 108 | female sex differentiation |
GO:0022612 | 5e-04 | 3.232 | 4.4457 | 13 | 109 | gland morphogenesis |
GO:0008016 | 5e-04 | 2.4725 | 8.7283 | 20 | 214 | regulation of heart contraction |
GO:0050890 | 5e-04 | 2.3478 | 10.0743 | 22 | 247 | cognition |
GO:0098660 | 5e-04 | 1.7402 | 29.3255 | 48 | 719 | inorganic ion transmembrane transport |
GO:0007188 | 6e-04 | 2.8911 | 5.6693 | 15 | 139 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0098655 | 6e-04 | 1.7375 | 29.3663 | 48 | 720 | cation transmembrane transport |
GO:0060012 | 6e-04 | 35.4452 | 0.2039 | 3 | 5 | synaptic transmission, glycinergic |
GO:0060157 | 6e-04 | 35.4452 | 0.2039 | 3 | 5 | urinary bladder development |
GO:0072028 | 6e-04 | 3.8395 | 2.9366 | 10 | 72 | nephron morphogenesis |
GO:0071805 | 7e-04 | 2.7116 | 6.4054 | 16 | 158 | potassium ion transmembrane transport |
GO:0009952 | 7e-04 | 2.5351 | 7.6679 | 18 | 188 | anterior/posterior pattern specification |
GO:0001964 | 7e-04 | 13.6021 | 0.4461 | 4 | 11 | startle response |
GO:0050767 | 7e-04 | 1.8412 | 21.9262 | 38 | 543 | regulation of neurogenesis |
GO:0021889 | 7e-04 | 13.5204 | 0.4487 | 4 | 11 | olfactory bulb interneuron differentiation |
GO:0060573 | 7e-04 | 13.5204 | 0.4487 | 4 | 11 | cell fate specification involved in pattern specification |
GO:0000904 | 8e-04 | 1.7868 | 24.3495 | 41 | 597 | cell morphogenesis involved in differentiation |
GO:0046661 | 8e-04 | 2.7781 | 5.8733 | 15 | 144 | male sex differentiation |
GO:0060359 | 8e-04 | 3.0406 | 4.6904 | 13 | 115 | response to ammonium ion |
GO:0042698 | 8e-04 | 3.2142 | 4.1194 | 12 | 101 | ovulation cycle |
GO:0021515 | 9e-04 | 4.5255 | 2.0393 | 8 | 50 | cell differentiation in spinal cord |
GO:0060562 | 9e-04 | 2.1593 | 11.8689 | 24 | 291 | epithelial tube morphogenesis |
GO:0048729 | 9e-04 | 1.7869 | 23.7377 | 40 | 582 | tissue morphogenesis |
GO:0071773 | 0.001 | 2.7144 | 5.9956 | 15 | 147 | cellular response to BMP stimulus |
GO:0006836 | 0.001 | 2.6015 | 6.6482 | 16 | 163 | neurotransmitter transport |
GO:0031290 | 0.001 | 7.8955 | 0.8157 | 5 | 20 | retinal ganglion cell axon guidance |
GO:0031175 | 0.001 | 2.0005 | 14.8853 | 28 | 374 | neuron projection development |
GO:0021984 | 0.001 | 11.8295 | 0.4894 | 4 | 12 | adenohypophysis development |
GO:0060134 | 0.001 | 11.8295 | 0.4894 | 4 | 12 | prepulse inhibition |
GO:0015837 | 0.0011 | 3.5517 | 3.1406 | 10 | 77 | amine transport |
GO:0009653 | 0.0011 | 1.5493 | 46.084 | 67 | 1203 | anatomical structure morphogenesis |
GO:0042755 | 0.0012 | 5.9276 | 1.2236 | 6 | 30 | eating behavior |
GO:0051930 | 0.0012 | 5.9276 | 1.2236 | 6 | 30 | regulation of sensory perception of pain |
GO:0045666 | 0.0012 | 2.1031 | 12.1544 | 24 | 298 | positive regulation of neuron differentiation |
GO:0019336 | 0.0012 | 23.6285 | 0.2447 | 3 | 6 | phenol-containing compound catabolic process |
GO:0060687 | 0.0012 | 23.6285 | 0.2447 | 3 | 6 | regulation of branching involved in prostate gland morphogenesis |
GO:0086073 | 0.0012 | 23.6285 | 0.2447 | 3 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
GO:0010720 | 0.0012 | 1.8815 | 18.0276 | 32 | 442 | positive regulation of cell development |
GO:0045669 | 0.0013 | 4.223 | 2.1617 | 8 | 53 | positive regulation of osteoblast differentiation |
GO:0035108 | 0.0013 | 2.7384 | 5.547 | 14 | 136 | limb morphogenesis |
GO:0008038 | 0.0014 | 5.6901 | 1.2644 | 6 | 31 | neuron recognition |
GO:0021517 | 0.0014 | 4.7463 | 1.713 | 7 | 42 | ventral spinal cord development |
GO:0035296 | 0.0014 | 2.8439 | 4.976 | 13 | 122 | regulation of tube diameter |
GO:0045600 | 0.0015 | 4.1309 | 2.2025 | 8 | 54 | positive regulation of fat cell differentiation |
GO:0046883 | 0.0015 | 2.8243 | 5.0041 | 13 | 124 | regulation of hormone secretion |
GO:0001655 | 0.0015 | 2.0978 | 11.6649 | 23 | 286 | urogenital system development |
GO:0008217 | 0.0016 | 2.5764 | 6.2811 | 15 | 154 | regulation of blood pressure |
GO:0009725 | 0.0016 | 1.6335 | 31.6911 | 49 | 777 | response to hormone |
GO:0050433 | 0.0016 | 4.6141 | 1.7538 | 7 | 43 | regulation of catecholamine secretion |
GO:0019229 | 0.0016 | 4.0427 | 2.2433 | 8 | 55 | regulation of vasoconstriction |
GO:0045987 | 0.0016 | 5.4709 | 1.3052 | 6 | 32 | positive regulation of smooth muscle contraction |
GO:0021842 | 0.0017 | Inf | 0.0816 | 2 | 2 | chemorepulsion involved in interneuron migration from the subpallium to the cortex |
GO:0086097 | 0.0017 | Inf | 0.0816 | 2 | 2 | phospholipase C-activating angiotensin-activated signaling pathway |
GO:1904008 | 0.0017 | Inf | 0.0816 | 2 | 2 | response to monosodium glutamate |
GO:2000041 | 0.0017 | Inf | 0.0816 | 2 | 2 | negative regulation of planar cell polarity pathway involved in axis elongation |
GO:0072078 | 0.0017 | 3.626 | 2.7735 | 9 | 68 | nephron tubule morphogenesis |
GO:0021536 | 0.0019 | 3.5653 | 2.8143 | 9 | 69 | diencephalon development |
GO:0043200 | 0.002 | 3.0447 | 3.9563 | 11 | 97 | response to amino acid |
GO:0055075 | 0.002 | 9.4623 | 0.571 | 4 | 14 | potassium ion homeostasis |
GO:0021826 | 0.0021 | 17.7201 | 0.2855 | 3 | 7 | substrate-independent telencephalic tangential migration |
GO:0021830 | 0.0021 | 17.7201 | 0.2855 | 3 | 7 | interneuron migration from the subpallium to the cortex |
GO:0060075 | 0.0021 | 17.7201 | 0.2855 | 3 | 7 | regulation of resting membrane potential |
GO:0071420 | 0.0021 | 17.7201 | 0.2855 | 3 | 7 | cellular response to histamine |
GO:0050880 | 0.0022 | 2.6944 | 5.2207 | 13 | 128 | regulation of blood vessel size |
GO:0003015 | 0.0022 | 2.1564 | 9.8703 | 20 | 242 | heart process |
GO:0007409 | 0.0024 | 1.8804 | 15.7361 | 28 | 387 | axonogenesis |
GO:0030514 | 0.0024 | 4.2583 | 1.8762 | 7 | 46 | negative regulation of BMP signaling pathway |
GO:1900372 | 0.0024 | 4.2583 | 1.8762 | 7 | 46 | negative regulation of purine nucleotide biosynthetic process |
GO:0021511 | 0.0025 | 6.2315 | 0.9789 | 5 | 24 | spinal cord patterning |
GO:0060740 | 0.0025 | 6.2315 | 0.9789 | 5 | 24 | prostate gland epithelium morphogenesis |
GO:0061326 | 0.0026 | 3.1291 | 3.5076 | 10 | 86 | renal tubule development |
GO:0007588 | 0.0026 | 3.7246 | 2.4064 | 8 | 59 | excretion |
GO:0060579 | 0.0026 | 8.6015 | 0.6118 | 4 | 15 | ventral spinal cord interneuron fate commitment |
GO:0034765 | 0.0027 | 1.8635 | 15.8659 | 28 | 389 | regulation of ion transmembrane transport |
GO:0015872 | 0.0027 | 4.9039 | 1.4275 | 6 | 35 | dopamine transport |
GO:0097485 | 0.0027 | 2.2178 | 8.6467 | 18 | 212 | neuron projection guidance |
GO:0050803 | 0.0027 | 2.7478 | 4.7312 | 12 | 116 | regulation of synapse structure or activity |
GO:0090092 | 0.0028 | 2.2687 | 7.9942 | 17 | 196 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0003148 | 0.003 | 5.9195 | 1.0197 | 5 | 25 | outflow tract septum morphogenesis |
GO:0021884 | 0.003 | 5.9195 | 1.0197 | 5 | 25 | forebrain neuron development |
GO:0006813 | 0.003 | 2.5885 | 5.4087 | 13 | 134 | potassium ion transport |
GO:0008344 | 0.0031 | 3.2899 | 3.0182 | 9 | 74 | adult locomotory behavior |
GO:0055085 | 0.0031 | 1.4586 | 51.3502 | 71 | 1259 | transmembrane transport |
GO:0048565 | 0.0032 | 2.6955 | 4.8128 | 12 | 118 | digestive tract development |
GO:0060079 | 0.0033 | 3.0097 | 3.63 | 10 | 89 | excitatory postsynaptic potential |
GO:0050804 | 0.0033 | 1.9955 | 11.6649 | 22 | 286 | modulation of chemical synaptic transmission |
GO:0016358 | 0.0034 | 2.2867 | 7.4639 | 16 | 183 | dendrite development |
GO:0001657 | 0.0036 | 2.9719 | 3.6708 | 10 | 90 | ureteric bud development |
GO:0043266 | 0.0036 | 2.9719 | 3.6708 | 10 | 90 | regulation of potassium ion transport |
GO:0035270 | 0.0036 | 2.6453 | 4.8944 | 12 | 120 | endocrine system development |
GO:0006942 | 0.0037 | 3.1912 | 3.0998 | 9 | 76 | regulation of striated muscle contraction |
GO:0051480 | 0.0037 | 2.0101 | 11.0531 | 21 | 271 | regulation of cytosolic calcium ion concentration |
GO:0006811 | 0.0039 | 1.424 | 57.0195 | 77 | 1398 | ion transport |
GO:0072163 | 0.0039 | 2.935 | 3.7116 | 10 | 91 | mesonephric epithelium development |
GO:0048709 | 0.004 | 3.1441 | 3.1406 | 9 | 77 | oligodendrocyte differentiation |
GO:0048483 | 0.0041 | 4.4433 | 1.5499 | 6 | 38 | autonomic nervous system development |
GO:0051216 | 0.0041 | 2.3079 | 6.9337 | 15 | 170 | cartilage development |
GO:1905114 | 0.0042 | 1.6818 | 21.8616 | 35 | 536 | cell surface receptor signaling pathway involved in cell-cell signaling |
GO:0042053 | 0.0043 | 7.2772 | 0.6934 | 4 | 17 | regulation of dopamine metabolic process |
GO:0086014 | 0.0043 | 7.2772 | 0.6934 | 4 | 17 | atrial cardiac muscle cell action potential |
GO:0086066 | 0.0043 | 7.2772 | 0.6934 | 4 | 17 | atrial cardiac muscle cell to AV node cell communication |
GO:0045165 | 0.0043 | 2.064 | 9.748 | 19 | 239 | cell fate commitment |
GO:0008584 | 0.0044 | 2.5732 | 5.0167 | 12 | 123 | male gonad development |
GO:0030029 | 0.0045 | 1.6267 | 25.1653 | 39 | 617 | actin filament-based process |
GO:0007600 | 0.0046 | 1.5523 | 31.7727 | 47 | 779 | sensory perception |
GO:0042428 | 0.0047 | 11.8118 | 0.3671 | 3 | 9 | serotonin metabolic process |
GO:0046877 | 0.0047 | 11.8118 | 0.3671 | 3 | 9 | regulation of saliva secretion |
GO:0071670 | 0.0047 | 11.8118 | 0.3671 | 3 | 9 | smooth muscle cell chemotaxis |
GO:0086015 | 0.0047 | 11.8118 | 0.3671 | 3 | 9 | SA node cell action potential |
GO:0098598 | 0.0047 | 11.8118 | 0.3671 | 3 | 9 | learned vocalization behavior or vocal learning |
GO:0019226 | 0.0048 | 3.3311 | 2.6511 | 8 | 65 | transmission of nerve impulse |
GO:1903524 | 0.0048 | 3.3311 | 2.6511 | 8 | 65 | positive regulation of blood circulation |
GO:0010717 | 0.0048 | 3.0538 | 3.2221 | 9 | 79 | regulation of epithelial to mesenchymal transition |
GO:0015820 | 0.0048 | 47.1863 | 0.1224 | 2 | 3 | leucine transport |
GO:0021524 | 0.0048 | 47.1863 | 0.1224 | 2 | 3 | visceral motor neuron differentiation |
GO:0021557 | 0.0048 | 47.1863 | 0.1224 | 2 | 3 | oculomotor nerve development |
GO:0033563 | 0.0048 | 47.1863 | 0.1224 | 2 | 3 | dorsal/ventral axon guidance |
GO:0034059 | 0.0048 | 47.1863 | 0.1224 | 2 | 3 | response to anoxia |
GO:0048936 | 0.0048 | 47.1863 | 0.1224 | 2 | 3 | peripheral nervous system neuron axonogenesis |
GO:0060221 | 0.0048 | 47.1863 | 0.1224 | 2 | 3 | retinal rod cell differentiation |
GO:0060278 | 0.0048 | 47.1863 | 0.1224 | 2 | 3 | regulation of ovulation |
GO:0061364 | 0.0048 | 47.1863 | 0.1224 | 2 | 3 | apoptotic process involved in luteolysis |
GO:0070294 | 0.0048 | 47.1863 | 0.1224 | 2 | 3 | renal sodium ion absorption |
GO:1901079 | 0.0048 | 47.1863 | 0.1224 | 2 | 3 | positive regulation of relaxation of muscle |
GO:1904349 | 0.0048 | 47.1863 | 0.1224 | 2 | 3 | positive regulation of small intestine smooth muscle contraction |
GO:2000721 | 0.0048 | 47.1863 | 0.1224 | 2 | 3 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation |
GO:0086002 | 0.0049 | 5.1757 | 1.1359 | 5 | 28 | cardiac muscle cell action potential involved in contraction |
GO:0055082 | 0.005 | 1.5949 | 26.9599 | 41 | 661 | cellular chemical homeostasis |
GO:0021988 | 0.005 | 5.1464 | 1.142 | 5 | 28 | olfactory lobe development |
GO:0043114 | 0.005 | 5.1464 | 1.142 | 5 | 28 | regulation of vascular permeability |
GO:0048265 | 0.005 | 5.1464 | 1.142 | 5 | 28 | response to pain |
GO:0009790 | 0.005 | 1.5114 | 36.0961 | 52 | 885 | embryo development |
GO:0031344 | 0.0051 | 1.6724 | 21.3313 | 34 | 523 | regulation of cell projection organization |
GO:0021537 | 0.0051 | 2.1832 | 7.7817 | 16 | 192 | telencephalon development |
GO:0048762 | 0.0051 | 2.2492 | 7.0969 | 15 | 174 | mesenchymal cell differentiation |
GO:0048846 | 0.0053 | 6.7569 | 0.7342 | 4 | 18 | axon extension involved in axon guidance |
GO:2000505 | 0.0053 | 6.7569 | 0.7342 | 4 | 18 | regulation of energy homeostasis |
GO:0007612 | 0.0054 | 2.505 | 5.1391 | 12 | 126 | learning |
GO:0048468 | 0.0056 | 1.5047 | 36.3229 | 52 | 937 | cell development |
GO:0014013 | 0.0057 | 2.7634 | 3.9155 | 10 | 96 | regulation of gliogenesis |
GO:0045980 | 0.0057 | 3.2178 | 2.7327 | 8 | 67 | negative regulation of nucleotide metabolic process |
GO:0001941 | 0.0058 | 4.9316 | 1.1828 | 5 | 29 | postsynaptic membrane organization |
GO:0003203 | 0.0058 | 4.9316 | 1.1828 | 5 | 29 | endocardial cushion morphogenesis |
GO:0019098 | 0.0058 | 4.9316 | 1.1828 | 5 | 29 | reproductive behavior |
GO:0048736 | 0.0059 | 2.2844 | 6.5258 | 14 | 160 | appendage development |
GO:0046887 | 0.006 | 2.5898 | 4.5681 | 11 | 112 | positive regulation of hormone secretion |
GO:0001658 | 0.0061 | 3.5315 | 2.2025 | 7 | 54 | branching involved in ureteric bud morphogenesis |
GO:0060349 | 0.0061 | 2.9277 | 3.3445 | 9 | 82 | bone morphogenesis |
GO:0052652 | 0.0064 | 2.3446 | 5.914 | 13 | 145 | cyclic purine nucleotide metabolic process |
GO:0007210 | 0.0065 | 6.306 | 0.7749 | 4 | 19 | serotonin receptor signaling pathway |
GO:0035813 | 0.0065 | 6.306 | 0.7749 | 4 | 19 | regulation of renal sodium excretion |
GO:0021559 | 0.0065 | 10.1237 | 0.4079 | 3 | 10 | trigeminal nerve development |
GO:0030432 | 0.0065 | 10.1237 | 0.4079 | 3 | 10 | peristalsis |
GO:0086070 | 0.0065 | 10.1237 | 0.4079 | 3 | 10 | SA node cell to atrial cardiac muscle cell communication |
GO:0098719 | 0.0065 | 10.1237 | 0.4079 | 3 | 10 | sodium ion import across plasma membrane |
GO:0035773 | 0.0067 | 3.4577 | 2.2433 | 7 | 55 | insulin secretion involved in cellular response to glucose stimulus |
GO:0030501 | 0.0068 | 4.734 | 1.2236 | 5 | 30 | positive regulation of bone mineralization |
GO:0035115 | 0.0068 | 4.734 | 1.2236 | 5 | 30 | embryonic forelimb morphogenesis |
GO:0008015 | 0.0071 | 2.1011 | 8.0536 | 16 | 203 | blood circulation |
GO:0072009 | 0.0071 | 2.6697 | 4.0379 | 10 | 99 | nephron epithelium development |
GO:0010975 | 0.0071 | 1.7595 | 15.4989 | 26 | 380 | regulation of neuron projection development |
GO:0014070 | 0.0071 | 1.4985 | 34.2199 | 49 | 839 | response to organic cyclic compound |
GO:0030803 | 0.0076 | 3.8415 | 1.7538 | 6 | 43 | negative regulation of cyclic nucleotide biosynthetic process |
GO:0007601 | 0.0077 | 2.1402 | 7.4231 | 15 | 182 | visual perception |
GO:0022600 | 0.0077 | 2.8116 | 3.4669 | 9 | 85 | digestive system process |
GO:0060041 | 0.0077 | 2.3787 | 5.3838 | 12 | 132 | retina development in camera-type eye |
GO:0007200 | 0.0078 | 3.0343 | 2.8763 | 8 | 71 | phospholipase C-activating G-protein coupled receptor signaling pathway |
GO:0001569 | 0.0078 | 4.5516 | 1.2644 | 5 | 31 | branching involved in blood vessel morphogenesis |
GO:0046839 | 0.0078 | 4.5516 | 1.2644 | 5 | 31 | phospholipid dephosphorylation |
GO:0050801 | 0.0079 | 1.556 | 26.8783 | 40 | 659 | ion homeostasis |
GO:0007214 | 0.0079 | 5.9115 | 0.8157 | 4 | 20 | gamma-aminobutyric acid signaling pathway |
GO:0015874 | 0.0079 | 5.9115 | 0.8157 | 4 | 20 | norepinephrine transport |
GO:0033688 | 0.0079 | 5.9115 | 0.8157 | 4 | 20 | regulation of osteoblast proliferation |
GO:0051482 | 0.0079 | 5.9115 | 0.8157 | 4 | 20 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway |
GO:0051968 | 0.0079 | 5.9115 | 0.8157 | 4 | 20 | positive regulation of synaptic transmission, glutamatergic |
GO:0086012 | 0.0079 | 5.9115 | 0.8157 | 4 | 20 | membrane depolarization during cardiac muscle cell action potential |
GO:0007605 | 0.0082 | 2.3589 | 5.4246 | 12 | 133 | sensory perception of sound |
GO:0030030 | 0.0082 | 1.5196 | 30.2952 | 44 | 759 | cell projection organization |
GO:0003206 | 0.0083 | 2.4668 | 4.772 | 11 | 117 | cardiac chamber morphogenesis |
GO:0019935 | 0.0087 | 2.5821 | 4.1602 | 10 | 102 | cyclic-nucleotide-mediated signaling |
GO:0060379 | 0.0087 | 8.8576 | 0.4487 | 3 | 11 | cardiac muscle cell myoblast differentiation |
GO:0060452 | 0.0087 | 8.8576 | 0.4487 | 3 | 11 | positive regulation of cardiac muscle contraction |
GO:1905065 | 0.0087 | 8.8576 | 0.4487 | 3 | 11 | positive regulation of vascular smooth muscle cell differentiation |
GO:0035113 | 0.0088 | 2.4436 | 4.8128 | 11 | 118 | embryonic appendage morphogenesis |
GO:0098656 | 0.0089 | 1.9521 | 9.7072 | 18 | 238 | anion transmembrane transport |
GO:0007190 | 0.009 | 4.3827 | 1.3052 | 5 | 32 | activation of adenylate cyclase activity |
GO:1901381 | 0.009 | 4.3827 | 1.3052 | 5 | 32 | positive regulation of potassium ion transmembrane transport |
GO:0021872 | 0.009 | 3.2536 | 2.3656 | 7 | 58 | forebrain generation of neurons |
GO:0006814 | 0.0091 | 2.0393 | 8.2797 | 16 | 203 | sodium ion transport |
GO:0051937 | 0.0092 | 23.912 | 0.1611 | 2 | 4 | catecholamine transport |
GO:0007613 | 0.0093 | 2.5541 | 4.201 | 10 | 103 | memory |
GO:0010842 | 0.0094 | 5.5634 | 0.8565 | 4 | 21 | retina layer formation |
GO:0021952 | 0.0094 | 5.5634 | 0.8565 | 4 | 21 | central nervous system projection neuron axonogenesis |
GO:0007198 | 0.0094 | 23.5915 | 0.1631 | 2 | 4 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0021555 | 0.0094 | 23.5915 | 0.1631 | 2 | 4 | midbrain-hindbrain boundary morphogenesis |
GO:0021913 | 0.0094 | 23.5915 | 0.1631 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0032430 | 0.0094 | 23.5915 | 0.1631 | 2 | 4 | positive regulation of phospholipase A2 activity |
GO:0034287 | 0.0094 | 23.5915 | 0.1631 | 2 | 4 | detection of monosaccharide stimulus |
GO:0042420 | 0.0094 | 23.5915 | 0.1631 | 2 | 4 | dopamine catabolic process |
GO:0051414 | 0.0094 | 23.5915 | 0.1631 | 2 | 4 | response to cortisol |
GO:0051594 | 0.0094 | 23.5915 | 0.1631 | 2 | 4 | detection of glucose |
GO:0061056 | 0.0094 | 23.5915 | 0.1631 | 2 | 4 | sclerotome development |
GO:0071504 | 0.0094 | 23.5915 | 0.1631 | 2 | 4 | cellular response to heparin |
GO:0090244 | 0.0094 | 23.5915 | 0.1631 | 2 | 4 | Wnt signaling pathway involved in somitogenesis |
GO:0097118 | 0.0094 | 23.5915 | 0.1631 | 2 | 4 | neuroligin clustering involved in postsynaptic membrane assembly |
GO:0099638 | 0.0094 | 23.5915 | 0.1631 | 2 | 4 | endosome to plasma membrane protein transport |
GO:1901843 | 0.0094 | 23.5915 | 0.1631 | 2 | 4 | positive regulation of high voltage-gated calcium channel activity |
GO:0045761 | 0.0096 | 2.9195 | 2.9774 | 8 | 73 | regulation of adenylate cyclase activity |
GO:0051963 | 0.0096 | 2.9195 | 2.9774 | 8 | 73 | regulation of synapse assembly |
GO:0035282 | 0.0096 | 2.7042 | 3.5892 | 9 | 88 | segmentation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042393 | 0 | 4.0527 | 5.5622 | 20 | 179 | histone binding |
GO:0046982 | 0 | 2.6372 | 14.1385 | 34 | 455 | protein heterodimerization activity |
GO:0003723 | 2e-04 | 1.6365 | 49.6867 | 75 | 1599 | RNA binding |
GO:0019904 | 2e-04 | 2.0062 | 19.2035 | 36 | 618 | protein domain specific binding |
GO:0030676 | 7e-04 | 12.5716 | 0.435 | 4 | 14 | Rac guanyl-nucleotide exchange factor activity |
GO:0052650 | 0.0015 | 18.8232 | 0.2486 | 3 | 8 | NADP-retinol dehydrogenase activity |
GO:0004033 | 0.0036 | 7.3915 | 0.6525 | 4 | 21 | aldo-keto reductase (NADP) activity |
GO:0016493 | 0.0053 | 10.4545 | 0.3729 | 3 | 12 | C-C chemokine receptor activity |
GO:0050681 | 0.0054 | 4.9139 | 1.1497 | 5 | 37 | androgen receptor binding |
GO:0051575 | 0.0055 | 31.3112 | 0.1243 | 2 | 4 | 5'-deoxyribose-5-phosphate lyase activity |
GO:0016817 | 0.0064 | 1.6094 | 24.1131 | 37 | 776 | hydrolase activity, acting on acid anhydrides |
GO:0017111 | 0.0081 | 1.6043 | 22.8391 | 35 | 735 | nucleoside-triphosphatase activity |
GO:0004028 | 0.0091 | 20.8727 | 0.1554 | 2 | 5 | 3-chloroallyl aldehyde dehydrogenase activity |
GO:0003743 | 0.0094 | 4.2484 | 1.3051 | 5 | 42 | translation initiation factor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 0 | 2.6975 | 24.2933 | 58 | 617 | calcium ion binding |
GO:0022836 | 0 | 3.3109 | 11.2607 | 33 | 286 | gated channel activity |
GO:0022838 | 0 | 2.7323 | 15.0012 | 37 | 381 | substrate-specific channel activity |
GO:0022803 | 0 | 2.5873 | 16.1824 | 38 | 411 | passive transmembrane transporter activity |
GO:0004888 | 0 | 1.9542 | 40.4622 | 72 | 1031 | transmembrane signaling receptor activity |
GO:0004872 | 0 | 1.7976 | 51.8545 | 85 | 1317 | receptor activity |
GO:0030594 | 0 | 5.0458 | 3.268 | 14 | 83 | neurotransmitter receptor activity |
GO:0004871 | 0 | 1.7386 | 56.0281 | 89 | 1423 | signal transducer activity |
GO:0008201 | 0 | 3.5289 | 5.3941 | 17 | 137 | heparin binding |
GO:0042577 | 0 | 20.496 | 0.4331 | 5 | 11 | lipid phosphatase activity |
GO:0005244 | 1e-04 | 2.9979 | 6.9691 | 19 | 177 | voltage-gated ion channel activity |
GO:0008195 | 1e-04 | 15.3699 | 0.5119 | 5 | 13 | phosphatidate phosphatase activity |
GO:0005230 | 1e-04 | 4.8488 | 2.4018 | 10 | 61 | extracellular ligand-gated ion channel activity |
GO:0015075 | 2e-04 | 2.0198 | 19.0894 | 36 | 492 | ion transmembrane transporter activity |
GO:0005261 | 2e-04 | 2.836 | 6.9249 | 18 | 178 | cation channel activity |
GO:0005328 | 4e-04 | 10.2438 | 0.6693 | 5 | 17 | neurotransmitter:sodium symporter activity |
GO:0008013 | 4e-04 | 4.0511 | 2.7955 | 10 | 71 | beta-catenin binding |
GO:0048495 | 6e-04 | 36.778 | 0.1969 | 3 | 5 | Roundabout binding |
GO:0015079 | 8e-04 | 2.776 | 5.8666 | 15 | 149 | potassium ion transmembrane transporter activity |
GO:0016594 | 9e-04 | 12.275 | 0.4725 | 4 | 12 | glycine binding |
GO:0008188 | 0.001 | 5.0712 | 1.6143 | 7 | 41 | neuropeptide receptor activity |
GO:0086083 | 0.0011 | 24.5169 | 0.2362 | 3 | 6 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication |
GO:0004890 | 0.0013 | 10.9104 | 0.5119 | 4 | 13 | GABA-A receptor activity |
GO:0031005 | 0.0013 | 10.9104 | 0.5119 | 4 | 13 | filamin binding |
GO:0004063 | 0.0015 | Inf | 0.0787 | 2 | 2 | aryldialkylphosphatase activity |
GO:0008281 | 0.0015 | Inf | 0.0787 | 2 | 2 | sulfonylurea receptor activity |
GO:0036461 | 0.0015 | Inf | 0.0787 | 2 | 2 | BLOC-2 complex binding |
GO:0031406 | 0.0017 | 2.5457 | 6.3391 | 15 | 161 | carboxylic acid binding |
GO:0043169 | 0.0018 | 1.3173 | 146.1052 | 177 | 3733 | cation binding |
GO:0005004 | 0.0019 | 18.3864 | 0.2756 | 3 | 7 | GPI-linked ephrin receptor activity |
GO:0005262 | 0.0021 | 3.0194 | 3.9767 | 11 | 101 | calcium channel activity |
GO:0005249 | 0.0022 | 3.2058 | 3.4255 | 10 | 87 | voltage-gated potassium channel activity |
GO:0000981 | 0.0024 | 1.6514 | 27.4431 | 43 | 697 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
GO:0022890 | 0.0028 | 1.962 | 12.9331 | 24 | 333 | inorganic cation transmembrane transporter activity |
GO:0072509 | 0.0029 | 2.4926 | 6.0241 | 14 | 153 | divalent inorganic cation transmembrane transporter activity |
GO:0015081 | 0.0038 | 2.511 | 5.5516 | 13 | 141 | sodium ion transmembrane transporter activity |
GO:0008504 | 0.0045 | 49.1171 | 0.1178 | 2 | 3 | monoamine transmembrane transporter activity |
GO:0016934 | 0.0045 | 48.9577 | 0.1181 | 2 | 3 | extracellularly glycine-gated chloride channel activity |
GO:0035651 | 0.0045 | 48.9577 | 0.1181 | 2 | 3 | AP-3 adaptor complex binding |
GO:0060002 | 0.0045 | 48.9577 | 0.1181 | 2 | 3 | plus-end directed microfilament motor activity |
GO:0102007 | 0.0045 | 48.9577 | 0.1181 | 2 | 3 | acyl-L-homoserine-lactone lactonohydrolase activity |
GO:0022892 | 0.0051 | 1.4889 | 39.4913 | 56 | 1003 | substrate-specific transporter activity |
GO:0043565 | 0.0055 | 1.4974 | 37.1289 | 53 | 943 | sequence-specific DNA binding |
GO:0004993 | 0.0058 | 6.5435 | 0.7481 | 4 | 19 | G-protein coupled serotonin receptor activity |
GO:0022840 | 0.0058 | 6.5435 | 0.7481 | 4 | 19 | leak channel activity |
GO:0042578 | 0.0059 | 1.8613 | 12.9932 | 23 | 330 | phosphoric ester hydrolase activity |
GO:0035240 | 0.0059 | 10.5044 | 0.3937 | 3 | 10 | dopamine binding |
GO:0015276 | 0.0063 | 3.492 | 2.2154 | 7 | 57 | ligand-gated ion channel activity |
GO:0042562 | 0.0068 | 3.4446 | 2.2443 | 7 | 57 | hormone binding |
GO:0042923 | 0.007 | 6.1341 | 0.7875 | 4 | 20 | neuropeptide binding |
GO:0005160 | 0.0072 | 3.8815 | 1.7324 | 6 | 44 | transforming growth factor beta receptor binding |
GO:0008528 | 0.008 | 3.0131 | 2.8871 | 8 | 74 | G-protein coupled peptide receptor activity |
GO:0001537 | 0.0088 | 24.4772 | 0.1575 | 2 | 4 | N-acetylgalactosamine 4-O-sulfotransferase activity |
GO:0005329 | 0.0088 | 24.4772 | 0.1575 | 2 | 4 | dopamine transmembrane transporter activity |
GO:0035650 | 0.0088 | 24.4772 | 0.1575 | 2 | 4 | AP-1 adaptor complex binding |
GO:0047961 | 0.0088 | 24.4772 | 0.1575 | 2 | 4 | glycine N-acyltransferase activity |
GO:0086007 | 0.0088 | 24.4772 | 0.1575 | 2 | 4 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential |
GO:0004714 | 0.009 | 3.2489 | 2.3624 | 7 | 60 | transmembrane receptor protein tyrosine kinase activity |
GO:0008509 | 0.0095 | 1.898 | 10.5126 | 19 | 267 | anion transmembrane transporter activity |
GO:0043014 | 0.0099 | 5.4518 | 0.8662 | 4 | 22 | alpha-tubulin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007156 | 0 | 11.11 | 1.387 | 13 | 144 | homophilic cell adhesion via plasma membrane adhesion molecules |
GO:0007399 | 0 | 3.4024 | 13.4272 | 36 | 1540 | nervous system development |
GO:0007267 | 0 | 3.8378 | 8.1029 | 26 | 898 | cell-cell signaling |
GO:0098609 | 0 | 3.6198 | 6.9736 | 22 | 724 | cell-cell adhesion |
GO:0099537 | 0 | 4.028 | 5.365 | 19 | 557 | trans-synaptic signaling |
GO:0042755 | 0 | 21.2629 | 0.289 | 5 | 30 | eating behavior |
GO:0032502 | 0 | 2.0728 | 52.398 | 78 | 5440 | developmental process |
GO:0007275 | 0 | 2.1148 | 42.6014 | 67 | 4548 | multicellular organism development |
GO:0010720 | 0 | 3.9133 | 4.2573 | 15 | 442 | positive regulation of cell development |
GO:0050808 | 0 | 8.7548 | 0.8943 | 7 | 96 | synapse organization |
GO:0007420 | 1e-04 | 3.1895 | 5.9044 | 17 | 613 | brain development |
GO:0007155 | 1e-04 | 3.6339 | 4.2831 | 14 | 499 | cell adhesion |
GO:0051962 | 2e-04 | 3.6157 | 3.9355 | 13 | 414 | positive regulation of nervous system development |
GO:0007268 | 2e-04 | 4.4731 | 2.4412 | 10 | 265 | chemical synaptic transmission |
GO:0007218 | 3e-04 | 7.44 | 0.8861 | 6 | 92 | neuropeptide signaling pathway |
GO:0061364 | 3e-04 | 208.5035 | 0.0289 | 2 | 3 | apoptotic process involved in luteolysis |
GO:1904349 | 3e-04 | 208.5035 | 0.0289 | 2 | 3 | positive regulation of small intestine smooth muscle contraction |
GO:0021537 | 3e-04 | 4.6098 | 2.119 | 9 | 220 | telencephalon development |
GO:0031644 | 3e-04 | 9.1447 | 0.6068 | 5 | 63 | regulation of neurological system process |
GO:0015844 | 4e-04 | 8.9891 | 0.6164 | 5 | 64 | monoamine transport |
GO:0050767 | 4e-04 | 2.8442 | 6.1548 | 16 | 639 | regulation of neurogenesis |
GO:0051414 | 5e-04 | 104.2448 | 0.0385 | 2 | 4 | response to cortisol |
GO:0071504 | 5e-04 | 104.2448 | 0.0385 | 2 | 4 | cellular response to heparin |
GO:0045666 | 6e-04 | 3.7605 | 2.8703 | 10 | 298 | positive regulation of neuron differentiation |
GO:1905114 | 7e-04 | 2.9455 | 5.1627 | 14 | 536 | cell surface receptor signaling pathway involved in cell-cell signaling |
GO:0042391 | 8e-04 | 3.3948 | 3.4964 | 11 | 363 | regulation of membrane potential |
GO:0015874 | 9e-04 | 18.507 | 0.1926 | 3 | 20 | norepinephrine transport |
GO:0070100 | 9e-04 | 69.4918 | 0.0482 | 2 | 5 | negative regulation of chemokine-mediated signaling pathway |
GO:1904304 | 9e-04 | 69.4918 | 0.0482 | 2 | 5 | regulation of gastro-intestinal system smooth muscle contraction |
GO:0071398 | 9e-04 | 10.2875 | 0.4334 | 4 | 45 | cellular response to fatty acid |
GO:1900745 | 0.0012 | 16.5567 | 0.2119 | 3 | 22 | positive regulation of p38MAPK cascade |
GO:0048666 | 0.0013 | 2.3472 | 8.8518 | 19 | 919 | neuron development |
GO:0001964 | 0.0013 | 15.7278 | 0.2215 | 3 | 23 | startle response |
GO:0060079 | 0.0017 | 6.3031 | 0.8572 | 5 | 89 | excitatory postsynaptic potential |
GO:0007416 | 0.0018 | 5.0242 | 1.2811 | 6 | 133 | synapse assembly |
GO:0014827 | 0.0019 | 41.6895 | 0.0674 | 2 | 7 | intestine smooth muscle contraction |
GO:0035385 | 0.0019 | 41.6895 | 0.0674 | 2 | 7 | Roundabout signaling pathway |
GO:0008585 | 0.0019 | 6.0846 | 0.8861 | 5 | 92 | female gonad development |
GO:0016358 | 0.002 | 4.2462 | 1.7627 | 7 | 183 | dendrite development |
GO:0060560 | 0.002 | 4.2219 | 1.7723 | 7 | 184 | developmental growth involved in morphogenesis |
GO:0016339 | 0.0022 | 13.103 | 0.2601 | 3 | 27 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0010811 | 0.0026 | 5.6897 | 0.9439 | 5 | 98 | positive regulation of cell-substrate adhesion |
GO:0019098 | 0.0027 | 12.0934 | 0.2793 | 3 | 29 | reproductive behavior |
GO:0008354 | 0.0032 | 29.7742 | 0.0867 | 2 | 9 | germ cell migration |
GO:0038003 | 0.0032 | 29.7742 | 0.0867 | 2 | 9 | opioid receptor signaling pathway |
GO:0046877 | 0.0032 | 29.7742 | 0.0867 | 2 | 9 | regulation of saliva secretion |
GO:0032990 | 0.0033 | 2.5519 | 5.4613 | 13 | 567 | cell part morphogenesis |
GO:0008366 | 0.0033 | 5.3427 | 1.0017 | 5 | 104 | axon ensheathment |
GO:0045987 | 0.0035 | 10.8402 | 0.3082 | 3 | 32 | positive regulation of smooth muscle contraction |
GO:0050919 | 0.0035 | 10.8402 | 0.3082 | 3 | 32 | negative chemotaxis |
GO:0045687 | 0.0039 | 10.4782 | 0.3179 | 3 | 33 | positive regulation of glial cell differentiation |
GO:0046660 | 0.0039 | 5.1338 | 1.0403 | 5 | 108 | female sex differentiation |
GO:0030432 | 0.0039 | 26.0507 | 0.0963 | 2 | 10 | peristalsis |
GO:0098719 | 0.0039 | 26.0507 | 0.0963 | 2 | 10 | sodium ion import across plasma membrane |
GO:0021953 | 0.0043 | 4.1907 | 1.5219 | 6 | 158 | central nervous system neuron differentiation |
GO:0048699 | 0.0046 | 2.4578 | 5.6916 | 13 | 636 | generation of neurons |
GO:0021521 | 0.0048 | 23.1546 | 0.106 | 2 | 11 | ventral spinal cord interneuron specification |
GO:0031643 | 0.0048 | 23.1546 | 0.106 | 2 | 11 | positive regulation of myelination |
GO:0000904 | 0.0051 | 2.4157 | 5.7503 | 13 | 597 | cell morphogenesis involved in differentiation |
GO:0050803 | 0.0053 | 4.7613 | 1.1173 | 5 | 116 | regulation of synapse structure or activity |
GO:0051932 | 0.0054 | 9.243 | 0.3564 | 3 | 37 | synaptic transmission, GABAergic |
GO:0032354 | 0.0057 | 20.8378 | 0.1156 | 2 | 12 | response to follicle-stimulating hormone |
GO:0033605 | 0.0057 | 20.8378 | 0.1156 | 2 | 12 | positive regulation of catecholamine secretion |
GO:0097067 | 0.0057 | 20.8378 | 0.1156 | 2 | 12 | cellular response to thyroid hormone stimulus |
GO:0050804 | 0.0065 | 3.0733 | 2.7547 | 8 | 286 | modulation of chemical synaptic transmission |
GO:0120039 | 0.0066 | 2.4241 | 5.2687 | 12 | 547 | plasma membrane bounded cell projection morphogenesis |
GO:0035112 | 0.0067 | 18.9421 | 0.1252 | 2 | 13 | genitalia morphogenesis |
GO:0097106 | 0.0067 | 18.9421 | 0.1252 | 2 | 13 | postsynaptic density organization |
GO:0010717 | 0.0071 | 5.611 | 0.7609 | 4 | 79 | regulation of epithelial to mesenchymal transition |
GO:0007626 | 0.0074 | 3.7203 | 1.7049 | 6 | 177 | locomotory behavior |
GO:0048588 | 0.0074 | 3.7203 | 1.7049 | 6 | 177 | developmental cell growth |
GO:0048644 | 0.0074 | 5.5368 | 0.7706 | 4 | 80 | muscle organ morphogenesis |
GO:0007157 | 0.0076 | 8.0553 | 0.4045 | 3 | 42 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
GO:0030534 | 0.0077 | 4.3287 | 1.2233 | 5 | 127 | adult behavior |
GO:0042711 | 0.0078 | 17.3625 | 0.1348 | 2 | 14 | maternal behavior |
GO:0030111 | 0.0081 | 2.9541 | 2.8607 | 8 | 297 | regulation of Wnt signaling pathway |
GO:0055123 | 0.0082 | 4.2584 | 1.2425 | 5 | 129 | digestive system development |
GO:0040012 | 0.0082 | 2.1333 | 7.513 | 15 | 780 | regulation of locomotion |
GO:0030198 | 0.0084 | 2.9334 | 2.88 | 8 | 299 | extracellular matrix organization |
GO:0120036 | 0.0088 | 1.8784 | 12.0785 | 21 | 1254 | plasma membrane bounded cell projection organization |
GO:0007379 | 0.0089 | 16.0258 | 0.1445 | 2 | 15 | segment specification |
GO:0022010 | 0.0089 | 16.0258 | 0.1445 | 2 | 15 | central nervous system myelination |
GO:0044849 | 0.0089 | 16.0258 | 0.1445 | 2 | 15 | estrous cycle |
GO:0060457 | 0.0089 | 16.0258 | 0.1445 | 2 | 15 | negative regulation of digestive system process |
GO:0060581 | 0.0089 | 16.0258 | 0.1445 | 2 | 15 | cell fate commitment involved in pattern specification |
GO:0071380 | 0.0089 | 16.0258 | 0.1445 | 2 | 15 | cellular response to prostaglandin E stimulus |
GO:1902001 | 0.0089 | 16.0258 | 0.1445 | 2 | 15 | fatty acid transmembrane transport |
GO:0032970 | 0.0091 | 2.8928 | 2.9185 | 8 | 303 | regulation of actin filament-based process |
GO:0042698 | 0.0091 | 5.1988 | 0.8177 | 4 | 86 | ovulation cycle |
GO:0007160 | 0.0093 | 3.5321 | 1.7916 | 6 | 186 | cell-matrix adhesion |
GO:0051048 | 0.0093 | 3.5321 | 1.7916 | 6 | 186 | negative regulation of secretion |
GO:0007605 | 0.0093 | 4.1242 | 1.2811 | 5 | 133 | sensory perception of sound |
GO:0001979 | 0.0096 | Inf | 0.0096 | 1 | 1 | regulation of systemic arterial blood pressure by chemoreceptor signaling |
GO:0003029 | 0.0096 | Inf | 0.0096 | 1 | 1 | detection of hypoxic conditions in blood by carotid body chemoreceptor signaling |
GO:0006062 | 0.0096 | Inf | 0.0096 | 1 | 1 | sorbitol catabolic process |
GO:0019519 | 0.0096 | Inf | 0.0096 | 1 | 1 | pentitol metabolic process |
GO:0021972 | 0.0096 | Inf | 0.0096 | 1 | 1 | corticospinal neuron axon guidance through spinal cord |
GO:0036321 | 0.0096 | Inf | 0.0096 | 1 | 1 | ghrelin secretion |
GO:0042404 | 0.0096 | Inf | 0.0096 | 1 | 1 | thyroid hormone catabolic process |
GO:0044328 | 0.0096 | Inf | 0.0096 | 1 | 1 | canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration |
GO:0044329 | 0.0096 | Inf | 0.0096 | 1 | 1 | canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion |
GO:0044330 | 0.0096 | Inf | 0.0096 | 1 | 1 | canonical Wnt signaling pathway involved in positive regulation of wound healing |
GO:0044345 | 0.0096 | Inf | 0.0096 | 1 | 1 | stromal-epithelial cell signaling involved in prostate gland development |
GO:0050929 | 0.0096 | Inf | 0.0096 | 1 | 1 | induction of negative chemotaxis |
GO:0051042 | 0.0096 | Inf | 0.0096 | 1 | 1 | negative regulation of calcium-independent cell-cell adhesion |
GO:0051160 | 0.0096 | Inf | 0.0096 | 1 | 1 | L-xylitol catabolic process |
GO:0051615 | 0.0096 | Inf | 0.0096 | 1 | 1 | histamine uptake |
GO:0060804 | 0.0096 | Inf | 0.0096 | 1 | 1 | positive regulation of Wnt signaling pathway by BMP signaling pathway |
GO:0090024 | 0.0096 | Inf | 0.0096 | 1 | 1 | negative regulation of neutrophil chemotaxis |
GO:0090246 | 0.0096 | Inf | 0.0096 | 1 | 1 | convergent extension involved in somitogenesis |
GO:0097326 | 0.0096 | Inf | 0.0096 | 1 | 1 | melanocyte adhesion |
GO:0120063 | 0.0096 | Inf | 0.0096 | 1 | 1 | stomach smooth muscle contraction |
GO:0120064 | 0.0096 | Inf | 0.0096 | 1 | 1 | stomach pylorus smooth muscle contraction |
GO:0120072 | 0.0096 | Inf | 0.0096 | 1 | 1 | positive regulation of pyloric antrum smooth muscle contraction |
GO:1901950 | 0.0096 | Inf | 0.0096 | 1 | 1 | dense core granule transport |
GO:1903937 | 0.0096 | Inf | 0.0096 | 1 | 1 | response to acrylamide |
GO:1904328 | 0.0096 | Inf | 0.0096 | 1 | 1 | regulation of myofibroblast contraction |
GO:1904343 | 0.0096 | Inf | 0.0096 | 1 | 1 | positive regulation of colon smooth muscle contraction |
GO:1904425 | 0.0096 | Inf | 0.0096 | 1 | 1 | negative regulation of GTP binding |
GO:1990048 | 0.0096 | Inf | 0.0096 | 1 | 1 | anterograde neuronal dense core vesicle transport |
GO:1990708 | 0.0096 | Inf | 0.0096 | 1 | 1 | conditioned place preference |
GO:2000080 | 0.0096 | Inf | 0.0096 | 1 | 1 | negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation |
GO:0034220 | 0.0097 | 1.994 | 9.1311 | 17 | 948 | ion transmembrane transport |
GO:0009952 | 0.0097 | 3.4928 | 1.8108 | 6 | 188 | anterior/posterior pattern specification |
GO:0030514 | 0.0098 | 7.304 | 0.4431 | 3 | 46 | negative regulation of BMP signaling pathway |
GO:0048675 | 0.0099 | 5.0674 | 0.838 | 4 | 87 | axon extension |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008035 | 9e-04 | 60.1205 | 0.0451 | 2 | 8 | high-density lipoprotein particle binding |
GO:0016493 | 0.002 | 36.0627 | 0.0677 | 2 | 12 | C-C chemokine receptor activity |
GO:0018455 | 0.0056 | Inf | 0.0056 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
GO:0035438 | 0.0056 | Inf | 0.0056 | 1 | 1 | cyclic-di-GMP binding |
GO:0035478 | 0.0056 | Inf | 0.0056 | 1 | 1 | chylomicron binding |
GO:0042497 | 0.0056 | Inf | 0.0056 | 1 | 1 | triacyl lipopeptide binding |
GO:0061507 | 0.0056 | Inf | 0.0056 | 1 | 1 | cyclic-GMP-AMP binding |
GO:0098621 | 0.0056 | Inf | 0.0056 | 1 | 1 | phosphoseryl-selenocysteinyl-tRNA selenium transferase activity |
GO:0071814 | 0.0062 | 18.9689 | 0.1185 | 2 | 21 | protein-lipid complex binding |
GO:0004181 | 0.0068 | 18.0193 | 0.1242 | 2 | 22 | metallocarboxypeptidase activity |
GO:0030371 | 0.0074 | 17.1601 | 0.1298 | 2 | 23 | translation repressor activity |
GO:0001637 | 0.008 | 16.379 | 0.1354 | 2 | 24 | G-protein coupled chemoattractant receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 0 | 4.5277 | 5.6944 | 22 | 617 | calcium ion binding |
GO:0001653 | 1e-04 | 7.2068 | 1.0706 | 7 | 116 | peptide receptor activity |
GO:0019903 | 4e-04 | 6.7546 | 0.9691 | 6 | 105 | protein phosphatase binding |
GO:0005237 | 5e-04 | 108.9051 | 0.0369 | 2 | 4 | inhibitory extracellular ligand-gated ion channel activity |
GO:0043237 | 8e-04 | 72.5985 | 0.0461 | 2 | 5 | laminin-1 binding |
GO:0048495 | 8e-04 | 72.5985 | 0.0461 | 2 | 5 | Roundabout binding |
GO:0008504 | 0.0017 | 43.5533 | 0.0646 | 2 | 7 | monoamine transmembrane transporter activity |
GO:0015386 | 0.0023 | 36.292 | 0.0738 | 2 | 8 | potassium:proton antiporter activity |
GO:0043169 | 0.0027 | 1.6971 | 33.9837 | 49 | 3733 | cation binding |
GO:0015385 | 0.0029 | 31.1053 | 0.0831 | 2 | 9 | sodium:proton antiporter activity |
GO:0045294 | 0.0029 | 31.1053 | 0.0831 | 2 | 9 | alpha-catenin binding |
GO:0005201 | 0.0032 | 7.1016 | 0.6091 | 4 | 66 | extracellular matrix structural constituent |
GO:0042577 | 0.0044 | 24.1898 | 0.1015 | 2 | 11 | lipid phosphatase activity |
GO:0016594 | 0.0053 | 21.7693 | 0.1107 | 2 | 12 | glycine binding |
GO:0004871 | 0.0055 | 1.9151 | 13.1331 | 23 | 1423 | signal transducer activity |
GO:0008195 | 0.0062 | 19.789 | 0.12 | 2 | 13 | phosphatidate phosphatase activity |
GO:0005231 | 0.0063 | 8.6401 | 0.3784 | 3 | 41 | excitatory extracellular ligand-gated ion channel activity |
GO:0008188 | 0.0063 | 8.6401 | 0.3784 | 3 | 41 | neuropeptide receptor activity |
GO:0008324 | 0.0076 | 2.3835 | 5.3621 | 12 | 581 | cation transmembrane transporter activity |
GO:0015299 | 0.0082 | 16.7423 | 0.1384 | 2 | 15 | solute:proton antiporter activity |
GO:0022857 | 0.0084 | 2.0782 | 8.2601 | 16 | 895 | transmembrane transporter activity |
GO:0050840 | 0.0087 | 7.6329 | 0.4245 | 3 | 46 | extracellular matrix binding |
GO:0001616 | 0.0092 | Inf | 0.0092 | 1 | 1 | growth hormone secretagogue receptor activity |
GO:0003939 | 0.0092 | Inf | 0.0092 | 1 | 1 | L-iditol 2-dehydrogenase activity |
GO:0004419 | 0.0092 | Inf | 0.0092 | 1 | 1 | hydroxymethylglutaryl-CoA lyase activity |
GO:0004990 | 0.0092 | Inf | 0.0092 | 1 | 1 | oxytocin receptor activity |
GO:0005020 | 0.0092 | Inf | 0.0092 | 1 | 1 | stem cell factor receptor activity |
GO:0005334 | 0.0092 | Inf | 0.0092 | 1 | 1 | norepinephrine:sodium symporter activity |
GO:0033798 | 0.0092 | Inf | 0.0092 | 1 | 1 | thyroxine 5-deiodinase activity |
GO:0038046 | 0.0092 | Inf | 0.0092 | 1 | 1 | enkephalin receptor activity |
GO:0038048 | 0.0092 | Inf | 0.0092 | 1 | 1 | dynorphin receptor activity |
GO:0046526 | 0.0092 | Inf | 0.0092 | 1 | 1 | D-xylulose reductase activity |
GO:0099600 | 0.0098 | 1.9553 | 9.9029 | 18 | 1073 | transmembrane receptor activity |
No LOLA Enrichment Analysis was conducted